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ABSTRACT 
Lanthanide luminescence and in particular sensitised emission from both europium 
(III) and terbium (III) is reviewed. The use of both europlum and terbium as 
biological markers is covered, concentrating on time-resolved fl uoroimm uno assays 
(TR-FIA), and more recently nucleic acid hybridisation assays. 
A new approach is described for the design of cooperative ligands that enhance 
europium luminescence in aqueous solution. This involves a three-component system 
comprised of the europium. ion, a sensitising ligand, 1,10-Phenanthroline-2,9- 
biscarboxylic acid, and a separate non-sensitising ligand, N-(butylacetamido)- 
ethyl enediamine-N, N, N'-tri acetate. 
The synthesis of a novel class of europium sensitiser is described 5- 
(Hexanoylphenanthridinium)-2,9-biscarboxylic acid- 1,1 O-phenanthroline. 
A homogeneous method for identifying the presence of a single strand of DNA is 
described which employs 5-(Hexanoylphenanthridinium)-2,9-biscarboxylic acid- 1,10- 
phenanthroline as a cooperative sensitiser of europium (M) luminescence. 
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1.1 INTRODUCTION 
Advances in molecular biology and biotechnology are creating exciting possibilities for 
DNA diagnostics'-the analysis of disease at the nucleic acid level. These developments will 
profoundly alter many aspects of modem medicine. 
DNA probes are an attractive target for clinical diagnosis. They can be used to detect DNA 
sequences in a wide range of pathogenic organisms such as viruses (Hepatitis B, Herpes 
and IHV), and bacteria (Chlamydia)(Table 1.1); the presence of gene sequences associated 
with genetic diseases (cystic fibrosis, sickle cell anaemia); to establish the identity of a 
particular person in crime cases and paternity disputes (genetic fingerprinting) and to test 
for mutation, activation, amplification, and the expression of oncogenes. 
In the future, the availability of the complete sequence of the human genome should make 
it possible to identify all human genes; the accompanying complete physical map of the 
2 human genome will serve as the ulfimate source of DNA probes for any human gene. 
Table 1.1 Infectious organisms detected by DNA probes' 
Viruses I Bacteria Others 
Hepatitis B Escherichia coli Trypanosoma 
Hepatitis A I Shigella Plasmodium sp. 
Cytomegalovirus Salmonella Chlamydia 
AA "', ,, denoviruses Legionella Candida 
Herpes simplex Campylobacter 
Measles Mobiluncus 
Epstein-Barr Staphylococcus a. 
Enteroviruses 
Varicella zoster 
Human papilloma 
Rotavirus 
HTLVI 
HIV 
Papoviruses 
Rubella 
I 
Although there are plenty of applications for DNA probe tests the big challenge has been 
turning the basic concept into a commercial reality, and making the transition from a 
specialised research technique to a clinical tool. Obtaining suitable complementary DNA 
sequences and reagents'is fairly easy. The DNA sequence for a number of bacteria and 
viruses have been published and can be used to design an appropriate complementary 
probe. The specificity of a strand of DNA for alarget molecule varies with the length of 
the strand". Most useful probes need only be 20-50 bases long to avoid mismatches and 
such DNA strands can easily be made with the new generation of DNA synthesisers. 
The difficult part has been in finding a sensitive detection method. In the past researchers 
have generally opted for radioisotopic markers but because of the cost, short half-life and 
health hazards associated with the commonly used radionuclides, major efforts are under 
way to develop alternatives based on non-isotopic detection systems. DNA probes can be 
labelled with fluorescent or chemiluminescent molecules, or attached to an enzyme that can 
be used to generate a large number of coloured molecules. All of the DNA probe tests 
currently on the market are based on a heterogeneous assay design and use one or more 
of the detection labels described above. They are all labour intensive, and not very easy 
to use. This has hindered their transition from specialised testing to routine clinical use. 
The ideal would be completely automated DNA probe tests, which could be used in 
hospitals where rapid testing of a large number of samples is required, in small clinical 
laboratories and even the doctor's office. For this to occur there has to be a shift from the 
two-phase heterogeneous assay system. In heterogeneous assays the nucleic acid material 
being investigated is immobilised on a solid matrix and then incubated in individual steps 
(pre-hybridisation, hybridisation with the reagent probe, washing and detection) with 
various solutions. Homogeneous assay conditions would make the pre-hybridisation and 
washing steps superfluous and would eliminate the need for a solid support. This 
appreciable simplification would lend itself to the development of automated procedures. 
2 
The development of a single-phase homogeneous DNA assay is thus a real commercial 
target. However such homogeneous assays have been few and far between. The difficulty 
has been in determining the difference between single stranded and hybridised probes in 
solution. This will require the design of a signalling system that will exploit the 
characteristics of the duplex, to give a measurable signal only after hybrid formation with 
the complementary sequence has taken place. 
Potentially, fluorescence resonance energy transfer (FRET) may provide a practical basis 
for a homogeneous hybridisation assay'. In one format, two probes binding to adjacent 
sequences on a target nucleic acid contained fluorescein and rhodamine, respectively. When 
both probes are bound, fluorescein emission was quenched and rhodamine emission 
enhanced (Figure 1.1)6,7 . 
However, this approach suffers from a lack of sensitivity due to 
high background problem that afflicts most fluorescent labels. 
Several approaches have been described that attempt to overcome the background problem 
with fluorescence detection. The most significant of these are those employing labels which 
have delayed (long-lived) luminescence, namely lanthanide metal chelates. Over the last 
ten years lanthanide chelates (europium and terbium) have become the labels of choice in 
fluorescence immunoassays and recently in DNA hybridisation assays. This has not been 
by accident but has been as a result of the unique photophysical properties of certain 
members of the lanthanides. This review will cover the literature of lanthanide chelates as 
luminescent probes and markers. 
Energy transfer fluorescence 
RFI 
3ý 
Hybridise 
lop 
Figure 1.1 A homogeneous DNA assay based on energy transfer 
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1.2 USE OF LANTHANYDES IN LUMINESCENT PROBES 
Lanthanide luminescent probes are presently extensively used to solve a variety of 
structural and analytical problems. This includes the determination of the local structures 
in crystalline materials and glasses. Isomorphous substi I of Ca(II) or Zn(11) by 
lanthanide ions help the investigation of metal-binding sites in biological materials: the 
number of these sites and their chemical composition as well as the number of metal- 
bonded water molecules can be assessed by this method. Trivalent lanthanide probes also 
facilitate the study of the effects of chemical and thermal treatment on catalysts. They are 
also used in the analysis of inorganic anions and cations and in the development of 
immunoassays having a sensitivity comparable to that of radioisotopic methods. The 
various applications of lanthanide luminescent probes are summarised in Table 1.2, together 
with a list of the relevant review articles. 
Table 1.2 Luminescent lanthanide probes: Applications and recent reviews 
Applications Probe Refs. 
Detem-lination of local symmetries incrystalline inorganic Ln3+ 8 
. le material. 
Detern-lination of local structure in inorganic glasses by laser Ln 
3+ 9-10 
spectroscopy 
Probing the structure of biological molecules (Ca-binding sites) 
EU3+ 11-15 
ri, b3+ 
Catalysts: coordination environments, changes upon thermal Ln3+ 16 
and chemical treatments, oxidation state changes 
Analysis of inorganic anions and cations by SEPEL (selectively Eu' 17 
excited probe ion luminescence) 
Er3+ 
Ho' 
Immuno/DNA hybridisation assays using lanthanide probes and Eu 
3+ 18-20 
time-resolve, d fluorescence I rib3+ 
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1.2.1 Lanthanide Complexes and Spectroscopic Properties 
Most metal ion complexes absorb visible and/or UV radiation, however, very few re-emit 
even a small fraction of the absorbed energy in the form of UV or visible photons. This 
situation is a consequence of the facile non-radiative deexcitation pathways that compete 
efficiently With radiative modes. The lack of many luminescent complexes of transition 
metal complexes is a result of the strong coupling of their d-electron excited states With 
the environment (e. g water molecules) via the ligand field which provides an efficient de- 
excitation mechanism, 
On the other hand, all of the trivalent lanthanide ions, symbolically Ln(HI), are known to 
luminesce, particularly in the solid state under anhydrous conditions. This property is also 
shown by their complexes and is due to fact that the low energy excited states originate 
from the 4f' configurations. 
The basic excited-state properties of lanthanide ions have been extensively described in 
many monographs. ", ", " 
24 
All 14 lanthanides have the same number of electrons in their outer shell. Their differences 
lie deep within their electronic cores, far from the hurly-burly of chemical reactions. 
(Table 1.3) 
Table 1.3 Ground state electronic configurations of the lanthanides 
Element Lno Ln'* 
Lanthanum (La) 
I 
5d16S2 
- 4V 
Cerium (Ce) 4f5d'6S2 4V 
Praseodymium (Pr) 4f"6s 02 
Neodymium (Nd) M46S2 4f' 
Promethium (Pm) 0 6s2 4f' 
Samarium (SM) 4f6s2 4f" 
Europium (Eu) 4f6S2 4f6 
Gadolinfum (Gd) .jIz -2 4f5d os 41C 
Terbium (Th) 4f96s2 4f* 
Dysprosium (Dy) 4fo6s2 09 
Holmium (Ho) 006S2 4VO 
Erblum (Er) 4P26s2 401 
Tbulium (Tm) 03 6s2 402 
Ytterbium (Yb) 4f44 6S2 03 
Lutetium (Lu) 04 5d'6s2 404 
5 
The lanthanide elements are associated with the progressive filling of the 4f-electronic sub- 
shell. The energy of the 4f eigen function drops suddenly at the beginning of the serles, 
which means their maximum lies inside the 5s'5p' closed subshells of the xenon structure. 
The 4f orbitals of a lanthanide cation are thus shielded from the effects of its immediate 
environment (surrounding anions and dipolar molecules) by the outer s and p orbitals and 
are minimally involved in bonding. This results in minimal pertubation of electronic 
transitions between the energy levels of these f orbitals. As a consequence radiationless 
deactivation processess in Ln(III) are relatively inefficient, and the emission of radiation 
as luminescence is able to compete in many instances. The important characteristics of 
lanthanide ion luminescence, namely the long radiative lifetimes and line-like emission 
bands, in contrast to the broad d-d absorption bands of the transition elements, makes these 
ions unique among the species that are known to luminesce. 
The energy of the 4f' electronic configuration of a lanthanide ion is determined by a 
combination of inter-electronic repulsion (electrostatic interaction), spin-orbit coupling and, 
in a coordination environment, the ligand field (Figure 1.2). 25 
103CM-1 
L. F 102CM-1 
7Fj=0-6 
Figure 1.2 Splitting of the 4f6electronic configuration 
of Eu3+ ion owing to electronic interaction, 
spin-orbit coupling, and ligand field, 
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The intensities of the f-ýf absorption spectra can be explained by the Judd-Ofelt theory. 2' 
Electric dipole transitions between 4f levels, involving no change in parity are forbidden 
by the Laporte rule and only occur because of interaction with the ligand field causes 
mixing of electronic states, the so-called J-mixing". The transitions between these modified 
states are called forced (or induced) electric dipole transitions. Although these 
admixtures make transitions possible the consequences are f--*f transitions which are both 
weak in absorption and emission. The probability of such transitions is so low that molar 
extinction coefficients are of the order of I (weak absorption bands) and radiative lifetimes 
of the excited state are in the millisecond timescale. " This behaviour contrasts sharply with 
organic fluorescent molecules where molar extinction coefficients of tens of thousands and 
radiative lifetimes in the nanosecond range are common. 
Basic to the understanding of any Ln(III) luminescence experiment is the appropriate 
energy level diagram. Figure 1.31' shows the energy levels of the five central members: 
Sm(IH), Eu(EII), Gd(RI), Tb(HI) and Dy(HI). 
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Figure 1.3 Principle emission lines of certain lanthanides. 
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The remaining members rarely luminesce except in the solid state. The principal reasons 
for this is that there are no large gaps between potential emissive levels and acceptor levels 
of the ground manifold, These smaller energy level differences are efficiently bridged by 
non-radiative processes. The rate of radiationless de-excitation is a strong function of the 
energy gap. Both Eu(III) and Tb(III) have reasonably large energy gaps and emit relatively 
strongly in the visible region of the spectrum. The emission of the Eu" ion consists of 
transitions from the 'D manifold (mainly from the 'Do level) to the T manifold. (See 
Figure 1.3) 
The emissive levels of Eu" ('DO) and Th" ('D4) lie 17,250 cm-' (580 nm) and 20,500cm-' 
(488 nm) above the ground level. For Eu", the allowed transitions are 'D ()__ý7 F' 
2,4,6. The 
strongest emissions are observed in the 'Do--> 7 F, and 7 F2 transitions. The relative intensities 
of these two emissions are very sensitive to the detailed nature of the ligand environment, 
reflecting the hypersensitive character of 5DO-ý'F2. The 'Do-+ 7 FO, 3,5 transitions are strictly 
forbidden and emissions resulting from these are either weak or unobservable, see Table 
1.4. 
Table 1.4 Major characteristics of Tb' and EU3' emission intensity spectra for complexes in 
aqueous solution 
Fnsition 
Spectral 
region, 
nm. 
Relative 
Intensities 
Other characteristics 
Terbium 
5134-ý 7F6 485-500 med-strong moderate sensitivity to ligand 
environment 
-4 
7F5 540-555 stongest best probe transition 
--+7F4 580-595 medium moderate sensitivity to ligand 
environment 
7F3 615-625 med-weak some structuring under high 
resolution 
-4 
7F2 645-655 weak moderate sensitivity to ligand 
environment 
Europiurn 
5D 
0_47FO 578-580 weak nondegenerate transition: appears 
as a single sharp line 
-4 
7 F, 585-600 strongest sharp and structured under high 
resolution 
7F2 610-630 strongest intensitity exibits hypersensitivity 
to ligand environment 
7F3 645-660 weak always very weak 
7F4 680-705 weak intensity and structuring very 
sensitive to ligand environment 
8 
The generally low emission quantum yieldS28 and the fact that experimentally measured 
decay times are one or two orders of magnitude lower than the estimated radiative lifetimes 
timeS26 indicate that the decay of the emitting 5 Do state is mainly governed by non-radiative 
transitions. 
According to the theory of non-radiative transitions in lanthanide CoMpleXeS22,23 , 
29 the 
radiative relaxation between the various j states may occur by interaction of the electronic 
levels of the lanthanide ion with suitable vibrational modes of the environment. The 
efficiency of these processes depends on the energy gap between the ground and excited 
states and the vibrational energy of the oscillators. ", ", " 
The pronounced hard character of Eu` means it Will have a preferance for 'hard' bases. " 
Water molecules and hydroxide ions (OH-) are particularly strong ligands for Eu", so that 
water molecules are commonly coordinated to Eu" ions simultaneously with other ligands. 
When solvents containing O-H groups are coordinated to lanthanide ions, efficient non- 
radiative deactivation of the emitting 'Do level takes place via weak vibronic coupling with 
the vibrational states of the O-H oscillators . 
32 "' The consequences are that lanthanide 
luminescence is rarely observed in aqueous solution. If the O-H oscillators are replaced by 
low frequency O-D oscillators, the vibronic deactivation pathway becomes much less 
efficient32,31 (Figure 1.4). 
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Figure 1.4 Radiationless deexcitation of Eu(III) and Tb(III) ions 
by OH and OD oscillators. 
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The OH oscillators act independently and the rate of radiationless de-excitation is therefore 
directly proportional to the number of OH oscillators in the inner coordination sphere of 
the metal ion. The differences in the effects of H-. O versus D. 0 upon luminescence 
lifetimes can be exploited in determining the number of water molecules coordinated to 
Eu" or Th" in the presence of other ligands. Horrocks and Sudwick""' by carrying out 
experiments in H, O and D. 0 solutions have shown that for Eu" and Th" complexes, the 
number of coordinated water molecules n, is given with an estimated uncertainty of 0.5 by 
equation (1), where -CH20 and CD20 are the experimental excited-state lifetimes (in ms) in 
H20 and D., O solutions and q is 1.05 and 4.2 for Eu" and Tb" complexes respectively. 
The q values show that the vibronic coupling is more effective for the Eu" ion than for 
Tb", as expected on the basis of the energy gap between the ground and excited states. 
n=q 
(^rH2() 
TD20) 
............................. (1) 
The method has been applied to various aminopolycarboxylate complexes including EDTA, 
NTA, and BEDTA among others, as well as encapsulating ligands like the fuctionalised 
polyaza macrocycles (Figure 1.5). " 
This work is important in designing and evaluating new ligand systems to evaluate how 
effectively they exclude water from the the coordination sphere of Ln", which is necessary 
for Ln" luminescence. 
We can conclude that the coordination environment effects the luminescence intensity and 
lifetimes via the presence of (i) solvent molecules coordinated to the metal ion and (h) low 
lying short-lived excited states. Non-radiative losses can therefore be controlled by an 
appropriate choice of the coordination environment of the lanthanide ion. The luminescence 
intensity, in addition to depending on the competition between radiative and non-radiative 
deactivations is related to the efficiency of light absorption. 
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Ak= 1/TH2 - I/Trp 
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1.2.2 Coordination Properties of the Lanthanides 
All of the trivalent lanthanide ions Ln", share a number of common coordination 
properties. They can all be classified as type 'a' cations in the Ahrland, Chatt and Davies 
classification scheme", and as 'hard acids in the Pearson classification scheme. " The 
binding preference is O>N>S. It is also generally agreed that Ln" coordination occurs 
predominanatly via ionic bonding interactions, leading to a strong preferance for negatively 
charged donor groups that are also 'hard bases. Water molecules and hydroxide ions 
(OH-) are particularly strong Ln" ligands and in neutral to basic aqueous solution, only 
donor groups having negatively charged oxygens can bind sufficiently strongly to prevent 
Ln(OH)3 precipitation. Also , in aqueous solution, neutral oxygen or nitrogen ligands are 
only able to bind when present in multidentate ligands that contain at least one or two 
other donor groups having negatively charged oxygens. The results are that many 
lanthanide complexes are highly labile in aqueous solution. However, recent spectroscopic 
studies on the hexaazamacrocyclic (HAM) complex Eu(C22H26N6 )3+ (Figure 1.6) has shown 
this complex to be remarkably stable in aqueous solution even in the presence of a strong 
chelating agent diethylenetriaminepentaacetic acid (dtpa) or a competing metal ion (Y"). 37,38 
NN 
', IIIIEU ým 
3+ Figure 1.6 Structure of Eu(HAM) 
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The predominantly Ionic character of Ln" interactions and the relative low charge to ionic 
n3+ II anthanide radius ratios of L can account, in large part, for several additional aspects of I 
coordination chemistry. Firstly, there is little or no 'directionahty' in Ln'--ligand 
interactions so that primary coordination numbers and complex geometries are determined 
almost entirely by ligand characteristics, (conformational properties and the number, size 
and charged nature of donor groups). The most common coordination numbers exibited by 
Ln 3' are eight and nine. 12,21 In aqueous solution, the 'average' primary hydration numbers 
2 for Eu` and Th" in water are between eight and nine. 
1ý, 22,39 
In the lanthanides there are no strong directionality requirements by ligand field effects, the 
ligands arranging as best they can around the spherical surface of the cation. 
13 
1.3 THE ANTENNA EFFECT: SENSITISED EMISSION 
Even though both europium and terbium have some unique photophysical properties - 
strong luminescent and long-lived excited states - they are very poor light absorbers With 
very small absorption coefficients in the visible and UV spectral regions . 
22The strongest 
absorption band of Eu"aq in the near UV and visible region occurs at 393 nm with an 
extinction coefficient lower than 3M-cm-'. Therefore, to make use of the excellent emitting 
properties of these ions, one has to compensate for the difficulty in populating their excited 
states, for the lack of absorption bands. 
Weissman's 1942 paper 40 effectively launched the area of sensitissed emission from 
lanthanide chelates. Using the sun as a source of white radiation, he noticed that the 
absorption of UV light by a variety of salicylaldehyde and P-diketonate ligands resulted 
in emission lines characteristic of the f-f transitions of Eu" ion, to which these ligands 
were coordinated. This has recently been demonstrated as the antenna effeCt. 41 , 42,43,44 -n1S 
study and subsequent work demonstrated that sensitised emission from Eu(HI) and Tb(IH) 
ions arises from the metal ion from an intermolecular energy transfer process. The transfer 
process is fast (10'-10' s-') and takes place between the triplet state of the chelating ligand, 
populated through an intersystem crossing process to the Ln(III) ion emissive levels. In 
some cases, Ln(E11) levels higher than the emissive levels may be involved, but are 
depopulated via non-radiative processes. The complete mechanism published by Crosby et 
aL 45 is illustrated in Figure 1.7. In its simplest form, the model for the fluorescence of a 
rare earth chelate can be described as a sequence of four steps. 
14 
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Figure 1.7 Schematic representation of the radiative processes of the 
chelate leading to Eu3+ metal ion luminescence. 
(i) Excitation of the organic ligand from the ground singlet state S.. This excitation brings 
the molecule to one of the vibrational multiples of the excited state S,. The molecule 
rapidly loses its excess vibrational energy through some non-radiative deactivation process 
and falls to the lowest level of S1. 
(ii) Intersystem crossing within the excited ligand; energy is transferred from the singlet 
excited state to a triplet excited state of the ligand. 
(iii) Intramolecular energy transfer: energy is transferred from the triplet excited state of 
the ligand to the resonance levels of the Ln(1111) metal ion. This process has no parallel in 
either the fluorescence or phosphorescence of organic molecules. 
(iv) Radiative transition resulting in light emission from the metal ion (metal-ion 
fluorescence). 
Not all excited energy levels of the lanthanide ions, however, have this ability. Those that 
do, and are therefore responsible for the metal-Ion fluorescence, are generally designated 
as 'resonance levels'. 
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Each route leading to ion fluorescence meets strong competition from parallel radi 1 'ative and 
non-radiative deactivating transitions which have to be minimised for efficient ion 
fluorescence. 
Thus for the above series of events to be completed successfully, the following 
requirements must be fulfilled: 
(a) Non-radiative deactivating transitions and S, -->S(, and TI-+S, radiative transitions (ligand 
fluorescence and phosphorescence respectively), should be minimal. The excited triplet 
state of the ligand must have an appropriate lifetime, favouring energy transfer to the metal 
ion, rather than phosphoresence or thermal decay. 
(b) The energy of the ion resonance level should be close to, and preferably just below that 
of the triplet state of the ligand. In that case the probability of the triplet to resonance level 
transition, (T, -*D) is high. 
(c) Radiationless transitions of the excited metal ion should be low. 
From the vast number of studies carried out, there emerges a clear picture of the 
photophysical processes following ligand singlet excitation in Ln(III) complexes 
culminating in energy transfer to the emissive levels of the metal Ion via a ligand localised 
triplet state (Intra-molecular energy transfer). An alternative view espoused by Kleinerman" 
is that energy transfer from the excited singlet state, SI, to the metal ion can occur directly 
with rate constants of 1 0" sec-' or higher. However the much slower rates of ligand to 
Ln(III) ion energy transfer observed, of -10' sec-', are not consistent with this view and 
can only be explained by triplet level participation. 
If the chelate cannot be efficiently excited by a given wavelength directly, a triplet 
sensitiser (such as benzophenone) (BP) with a triplet level higher than the triplet level of 
the ligand and which can be excited by this particular wavelength of light is added to the 
system; after the sensitiser is excited EU3+ emission appears via intermolecular energy 
transfer. 47 
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Intermolecular sensitisation of Ln(III)B-diketonate complexes by 'triplet sensitisers' were 
first observed by Matowich and Suzuki", EI-Sayed and Bhaumik 49 in the early 1960's. In 
later studies it was shown that energy transfer from the triplet state of the sensitiser to the 
triplet level of the chelate ligand occurs by a collisional process . 
49 This transfer, which 
occurs at a rate greater than 106 sec-1, provides important confirmation of the role of the 
triplet level in the sensitisation of Ln(IH) chelate luminescence, for they show that the 
triplet level of the ligand is higher than Eu` ion excited levels, and the triplet level of the 
sensitiser is higher than the chelate ligands. These are the necessary conditions for energy 
transfer. 
The intensity of lanthanide ion fluorescence is mainly controlled by two important factors: 
first, the ability of the triplet state of the ligand to receive energy from the excited singlet 
state and to transfer it to the resonance level of the ion; second, the extent of non-radiative 
(quenching) of the excited state of the lanthanide chelate. These factors are influenced by 
the nature of the ion, the ligand, the ion-ligand bond, loosely attached adduct molecules, 
and the solvent. The influence of these different factors on fluorescence properties has been 
reviewed by Sinha. " The effect of the organic ligand on intramolecular energy transfer in 
europium and terbium chelates has been studied by Filipescu et aL" These extensive 
studies with various B-diketonate chelates of europium and terbium were an attempt to find 
some correlation between the structure of the ligand, the position of the triplet level and 
the intensity of the fluorescence. Although some correlation was found between the 
structure of the ligand and the position of the triplet level, no systematic trends were 
observed between these two parameters and the variation in fluorescence intensity. 
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What is evident from both studies is that the overall ligand-ion energy transfer governs the 
absorption and emission properties of the ion, and the correct ligand-lon combination has 
to be found for optimal fluorescence intensity, 
In general, it is difficult to predict theoretically which organic ligands will form fluorescent 
complexes with the lanthanides. Apart from the B-diketonates, semi -quantitative studies on 
the fluorescent properties of a number of aromatic complexes with lanthanide ions 
identified certain classes of ligands as sensifisers of Eu` and/or Tb". These ligands 
included the phenanthrolines, acetylene derivatives, five-membered heterocyclic rings, 
benzoic acid derivatives, biphenyl derivatives, pyridine derivatives, pyrimidine and pyrazine 
derivatives, di- and tripyndyl derivatives and quinoline derivatives. " 
Recently, Mukhala and Kankare" have described the synthesis and luminescent properties 
of 20 different 2,, 2'-bipyri dine derivatives chelated with Eu" or Th" ions (Figure 1.8) The 
purpose of the work was to study the influence of substituents on the luminescence 
properties, With the aim to enhance the relative luminescence yield and to develop 
lanthanide chelates suitable for immunoassays. 
X, 
N 
rNý 
CC)2H C02H 
(1) X=X=Y 
(2) X=4-NO2, Y=4'-Me 
(3) X=4-NO2, Y=H 
(4) X=4-NO2, Y=4'-NO2 
(5) X=4-EtO, Y=I-I 
(6) X=4-EtO, Y=4'-EtO 
(7) X=4-Br, Y=H 
(8) X=4-Br, Y=4'-Br 
(9) X=5-Br, Y=H 
(10) X=3-COOEt, Y=3'-COOEt 
IN 
rN) 
C02H C02H 
(11) X=4-COOH, Y=4'-COOH 
(12) X=3-PhCOOH, Y=3'-PhCOOH 
(13) X=4-Ph, Y=4-Ph 
(14) X=4-(4-MeOC6H4), Y=4'-(4-MeOC6H4) 
(15) X=4-(fur-2-yl), Y=4'-(fur-2-yl) 
(16) X=4-(PhCH=CH), Y=4'-(PhCH=CH) 
(17) X=Y=H, N, N'-dioxide 
(18) X=4-NH2, Y=H 
(19) X=3-COOH, Y=3'-COOH 
(20) X=3-OH, Y=3'-OH 
Figure 1.8 2,2-Bipyridine derivatives 
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The substituents at the b, pyr, dne moiety have a sgn, f effect on the luminescence icant 
properties: the best relative luminescence yields R were obtained for 11gands with electron- 
donating substituents (Me, Ph), with electron-wlthdrawlng substItuents (NO., COOH) 
having a reverse effect (Table 1.5). 
This is in agreement with the general observatons of Sinha and Filipescu. However, no 
clear correlation between the relative luminescence yields and the substituent parameters 
could be found. 
Table 1.5 Relative luminescence yields (logR), excitation maxima (k, and emission decay 
constants(kh, I)of the Europium(IH) and Terbium(III) chelates of 2,2', 2", 2"'-[(2,2'- 
B ipyridine- 6,6'-diyl)bi s- (methylenenitrilo)] tetrakis- (acetic acids) 1-20 
Substitution at Eu3' Tb' 
bipyridine 
LogR xlxc khel LogR k,: hel 
tI I 
[nml [ms-'] [ms-'] 
1 us t1tut unsubstituted 5.50 307 1.70 5.27 0.82 
2 4,4'-dimethyl 5.61 310 1.69 5.51 0.68 
3 4-nitro 4.12 328 1.87 2.94 0.71 
4 4,4'-dinitro 4.14 338 1.87 weak ...... ............... ............... .... 11.1 .............. 
5 4-ethoxy 5.33 298 1.72 5.31 0.62 
6 4,4'-diethoxy 5.11 290 1.80 5.13 0.67 
7 4-bromo 5.36 315 1.76 5.12 0.96 
8 4,4'-dibromo 5.31 310 1 . 86 5.02 1.33 
9 5'-bromo 4.16 32,0 1.77 4.50 1.37 
10 3,3'-bis(ethoxycarbonyl) 4.31 275 1.80 weak 
......................... ........... 
11 4,4-dicarboxy 4.42 325 1.71 3.54 1.59 
12 3,3'-bis(benzyloxy) 5.36 292 1.84 2.38 1.59 
13 4,4-diphenyl 5.52 325 1.73 5.18 1.12 
14 4,4'-bis(4-methoxyphenyl) 5.57 325 1.78 4.84 3.07 
15 4,4'-bis(fur-2-yl) 5.32 330 1.76 2.10 1.50 
16 4,4, -distyryl 2.95 315 1.75 2.63 1.11 
17 N, N'-dioxide 4.72 280 1.35 3.74 1.11 
18 4-amino 4.42 290 1.72 4.62 0.67 
19 3,3'-dicarboxy 4.90 283 1.74 1 2.23 1 0.63 
20 3,3'-dihydroxy 3.91 340 2.62 weak 
19 
Further work by Mukhala et al. 5' concentrated on the role of the aromatic ligand in 
sensitising lanthanide ion luminescence. Twelve different candidates containing six- 
membered N-heteroaromatic rings as the energy absorbing and transferring moieties were 
synthesised (Figure 1.9), and the relative luminescence yields, excitation maxima, and 
emission decay constants of their europium(HI) and terbium(III) chelates determined 
(Table 1.6). 
Table 1.6 Relative luminescence yields (logR), excitation maxima and emission 
decay constant (kchel) of the Europium(IH) and Terbium(III) chelates of 
ligands 21-32 
Ligand Parent aromatic 
sI tructur e logR kexc kchel LogR kxc kchel 
LP en 
[nm] [ms-'] [nm] [ms-'] 
[ 
t 
; 
21 pyrnidine 4.83 265 2.48 4.87 2.67 0.80 
22 isoquinoline 4.44 324 2.63 weak ........... ... .......... ................. .......... 
23 benz(f)isoquinoline 4.41 355 2.65 2.35 355 ........................ ....................... ............... ............ ................ ....................... 
24 acridine weak 
........... ..................... ............. 
weak 
............ .... .... 
............. ............ .... ............ ..... I ...... . 
............. ......... ........... ....... ...... ....................... ........................ 
25 2,2'-bipyridine 5.50 307 1.70 5.27 307 0.82 
26 3,3; 'biisoquinoline 5.33 330 2.75 weak 
.............. ... ..................... ............... ...... ............... .......... ... 
............ ... 
....................... ...................... ... . ........ . ....... ....... 
................ 
27 di(pyrid-2-yl)ketone 4.61 272 1.02 4.51 272 0.54 
28 2,2'-bipyrimidine 5.17 250 1.96 weak ................ ............... . ............. ........... 
29 4,4'-bipyrimidine 5.08 290 1.78 2.27 284 1.60 
30 1,8-naphthyridine 4.65 312 
1 
3.09 4.50 312 1.02 
31 1,1 0-phenanthroline 5.26 272 1.98 4.71 272 1.46 
32 2,2': 6', 2"-terpyridine 5.94 333 0.73 5.64 333 0.76 
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The results show the importance of the ligand having a triplet state of the right energy in 
relation to the resonance levels of the metal-ion. The triplet state of the ligand must lie 
above the resonance levels of the lanthanide (III) ion to enable energy transfer to take 
place. The triplet states of the acridine, isoquinoline, 3,3'-bis-isoquinoline, and 2,21- 
bipyrimidine ligands, 22,24,26,28 probably lie below the resonance level of the Tb" ion. 
These complexes show very weak luminescence. Also in spite of the higher conjugation 
of benzyl(f)lsoquinoline, compared to isoquinoline, ligand 23 has almost the same relative 
luminescence yield with Eu" ion as 22, while the Eu" chelate of the 3,, 3'-bis-isoquinoline 
derivative 26 luminesces nearly ten times stronger than the EU3+ chelate of ligand 22. 
Since kchel of the chelates of 22 and 26 are almo st the same, the difference in their relative 
yields is due to the aromatic part of the complexes. The relative luminescence yields are 
generally higher for EU3+ than for Tb'+ chelates of the ligands 21-32. 
The excitation wavelengths X, 
.,,, of chelates is also very important, and should 
be as high 
as possible; a high excitation wavelegth makes the selection of materials (strips, lenses, 
excitation sources, etc. ) for a bioaffinity assay more flexible. 
Continuing their systematic studies, Mukhala et aL" have investigated the influence of 
chelating groups on the luminescence properties of a number Eu" and Th" chelates of 2,2'- 
bipyridine (Figure 2.0). Their results based on relative luminescence yields and emission 
decay constants identified the (methylenenitrilo)bis(acefic acid) 36 and 
(methylenenitrilo)bls(methylphosphonic acid) 40 as suitable chelating groups. In faq, ligand 
40 appears to offer better protection to the lanthanide ion from the surrounding solvent, 
with calculations showing there are fewer H20 molecules coordinated to the lanthanide ion 
than in the corresponding carboxylate chelate 36. " This might be due to the bulkiness of 
the phosphonate groups. 16 Ligand 34 had the lowest luminescence both with Eu" and Tb" 
ions, probably due to the low chelating ability of the amide functions and their influence 
on the triplet state of the ligand. The use of trimethylene bridges between the acetic acid 
groups in ligand 37 make the chelating parts more rigid compared to the parent ligand 36. 
However, this is not reflected in the luminescence parameters. 
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in a move away from traditional N-heterocyclic ligands as sensitisers of lanthanide 
luminescence Shinkai et aL" report on lipophilic phenylphosphonic acids which are able 
to form stable complexes with Eu" and Th" ions which show strong luminescence,, 
quantum yields (0-- 0.25-0.30 for Th" and 0.09-0.13 for Eu") (Figure 2.1). 
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Results of studies carried out in methanol/acetonitrile between the lanthanide complexes 
of ligands which have a chromophoric benzene ring 41,44,45,46 and those ligands which 
have no aryl group 42 and 43 indicates that emission of Tb` and Eu` luminescence is 
induced by an energy-transfer mechanism (sensitisation) (Figure 2.2). 57 
All the ligands form 1: 3 metal/lIgand complexes which ensures considerable encapsulation 
of the metal ion. Correlation between the ligand structure and the quantum yield reveals 
that energy-transfer from from Ar-P is about 12-90 times more efficient than that from 
ArO-P, implying that the sensitiser should be 'directly' linked to the ligation atom. 
Compund 44 which has two Ar-P groups within a molecule shows the highest quantum 
yield, probably a result of the more efficient energy transfer from two Ar-P groups and the 
podand-like metal encapsulation effect. 
h 
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Figure 2.2 
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1.3.1 Lanthanide cryptates. 
The choice of aromatic ligands to play the role of chromophore/sensitiser ligand in any 
lanthanide complex presents problems. Namely, lanthanide ions do not exibit strong 
coordinating ability towards such ligands, and in aqueous solution where solvent molecules 
efficiently compete to occupy coordination sites, the results are quite unstable chelates, 
with dissociation occurring, particularly at low concentrations. The problem can be 
overcome by the use of additional chelating groups, an example being the use of two 
(m ethyl enenitri lo) bis(acetic acid) groups in suitable positions to increase the stability of 
various aromatic chelates, Mukhala et aL 53,54 (Figures 1.6,1.7). 
A different approach is based on the use of encapsulating ligands. In this way the metal 
cannot escape its coordination sphere, and interactions with external species like solvent 
molecules are prevented or reduced. Lehn and co-workers were the first group to synthesise 
and study the photophysics of complexes of lanthanide ions with cage-type ligands. These 
were the Eu" complexes (cryptands) based on 221" and trispyridine" ligands, [Euc 
2.2.1 ]3' 47 and [Euc bpy. bpy. bpy]3' 48 respectively (Figure 2.3). 
N-00^ 
0 
L n3+ 
0 
Nj 
(47) 
Eu 3+ or Tb3+ 
2.2.1 cryptates 
(48) 
EU 3+ or Tb3+ 
bpy - bpy - bpy cryptates 
Figure 2.3 
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Results obtained for the [Eu(-- 2.2.1 ]'+ cryptate 
42.60.61 
showed that, although the cryptand 
ligand shielded the lanthanide ion from interactions with water molecules (average of 2.5 
coordinated water molecules), the absence of a chromophore and the presence of a 
thermally activated decay pathway involving LMCT (L, gan d-to, -Metal Charge Transfer) 
observed as absorption bands in the UV region resulted in complexes displaying poor 
luminescent properties. Although the energies of the LMCT excited states are not known, 
from the absorption spectrum of the [Euc: 2.2.1]" the lowest LMCT level can be expected 
to lie between the '7c7r* and 3 7r a* ligand-centred levels. 
However, in contrast the cryptand [Euc bpy. bpy. bpy]" displays excellent luminescent 
properties. 
41-44,62 This cryptand containing three 2,2'-bipyndine units exibits intense 
absorbtion bands in the near UV region due to 7r-7r* transitions in the bipyridine units 
(Figure 2.4) . 
42 Excitation to the spin-allowed '7r7r* ligand centered (LC) level leads to 
population of the luminescent metal centered (MC) 'D. f-f level of Eu" via intersystem 
crossing from the higher energy lowest spin-forbidden '7c7c* level with reasonably high 
efficiency (10%). The result is a complex which is an efficient molecular device for the 
conversion of UV light absorbed by the ligands into visible luminescence emitted by the 
metal ion. Even in very dilute aqueous solutions (10-'M) this complex is able to convert 
about I% of the incident photons into emitted visible photons. Lehn termed these 
complexes incorporating I* anthanides as Light Conversion Molecular Devices (Figure 2.5). " 
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200 270 330 390 nm 
Figure 2.4 Absorption spectra of Eu(aq)3+ 5x, 0-2M (a), 
[Eu 2.2.1]3+ IxIO-3M (b), 
and [Eu bpy. bpy. bpy]3+ 3xlO-5M (c). Note the difference in concentatiom 
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However, for both the [Euc: 48]" and [Tbc 48]" cryptates, comparisons of the lifetimes 
and quantum yields in H20and D20solutions indicates that non-radiative deactivation via 
O-H vibrations take place. It has been estimated that -2.5 water molecules are still 
coordinated to the encaged metal ions. 
This would explain the low values of the emission quantum yields, which in the case of 
the Th" complex is further aggravated by the presence of a thermally activated decay 
pathway involving the triplet excited state of the ligand. In an effort to reduce non-radiative 
loses and increase emission quantum yields, considerable effort has been devoted to the 
synthesis of a vast array of different encapsulating ligands (Figure 2.6). 63,64,65,66 
The results of the photophysical. characteristics of the corresponding EuI+ and Tb" 
CoMpleXeS63 has shown the difficulty in predicting how even small logical variations in the 
ligand structure will effect the photophysics of the lanthanide complex. 
63,64,65,66 
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Generally, Eu" complexes of N-Oxide cryptates 49 and 52 display excellent luminescent 
properties With quantum yields considerably higher than the corresponding [Eu c:: 48]" 
cryptate. This appears to be a result of (1) better protection of the encapsulated metal ion 
from H20molecules and (11) more efficient ligand-to-metal energy transfer due to a closer 
approach between the ligand and the metal ion. This, is in spite of the introduction of an 
additional decay pathway for the 'D. Eu 3+ level (population of LMCT excited states). Infact 
among the complexes examined the most intense luminescence is shown by the Eu" 
cryptate of 3,3'-biisoquinoline-2,2'-dioxide ((D-- 0.17) 52. Attempts to improve the 
photophysical properties of ligand 49 by the incorporation of more photoactive units 
(antenna) gave disappointing results with the [Euc 54]3+ showing a dramatic decrease in 
the quantum yield (0-- 
0-002). 65 
In contrast, although measurements indicate that for both the Eu3+ and Th3+ complex of the 
triazacyclonane ligand 51 there appears to be no water molecules coordinated to the metal 
ions, the Eu" complex displays short luminescent lifetimes and low quantum yields where 
28 
as the Tb 
3, 
complex displays a high quantum yield ((D= 0.37 in H, O). 
63.66 This difference 
has been attributed to the presence of low-lying LMCT levels in the Eu" complex. 
The main deactivation processes occurring in Tb" and Eu" complexes is illustrated in 
Figure 2.7.63 Studies have shown that both thermally activated decay processes involve 
different mechanisms. In EU31 complexes this process involves the population of low-lying 
LMCT states from the 'D. EU3' emitting state, followed by efficient non-radiative decay 
to the ground state. The role played by the LMCT states has been clearly pointed out by 
the photophysical behaviour of the ion pairs between the [Euc 2.2.1 ]" cryptate and fluoride 
anions. In Th" complexes, the Th" excited state ('D, ) undergoes back energy transfer to 
the triplet ligand level before decay to the ground state. This only occurs where the triplet 
excited state of the ligand lies just above the Tb" emitting level enabling thermal 
population at room temperature. On the whole, results have shown that the non-radiative 
deactivation due to LMCT states in Eu" complexes are more difficult to suppress than 
those due to the ligand triplet state in Th" complexes. 
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Figure 2.7 Scheme of the deactivation processes involved in the conversion of the light absorbed in the ligand into 
the light emitted by the metal ion in (a) Tb' and (b) Eu' complexes, The '7c7r* state is the ligand excited state 
obtained upon excitation and the3, nx* state is the ligand excited state involved in the ligand-to-metal energy transfer. 
The -5D4and 5 Do excited states are the luminescent states for the Th' and Eu3+ ions respectively. 'Me LMCT excited 
states are the ligand-to-metal energy transfer states in the Eu' complexes. 
ionalised calixarenes. This is clearly illustrated by the Th" and Eu" complexes of 
functi 1 67 
Both ions form relatively stable water-soluble complexes with p-t-butylcalix[4]arene 
tetraacetamide 55 (Figure 2.8). But, where as the -n3+ complex exibits, a remarkably 
high 
29 
luminescence quantum yield (0= 0.2) and a long luminescence lifetime (1.5 ms) which is 
temperature-in dependent, indicating the absence of thermally activated decay processes and 
in the ligand 55 a '7r7c* level from which efficient energy-transfer to 
5 D3 or 5 D4 can take 
place. The properties which make 55 an ideal ligand for Tb 
3+ 
means the corresponding Eu'+ 
complex suffers from a combination of low quantum yield (0-- 2xl 0-4 ) and short lifetime 
due to poor energy-transfer between the triplet excited state of the ligand (3 n7r) and the 
emitting level of EU3+ (5 Dj and the presence of LMCT states observed as a shoulder in the 
absorption spectra, efficiently deactivating the 'Do emitting state. 
lk"', 
N N 
zz/o 
Recently Shinkai et al. 6' have shown that by appropriately modifying the ionophoric cavity 
of a conventional calix[4]arene with a sensitiser, energy-transfer to Eu" becomes possible. 
Their modified calix[4]arenes bearing three amide groups (composing the metal-binding 
site) and one sensitiser group (phenacyl or diphenacylcarbonyl group) (Figure 2.9) exibits 
a high luminescence quantum yield for Th" (0-- 0.27) and a vastly improved quantum 
yield for Eu" (0--- 0.061). The significantly enhanced quantum yields for Tb" appears to 
be a result of energy-transfer from both the phenol units and the phenacyl unit (path A and 
path B) and just the phenacyl unit in the corresponding Eu" complexes (Figure 2.9). Their 
proposed energy diagram is shown in Figure 3.0. The triplet energy levels of the phenol 
unit and phenacyl unit are high enough to transfer the energy to Tb" ion levels whereas 
for the biphenyl-carbonyl group it is not sufficiently high. The energy levels for Eu" are 
lower than those for Tb 3' enabling energy transfer to take place from the triplet energy 
level of the biphenylcarbonyl group. The lack of energy transfer from the phenol unit to 
EU3+ is rationallsed by the C=O-to-EU3+ charge-transfer band which efficiently deactivates 
the excited state of the phenol to the ground state. 
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Figure 3.0 Energy transfer diagram for the system: excitation wavelength PhCO- (ý, - 270mn), PhCOCH2- 
325). Energy transfer to the Th' ion levels from triplet energy levels of the biphenyl carbonyl is 
not possible (see a in figure). As the C=O to Ee charge-transfer band deactivates the excited-state 
of the phenol units to the ground state one cannot transfer energy to the Tb3+ ion levels from the 
excited energy levels of the phenol units (see b). 
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1.4 APPLICATIONS. 
The considerable interest shown in luminescent lanthanide complexes reflects the view that 
as labels for both immuno/DNA hybridisation assays, they appear to represent a step 
forward from traditional organic fluorescent labels offering the kind of sensitivity to rival 
radioisotopes. 
1.4.1 Immunoassays. 
Immunoassay is a general analytical technique that relies upon the immunological reaction 
between the analyte to be measured (the antigen) with a specific antibody, under 
competitive or noncompetitive conditions. The immunological methods for the 
determination of biological materials are far superior to almost all other methods as far as 
sensitivity and specificity are concerned. They are used particularly for clinical 
investigation of compounds that are in very low concentrations and for which chemical 
methods are not sufficiently specific. Specifity and strong binding are intrinsic properties 
of antibodies which are necessary for their function as defence molecules. These same 
characteristics give specificity and sensitivity to immunoassays. The sensitivity of nucleic 
acid hybridisation assays arise from the specificity of one nucleotide sequence for its 
complementary sequence, The sensitivity of both techniques anse from the detection system 
employed to monitor the reaction, namely radioisotopes. Current state of the art competitive 
and noncompetitive radjoisotopicafly based immunoassays are capable of measuring in the 
sub-picomolar range, the limit being ~107 molecules/mL, according to Eklns. '9 
Radioimmuno assays (RIA) were introduced about 27 years ago by Yalow and Berson 70 
with radionuclides such as 1251,31p, 3 H and "S as labels of choice. However in the last 15 
years many alternative detection systems (labels) have been explored because of the serious 
disadvantages of radioactive labels (Table 1.7). " These are, the special handling techniques 
required, the problems of radioactive waste disposal, and the lifetime of an assay kit as 
determined by the half life of the isotope. 
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Table 1.7 Advantages and disadvantages of radioactive labels 
Advantages Disadvantages 
1. Very high sensitivity 1. Potential health hazzard 
2. Freedom from environmental 2. Require licensing 
interference (pH, temp., ionic 3. Special disposal 
strength, etc. 4. Limited shelf life 
3. Precise measurement of 5. Expensive y-counters 
radioactivity 6. Automation difficult 
4. No background signal from 
samples or reagents 
Among the alternative labels developed to substitute RIA, are enzymes (EIA, ELISA, 
ENUT), fluorescent labels (FIA) and luminescent labels or combinations (enzymes liberating 
fluorescent or luminescent products) (Table 1.8). 
20 Enzyme Immunoassays (EIA) are the 
most widely applied having practically the same sensitivity as RIA. The problems With EIA 
are caused by the bulky, labile label (enzyme), its susceptability to inhibition and 
denaturation and the additional incubation with a substrate for monitoring the enzyme's 
activity. 
Table 1.8 Nonisotopic labelling systems 
Type of label Example Measurement principle 
Enzymatic Horseradish peroxidase Colourless substrate 
(HRP) releases product absorbing 
in the UV-vis region 
Alkaline phosphotase S ame as above 
(ALP) 
Fluorometric Fluorescein, rhodamine Conventional fluorescence 
Chemiluminometric Luminol, isoluminol Oxidation by H202with 
light emission 
Acridinium esters Same as above 
Combination Enhanced luminescence Oxidation of isoluminol by 
H202 in the presence of 
HRP and an enhancer 
ALP with fluorogenic ALP releases fluorescent 
substrates products from 
nonfluorescing substrates 
ALP with ALP releases 
chemiluminogenic chemiluminescent products 
substrates from nonluminescing 
substrate 
Replicase enzyme with Replicase exponentially 
replicable substrate amplifies the substrate 
population 
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A wide range of fluorescent probes have been developed for use as direct labels in FIA 
(Figure 3.1)""2 fluoresceine and rhodamine derivatives being the most frequently used. 
Although in principle, fluoresceine measurement is very sensitive, giving many detectable 
events per labelled molecule and a quantum yield approaching unity, in practice the use 
of fluoresceine and rhodamine as labels has met with limited success with sensitivity being 
restricted to a concentration range of 10-' - io-10 m20,73 
This limited sensitivity of FIA is mainly attributed to high background signals, originating 
from light scattering, background fluorescence and self-quenching. 
Scattering causes very high background values in immunoassays of solutions containing 
high concentrations of proteins and even small colloidal particles (e. g. from serum). The 
excitation beam can be scattered from either soluble molecules (Rayleigh and Raman 
scattering), small particles or solid phase material (Tyndall scattering). Rayleigh and 
Tyndall scattering have the same wavelength as the excitation beam. These scattering 
interferences are aggravated by the small Stokes shifts (usually 24-50 nm) of conventional 
organic fluorophores. 
Background fluorescence signals are a major problem when dealing with biological samples 
like serum. This exibits a very high background fluorescence extending over a wide range 
of wavelengths (300-600 nm), which overlap extensively With the emission spectra of many 
organic fluorophores. 
A further problem in using conventional organic fluorophores is the so called 'inner filter' 
effect, which precludes the use of multiple labelling to increase sensitivity. This is caused 
by the significant overlapping of the excitation and emission spectra of many fluorophores 
resulting in energy transfer (self- quenching'). These drawbacks have confined FIA to the 
nanomolar range with the pico-range not being accessible. 
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Lanthanide chelates with their unique luminescent properties offer the possibility of very 
high detection sensitivity, comparable or better than radioisotopes. At a stroke the 
disadvatages of conventional fluorophores are overcome. These chelates exIbIt large Stoke 
shifts (-290nm), with no overlap between the excitation and emission spectra and very 
narrow (10nm wide band width) emission spectra, away from native serum fluorescence. 
The chelates of europium and terbium also exibit exceptionally long luminescence life- 
times (600-1000ps for Eu"), compared with 5-100ns for conventional fluorophores (Table 
1.9). 
HO r% 0 Et2N 
r% NEt2 
e-I - 
NMe2 
S02 Cl 
(59) Dansyl chloride 
(57) Fluorescein isothiocyanate 
S02CH=CH2 
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- S03U 
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(60) Lucifer yellow (6 1) Texas red 
I 
H04nno 0 
(63) Umbelliferone 
Figure 3.1 Fluorescent probes used in fluoroimmunoassays 
(62) Pyrene maleimide 
Table 1.9 Fluorescence decay time of some fluorophores and proteins 
Substance Decay time (ns) 
Humanserum albumin 4.1 
Cytochrome c 3.5 
Globin(haemoglobin) 3.0 
Fluorescein isothiocyanate 4.5 
Dansyl chloride 14 
Europium chelates 
103_ 106 
(58) Rhodamine isothiocyanate 
0) 
S03- 
OIT- ro 
S02CI 
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1.4.2 Time-Resolved Fluoroimmunoassays (TR-FIA) 
The key elements of time-resolved fluorescence techniques for blospecific assays are (i) 
a time-resolved fluorometer and (ii) a long decay time fluorescent label and Its conjugation 
with biornolecules. Each of these two elements were developed separately and the 
possibility of combining them became obvious in the middle of the 1970S. 71 
The principle of time-resolved fluorescence is illustrated in Figure 3.2. A delay is set 
between the excitation pulse and the measurement of the resulting luminescence. In this 
way short lived background fluorescence, which dissipates to zero in <100ps is eliminated, 
and long-lived luminescence signals can be measured with high sensitivity. 
The central problem of the availability of useful long-lived fluorescent probes was not 
resolved until the late 1970s. 
Leif' was one of the very first authors who suggested a complete concept of chemistry for 
TR-FIA, and in 1975 suggested the use of europlum complexes of the type Eu(B- 
diketonateband Eu(I, I 0-phenanthroline-x) complexed to antibodies as labels. He assumed 
that the complex would have the necessary thermodynamic stability and chemical inertness 
under the desired conditions of solvent, pH and concentration. Although this complex 
demonstrated long-lived europium luminescence with reasonable intensity, it proved to be 
unstable in aqueous environments and did not lead to any practical system. 
Excitation ). =340nrn 
C, 
U 
C 
4, 
V 
0 
U- 
Long-lived 
fluorescence 
Short-lived 
fluorescence 
Delay time 400 
Ccwnting X=613nm 
Counting 800 
time 
Time ps 
1000 New cycle 
Figure 3.2 Schematic presentation of operation of a pulsed source 
time-resolved fluorometer. 
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The use of lanthanide chelates as potential long lived probes suffers from a number of 
drawbacks, 
The lanthanides must be sensitised for effective emission to occur. The sensitiser must be 
capable of strongly complexing the lanthanide, forming both stable and kinetically inert 
chelates. Keeping the ion or chelate firmly on the immunoreagent at low concentrations in 
the vicinity of competing ligands requires the presence of powerful binding groups. Finally 
in aqueous media lanthanide luminescence is strongly quenched by interactions with water. 
Now since both Eu" and Tb" are nona-hydrates in aqueous media, a great deal of water 
needs to be removed to ensure effective luminescence. 
The drawbacks to the use of lanthanides in fluoroimmunoassays governs the design of 
effective sensitisers, and to achieve the maximum intensity of luminescence from the 
lanthanide chelate, the following general requirements must be met: 
(1) The sensitiser must bind the lanthanide strongly at low concentrations in water, 
at or above room temperature. 
(2) The sensitiser must have a very high extinction coefficient (> 10,000 M-'cm-') 
and the quantum efficiency for lanthanide emission to be high (0--I). 
(3) The sensitiser should absorb above 320nm. 
(4) Overall the complex should have good water solubility. 
(5) There should be the existence of functional groups for covalent coupling to 
antigen or antibody. 
I (6) The coupling process should neither increase nor decrease the immunoreactivity 
of the labelled substances nor increase its unspecific binding to plastics etc. 
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In spite of the difficulties of accomplishing the above requirements in a given lanthanide 
host, there have been two commercial TR-FIA avaliable since the early 1980s which have 
utilised lanthanide luminescence. 
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1.4.3 The LKB System. 
The first systematic studies on the use of europium as a label in immunoassays was started 
by Soini. and Hemmila in the mid 1970s, by the beginning of the 1980s Soin, and Hemmila 
75 had patented the first commercial heterogeneous time-resolved fl uoroimmuno assay. The 
procedure which has been found to be sufficiently reliable and robust for routine clinical 
use, was named'DELFIA'-Dissociation Enhanced Lanthanide Fluoro ImmunoAssay (LKB- 
Wallac Oy, Turku, Finland). 
The approach taken by Soini and Hemmila to overcome the problems of combining good 
absorption and energy transfer properties With a strong chelating capacity to the same 
ligand was to separate these two functions. Although the B-diketonates chelate Eu" ions 
and possess the properties required for sensitisation of lanthanide luminescence, these 
complexes are not stable enough to be used directly. Their approach was to stick with the 
B-diketonates as sensitisers but to separate the europlum labelling and measurement 
procedures. The LKB system is shown diagramatically in Figures 3.3,3.4.76 
! ýA 
Protein + 
N 
S=C=N EU3*---m- 
N 
Excess label 
=Protein 
ol 
+-5, 
I- 15 labels/protein 
I 
(), 
N --*-\ 
N 
Non-f Worescent 
Figure 3.3 Principle of protein labelling with isothiocyanatophenyl-EDTA-Eu'. The protein is reacted with 
60-fold molar excess of the label at pH 9.3 overnight at +4'. The labelled protein is separated from 
excess reagent by gelfiltration. The conjugation yield is obtained by comparison of the europium 
fluorescence of the labelled protein with europium. standards. 
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The lanthanide is bound to one of the immuno-components in an essentially non-fluorescent 
form. The immunoassay is carried out as a non-competitive or competitive reaction in a 
solid phase system. After the immuno-reaction has been completed, part of the labelled 
component (antigen or antibody) is bound to the solid phase and the separation of the free 
and bound fraction is accomplished by extensive washing of the solid phase surface. In the 
final step, the lanthanide ion is dissociated from the immunocomponent on the solid phase 
into solution where a highly fluorescent lanthanide chelate is formed before measurement. 
immunocomplex Eu 
3* 
N \--ý N 
R2 
,a 
Enhancemml 
solution 
pH<4 
Non-fluorescent 
RJýCELI Rl 
ý2 
Fluorescent 
01 
Figure 3.4 Principle for the release after the immunometric assay has been completed. As a final step before 
fluorescence measurement an enhancement solution is added consisting of 0.1 M acetone-potassium 
hydrogen phthalate, pH 3.2, containing 15M 2-naphthoylnifluoroacetate, 50M tri(n-octyl)phosphine 
oxide and 0.1% Triton X-100. The europium ion dissociates from the labelled protein and forms 
a new fluorescent chelate in solution. 
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I(N 
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In the DELFIA system, the binding of Eu" to an immunoreactive component is 
accomplished by using derivatives of strongly chelating compounds such as EDTA and 
DTPA containing a suitable functional group for covalent coupling, e. g. 
isothiocyanatophenyl-EDTA (Figure 3.3). 
Polycarboxylic acids like EDTA, EGTA and DTPA have a very high binding constant for 
the lanthanides (I 016_ 1012). 7' However, this property is strongly dependant on the pH, and 
if the pH is lowered the stability of chelate complex decreases and the lanthanide is readily 
dissociated into solution. This conditional stability is utilised in the quantitation of EU3+ 
performed by dissociating it from the immunocomponent after the immunoreaction by 
adding an enhancement solution which is at pH 3.2. This consists of a B-diketone 
(diketone-2-naphthoyltrifluoroacetone), tri-octylphosphine oxide and TritonX-100. The 
result is a highly fluorescent europium chelate solubilised in the micelles that are formed. 
The postulated fluorescent product is shown in Figure 3.5. 
The non-ionic detergent TritonX-100, dissolves the sparingly soluble organic component 
in the micellar phase and excludes water from the chelated EU3'. The insulation from the 
solvent is further optimised by the addition of a synergistic agent, tri-octylphosphine oxide. 
The success in insulating the europium chelate from the quenching effect of water, means 
the system can detect as little as 10-"moIL-' EU31' the same order of sensitivity as is 
commonly reported for 
1211. 
Eu 
O)o 
0 
.ý Cl%klt 
0 
C*4 C", 3 
C F3 
'%ýCF3 
00 
C F3 
C, -51 CA, 4 
,7 C- CAI, 
C"3 CH, 
-/ c 
cAf, (b) (elf, 
I Cli, 
1 0)" 
Figure 3.5 (a) micelle consisting of Triton X-100 molecules with an association number of about 140 in which 
a fluorescent europium chelate is solubilised. (b) A hypothesised form of the europium, chelate. 
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1.4.3.1 Applications of the DELFIA system. 
Since the introduction of the immunoassay based on the DELFIA concept, a great variety 
of assays have been developed. The technique is applicable generally and assay procedures 
have been successfully worked out for essentially all analytes intended to be measured with 
the DELFIA system. 
A. Protein and Peptide Hormone Assays. 
The first assays using the DELFIA system were the noncompetitive immunometric assays 
of proteins and peptide hormones: Rabbit IgG", hCG 
76,79,80 
, hTSH' 
1,82,83 
11 AFP"ý 
Phospholipase A2 853, Insulin', C-reactive protein 
87 
, LH", and Myelin basic protein'9. 
Most of these non-competitive assays are performed using monoclonal antibodies, 
employing polystyrene microtitration wells as the solid phase. Flow charts for two typical 
assay protocols (hTSH) and (hCG) are shown in Figure 3.6. " All other non-competitive 
and competitive analyte protocols are essentially similar to those presented in the flow 
chart. The major benefits of TR-fluorimetry in these non-competitive assays are sensitivity 
and a wide dynamic range, which are important, for example in assays of serum thyroid 
stimulating hormone (hTSH), where the determination of low and normal hormone levels 
contributes to an improved clinical discrimination of patients With thyroid disease. 
ASSAY PROTOCOL FOR MEASURING hTSH 
'Coated 12-well m1crotitre 
strip I 
Wash once 
Sample 2. Assay buffer containing tracer 
r-Addition of 150 ul sample 
j. -J: (unknown or standard) followed by 100 ul assay 
buffer containing 50 ng tracer 
Incubate overnight at + /-'C 
I 
Aspirate and --'qh 6f 11104 
Enhancement solution 
Add 200 ul enhancement 
solution/well 
I 
Shake the strip gently by means of on 
automatic shaking 
device. After 5 win. 
measure the fluorescence 
for one second 
in a TR-fluorometer. 
ASSAY PROTOCOL FOR MEASURING hCG 
r coated 12-well stcrotitre 0 
_LL11-- 
strip 
Wash once 
.I 
1. sample 2. Assay buffer 
Addition of 25 ul sample r (unknown or standard) 
.0 followed by 200 ul assay 
buffer 
Incubate for Ih at room temperature 
with gentle shaking 
Aspirate and wash 3 times 
Tracer 
r Add 100 ng Eu-1abelled anti- 
c(-UI In 725 ul essay buffer 
Incubate for )0 min at room temperature 
with gentle shaking 
pp ate and wash six times irancesent 
solution 
Add 200 ul enhancement 
solution Per well 
Shake the strip gently by means of an 
automatic shaking device. After 5 min. 
measure the fluorescence for one second 
in a TR-fluorometer. 
Figure 3.6 Assay protocols for (hTSH) and (hCG). 
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B. Hapten Assays 
The reported competitive hapten assays based on TR-fluorimetry using europium chelates 
87,92 
include those for cortisol", 9', testosterone"ý9, digoxin and thyroxine". These assays 
perform at least as well as corresponding radioimmuno assays. 
Competitive assays are carried out either using labelled haptens or labelled anfibodles. The 
assay principle is outlined in Figure 3.7". A constant amount of protein-bound thyroxine 
is immobilised on the wall of microtitration strip wells and the antibody is labelled with 
europium. After the immunoreaction has been completed, the label is released into solution 
by addition of the enhancement solution. 
US + 
CP 
Thyroxine 
VEU 
in samples 
Ij 
CP 
ýcr C3 Eu 
Solid phase Eu-1abelled 
Thyroxine anti-Thyroxine IgG 
CP = Carrier Protein 
Incubation 
and washing 
?b Fluorescence 
0- EU'-O measurement IVO 
Figure 3.7 The principle of the non-competitive assay of thyroxine. A constant ammount of protein-bound 
thyroxine is immobilised on the wall of the microtitration strip wells and the antibody is labelled 
with europium. After immunoreaction is complete, the label is released into solution by the 
addition of the enhancement solution. 
C. Serological, Assays 
in serological immunoassays labelled antispecies antibodies are widely used in various 
indirect and direct assays to measure human serum antibody levels. The DELFIA principle 
has been applied in assays for rubella" and tetanus" antibodies. 
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D. Virus Antigen Assays 
Originally even with the use of europium chelates and time-resolved fluorescence these 
assays were laborious and complicated, because indirect assay procedures requiring three 
different incubation steps were applied. " 
Recently these tests have been simplified by using a direct assay procedure. Direct one- 
incubation TR-fluorometric assays of the hepatitis-B surface antigen 96 , rotavirus and 
adenovirus in stool specimens and for influenza A have been developed. ", 9' All the assays 
were performed using a polyclonal antibody preparation both on the solid phase and as the 
labelled reagent (Figure 3.8) The sensitivity of these far simpler assays are at least as good 
as that obtained with the corresponding indirect radio- or enzyme immunoassays. 
Immunoreogent 
Layer Incubation 
Type Concentration at 37 OC 
Anti-viral 
indicator 
Specimen 
0 
Catching 
antibody 
YYY 
Solid phase 
Eu-chelate-labelled 100 ng per assay 
rabbit anti-virus Ig 
Virus 0.001-1mg MC, 1h 
(structural protein) 
Ig fraction of rabbit 
anti-virus hyperimmune 500 ng per tube 
serum 
Polystyrene tube 
Figure 3.8 
In the LKB system, because of the dissociation of the lanthanide ion from a solid phase, 
from the labelled compound, followed immediately by the development of a new chelate 
in the solution, the developing stage is very sensitive to external lanthanide contamination. 
The result can be an immediate growth of "background" fluorescence. 
" The possibility of 
contamination is excluded by the use of lanthanide chelates which are both stable and 
fluorescent 
In a recent patent Kankare" reports on a TR-lanthanide chelate assay which attempts to 
combine the advantages of both the DELFIA and Cyberfluor systems. 
(Figure 3.9) 
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The assay is based on the use of a stable fluorescent lanthanide chelate. After the 
immunochernical reaction of an antibody labelled with a fluorescent europium chelate, 
namely the isothiocyanate derivative of 4-am, nophenyl-ethynyl-2,6-bls (N, N'- 
bis(carboxymethyl)-aminomethyl)pyridine-Eu, with the antigen, the lanthanide chelate is 
released into solution before measurement. During the releasing process, the chelate 
complex between the lanthanide ion and the chelate ligand must remain intact. In this way 
only the fluorescent lanthanide chelate is released into the solution, and no background 
induced by the material of the solid phase nor any external contamination can interfere with 
the result. 
To achieve this, the europium chelate is bound to one of the immunochemical components 
using a single covalently breakable bond: e. g. a disulphide (-S-S-). a vicinal djol, an ester 
bond, a diselenium bond, or a photosensitive bond, or combinations of the above. 
support 
antigen 
i ch el: Eu 1 
antibody covalent stable and fluorescent bond 
I 
lanthanide chelate 
breakable covalent bond 
Figure 3.9 
45 
1.4.4 The CYBERFLUOR System. 
Instead of using europium as the label for TR-FIA, it is possible to introduce a europiun 
chelator into the immunoreactants and use an excess of Eu" to form the fluorescent 
complex. After the immunoreaction and all the washings have been completed in a 
competitive or non-competitive immunoassay, the fluorescence of the chelate-europium 
complex can be measured. The success of this approach depends on finding a suitable 
europium chelator, which apart from forming stable complexes is also an efficient 
sensitiser. 
The two most general types of chelates associated with the lanthanides, namely the 13- 
diketonates and the polycarboxylic acid (EDTA) derivatives do not fulfill the two main 
criteria, of forming a stable Eu" complex that exibits luminescence. 
The success of the Cyberfluor is due to a new type of europlum chelator: 4,7- 
bis(chlorosulphophenyl)-1,10-phenanthroline-2,9-dica, rboxylic acid (BCPDA) (67) which 
does fulfill the above criteria. ""' 
BCPDA is prepared in high yield (88% overall) in a three step synthesis starting from 2,9- 
dimethyl-4,7-diphenyl-1,10-phenanthroline (64) (Scheme 1.1)100"01 
(64) 
0 
It 
Cý-S- 
- 00. 
cl- 
(67) 
CDDH 
ODOH 
ocý 
ccb 
B 
(66) 
Scheme 1.1 Synthesis of BCPDA; A. NCS, Benzoyl peroxide, CC14 
B. c. H2SO4,90OC; C- chlorosulphonic acid, 900C. 
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(65) 
The chelating site consists of two heteroaromatic nitrogens and importantly, two carboxyl 
groups, enabling BCPDA to form a luminescent complex With Eu" both in aqueous 
solution and when absorbed to a solid phase, in a heterogeneous immunoassay 
configuration. The molecule has two sulphonyl chloride groups available for reaction under 
mild conditions with amino groups of proteins, making the labelling of proteins a simple 
procedure. 
Diamandis and co-workers have developed a universal detection system based on labelling 
Streptavidin with BCPDA. 
102 
The noncovalent, specific and very strong binding of the water soluble vitamin biotin to 
the tetrameric protein avidin (or streptavidin) has become one of the most useful tools in 
the field of immuno and DNA hybridisation assays. The affinity (formation) constant for 
the biotin-avidin interaction is amongst the highest reported at 10"M-' (compared to the 
antibody- antigen interactions of 1011-10 
12M-1). 
Biotin covalently bound to an antibody or DNA probe is still available for high-affinity 
interactions with avidin. If the avidin is labelled with a suitable reporter molecule (e. g. an 
enzyme or fluorescent compound), the avidin-biotin complex can be used for the 
quantification of the biotinylated molecule. 
The biotin-streptavidin system offers some distinct advantages: 
(1) It is a universal detection system; one streptavidin based reagent can be applied to any 
immunoassay or DNA hybridisation assay using biotnylated reactants, 
(2) Antibodies and DNA sequences can easily be biotinylated without the loss of bilogical 
activity, 
(3) The biotinylation process introduces many blotin molecules per antibody which intum 
bind to more than one labelled streptavidin, leading to a significant amplification factor, 
(4) Streptavidin is very stable and usually not deactivated on labelling. 
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A typical non-competitive assay based on biotin-streptavidin labelled with BCPDA is 
shown in Figure 4.0. 
All reactions are carried out in white microtitration strip wells and luminescence is 
measured on the dry solid phase. 
This system has been successfully applied in the non-competitive assay of alpha 
fetoprotein"' choriogonadotropin"', and the competitive assay of cortisol in serum 105 . 
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Figure 4.0 Non-competitive 'two-site' immunoassay of an antigen with the 
Cyberfluor system. Eurofluor= BCPDA, B= biotin and S= streptavidin 
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The Cyberfluor system does not suffer from the external lanthanide contamination problems 
that can afflict the DELFIA assay, since an excess of europlum is used In the developing 
stage. The use of excess europium is necessary because the stability of BCPDA chelates 
with Eu 3+ is relatively low (~101_106) . 
Also a 1: 1 Eu": BCPDA complex is formed, which 
allows the coordination of a number of water molecules to the lanthanide ion. This means 
that before any measurement of the luminescence can take place, the solid phase must be 
dried. 
Overall, the Cyberfluor assay system is less sensitive in comparison with DELFIA. Efforts 
to increase the sensitivity has concentrated on multiple fluorescent labelling with europium 
chelators. Diamandis and co-workers found that by labelling a streptavidin-thyroglobulin 
conjugate with BCPDA instead of directly labelling streptavidin they were able to 
incorporate approximately 150 BCPDA molecules per streptavidin"' as compared to 14 
incorporated by direct labelling. No quenching (inner filter) effects are observed, 
presumably due to the large Stokes shift of the label (BCPDA-Eu" complex) and the lack 
of overlap between the excitation and emission spectrum. By using the universal detection 
reagent based on the streptavidin-thyroglobulin conjugate (Figure 4.1), and excess Eu" they 
were able to improve the detection limit of a model (x-fetoprotein assay by a factor of 25- 
fold or 5-fold in comparison to BCPDA labelled antibody or BCPDA labelled streptavidin, 
respectivelylo' 
ABC 
Figure 4.1 Schematic representation of the BCPDA labelled reagents and their util'sation in 
the AFP assay. The solid phase is indicated by the horizontal line with hatched 
lines. The solid ball and stick represents BCPDA, AFP- a-fetoprotein, B= biotin, 
SA= streptavidin and TG= thyroglobulin. 
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In a further development Diamandis el al. "' found that by incubating SA-TG-(BCPDA)150 
(conjugate of streptavidin (SA) with thyroglobulin (TG), which is labelled with BCPDA), 
with BCPDA-labelled thyroglobulin [TG-(BCPDA),,, ], in the presence of a suitable amount 
of Eu",, a new macromolecular complex is formed with a molecular weight of 3x 10' 
(Figure 4.2). This macromolecular complex was found to be stable enough to be used as 
a sreptavidin based universal detection sysytem for TR-FIA. Detection limits of seven 
immunofluorometric assays showed an 8-26 fold improvement in comparison to the reagent 
SA-TG(BCPDA)15, described earlier"'. 
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Figure 4.2 Schematic representation of the proposed 
mechanism of the formation of the macromolecular 
complex. 
In order to overcome some of the limitations of the Cyberfluor system, Kropf and co- 
workers have reported"' a modification of the measurement stage. The amount of bound 
europiurn is quantified, but the luminescence is measured in solution after dissociation of 
the solid phase complex, analogous to the DELFIA system, BCPDA labelled solid phase 
complexes obtained by conventional immunoassay procedures are transferred into solution 
using urea/sodium dodecyl sulphate/Eu" as the dissociating and fluorescent lanthanide ion 
reagent. A "sandwich-type" assay based on this modification and using BCPDA labelled 
streptavidin was used in the determination of small amounts of fibronectin in biological 
fluids. 
The main problem with this variant is that, one has to assume the dissociating solution is 
in fact leading to complete dissociation of the BCPDA: EU3+ complexes attached to the solid 
phase. 
IG 
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Others have tried to tackle the problem of sensitivity associated with the Cyberfluor system 
by looking at alternative sensitising/strong binding ligands. 
Toner and Hinshaw at Eastman Kodak"" "" 11,112,113 have over the last six years synthesised 
a whole series of potential ligands capable of strongly binding both Eu" and Tb" and 
sensitising lanthanide luminescence in water. Their approach involved incorporation of 
powerful binding groups, usually iminodiacetates or carboxylates on suitable lanthanide 
sensitisers. 
One of the first class of sensitiser they examined were the benzophenones, which have 
excellent intersystem crossing efficiences ((Dj. =1.0 for benzophenone). (Figure 4.3) 
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However, the Eu" chelate of ligand 68 shows weak luminescence with low quantum 
efficiency ((DE,, =0.03). This is probably a result of poor energy transfer between the triplet 
level of the sensitiser and emitting level of the metal ion. 
The quantum efficiency is dramatically increased with the Eu" chelate of cournarin 69, 
indicative of a better match between the sensitiser triplet level and the lanthanide 
ion. 
Normally, cournarins are highly fluorescent which renders them inappropriate as lanthanide 
sensitisers. However, Farid and co-workers, demonstrated that the incorporation of a 
keto 
group in the 3-position of the coumarin nucleus converts the molecule to an excellent 
triplet sensitiser, with (%c approaching unity 
114 
. For all this, the 
EU31 chelate of 69 still 
ing the difficulty in designi exibits poor luminescence in aqueous environments, showl 11 ing 
ligands that fulfil all the criterea. 
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Better results, in terms of luminescence intensity, are achieved with substituted 
oligopyridines and phenanthrolines as sensitisers. Toner et al. synthesised a large number 
of these hosts in a systematic study (Figure 4.4), observing an increase in luminescence 
lifetimes and intensity with an increase in the number of chelation sites' 11,112,113 . 
This 
probably reflects greater shielding of the metal ion from the quenching effect of the 
solvent. 
Attempts by Toner to develop a competitive TR-FIA for thyroxin, by attaching thyroxin 
to one of the above chelators, gave poor results' 13 . 
Recently more impressive results have been obtained by Toner et al using the bifunctional 
terpyridine chelate 4'-(3-amino-4-methoxyphenyl)-6,6'-bis[N, N-bis(carboxymethyl) 
aminomethyl-2,2': 6', 2"-terpyridine] (TMT) 73. "' This ligand is able to form a nine- 
coordinate complex with Eu", occupying all EU31 coordination sites. The resultant 
TMT-Eu" complex appears to have excellent photophysical properties illustrated by its 
excitation and emission spectra. (Figure 4.5) By labelling a monoclonal antibody molecule 
with TMT,, Toner reports detection limits of 6x 10-16 Mol for the antibody. 
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Figure 4.5 Excitation and emission spectra of TMT-Eu3+ 
Sasamoto ef aL"' have recently developed a series of ligands which are able to form stable 
EU3+ complexes in water, which also exibit fairly intense luminescence. 
Their approach has been to incorporate two phenanthroline moities (as sensitisers) into an 
aza-crown framework containing two carboxylate groups 74. Crystallographic evidence of 
the N-tosyl derivative 75' 17 , 
indicates that the ring is not planar but bent. Thus what is 
postulated by Sasamoto is a europium complex of 74, where the lanthanide ion is 
coordinated three dimensionally, almost resembling a cryptand. This brings about improved 
stability of the complex and better shielding from solvent molecules (Figure 4.6) 
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By synthesising the BCPDA analogue 76 (Scheme 1.2), they were able to tap into the 
immunoassay technology 
developed by Diamandis and co-workers. 
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They describe three separate TR-FIA for hCG using: (i) anti-hCG monoclonal antibody 
labelled with 76, (ii) streptavidin labelled with (76), using biotinylated anti-hCG antibody, 
and (ill) anti-hCG antibody conjugated to bovine serum albumin (BSA) labelled with 76. 
The results show an amplification factor resulting in a five-fold increase in the sensitivity 
as compared to method (i). 
They also describe a TR-FIA for thyroxine using thyroxine labelled with 76, achieving 
detection limits of 5ng/ml; and a TR-FIA for the detection of antibody to the Hepatitis B 
surface antigen in human sera, comparison of the results with the commercially avallable 
enzyme immunoassay kit showing the TR-FIA method to be more sensitive. 
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The relentless search for new and better ligands to prepare luminescent lanthanide (111) 
complexes goes on unabated with the latest additions being the polyacid chelates derived 
from 2,, 6-bis(N-pyrazoyl)pyri dine 83"' and the tetraza phosph, nates 84"9 (Figure 4.7) 
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1.5 ENZYME-AMPLIERED LANTHANIDE LUMINESCENCE. 
Enzyme-amplified lanthanide luminescence (EALL) is an attempt to combine the 
capabilities of time-resolved fluorescence detection of lanthanide chelates with the 
amplification provided by the use of an enzyme as label. Signal generation is performed 
by enzymatically transforming a substrate which does not form a luminescent chelate with 
either Th" or Eu" into a product which does form such a chelate. Examples of such 
transformations include aromatic compounds which initially do not form highly luminescent 
complexes With the lanthanides, but contain groups which can be removed by enzymatic 
hydrolysis such as a phosphate, sulphate, acyl, or glycoside. Upon hydrolysis the product 
is a compound capable of forming a luminescent lanthanide chelate. One such example is 
the EALL detection of alkaline phosphatase using substituted salicylphosphates. 
(Figure 4.8) 120 
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Figure 4.8 EALL system for detection of AP using substituted salicyl 
phosphates; [A] dephosphorylation of XASP is followed 
by [B] formation of the luminescent ternary XAS: Tb: EDTA 
complex at elevated pH. 
Enzymes can also be used to promote a hydrolytic or oxidative reaction upon 
chromophores containing poorly coordinating groups which can be either hydrolysed by 
a hydrolytic enzyme in the presence of water or oxidised by an oxoreductase enzyme in 
the presence of a suitable oxidising agent to the more strongly coordinating carboxylic acid 
anion -COO-. Examples of such groups are esters, amides, aldehydes, and cyano groups. 
The detection of xanthine oxidase is based on the conversion of salicyladehyde to salicylic 
acid by xanthine oxidase in the presence of 
02 and H20. (Figure 4.9)120 
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Figure 4.9 Conversion of salicylaldehyde to salicylic acid by 
xanthine oxidase. Luminescence detection of SA 
is performed as for Figure 4,8 
The detection of glucose oxidase (GOD) involves a more sophisticated coupled or two-step 
detection system. Here the photoassisted oxidation of 1,1 0-phenanthroline-2,9-dicarboxylic 
acid dihydrazide (PDACdh) to 1,10-phenanthroline dicarboxylic acid (PDCA) by H, O, 
generates a compound able to form highly luminescent complexes with Eu". B-D-GOD is 
then detected using glucose as a substrate via the reactions illustrated in Scheme 1.3 120 
carried out in the presence of PDCAdh, Eu 3+ , and UV irradiation. 
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Scheme 1.3 Coupled EALL detection system for glucose oxidase 
using photoassisted oxidation of PDAdh by H202 
to form, lumines cent Eu3+ complexes. 
The principles of EALL have been translated into a model assay of cc-fetoprotein (AFP) 
by Diarriandis et aLl". In their sensitive time-resolved immunoassay (Figure 5.0), the 
primary immunological label is alkaline phosphatase (ALP); its substrate is the phosphate 
ester of 5-fluorosalicylic acid (FSAP). Enzymatic hydrolysis of FSAP produces 5- 
fluorosalicylic acid (FSA). The non-hyrolysed ester (FSAP) and the hydrolysed ester (FSA) 
have different behaviour in Th"-EDTA solutions. The free fluorosalicylic acid (FSA) is 
able to form a highly fluorescent ternary complex [FSA-Tb"-EDTA] on addition of the 
Tb3'-EDTA solution, which FSAP is unable to do. An intact hydroxyl group on the FSA 
molecule is essential to form these 
highly fluorescent complexes. The detection limit 
obtained corresponds to 1.5x 10' molecules of 
AFP in a sample volume of 100gL. The 
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sensitivity achieved is a result of the enzymatic amplification introduced by ALP and the 
quantification by laser-induced time-resolved fluorometry. 
Diamandi S122has embarked on a deliberate search of fluorogenic chelators of Eu" and/or 
Th" where the lanthanide binding site consists of at least one carboxyl group and a 
hydroxyl group. The hydroxyl group is needed for conversion to either a phosphate ester 
or a galactosidase, to act as substrates for ALP or B-galactosidase respectively. One of the 
compounds identified by Diamandis, 4-methylumbelliferylphosphate 85 forms a fluorescent, 
long-lived chelate with Eu", however, enzymatic cleavage of the phosphate group by ALP 
to form 4-methylumbelliferone 86, results in a compound which is unable to form 
fluorescent complexes With Eu". This pair of compunds which work in the opposite way 
in comparison with the reported FSAP-FSA-Tb" system, have been used to develop two 
model time-resolved fluonometric immunoassays for TSH and T4 in serum. "' 
(Figure 5.1) 
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Figure 5.0 The analyte is captured by the coating antibody. 
A 'sandwich' is formed by adding a biotinylated detection 
antibody, followed by the addition of alkaline phosphotase (ALP)- 
labelled streptavidin (SA). ALP hydrolyses the acid (FSA) 
which is then quantitated by adding Tb3+-EDTA solution 
and measuring the luminescence of terbium. 
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1.6 NUCLEIC ACID HYBRIDISATION ASSAYS. 
The sensitivity and specificity that can be achieved by nucleic acid hybridisation probes 
has made them irreplaceable in molecular biology for the detection of specific, 
complementary nucleic acid sequences. However, the use of isotopic labels has limited the 
acceptance of nucleic acid methodology in routine diagnosis. Today, a DNA detection 
method must fulfill the following criteria: safety, speed, specificity, sensitivity, 
reproducebility, and the possibility of automation. 
Various substances have been either used or advocated as labels for DNA probes , including 
radioisotopes, fluorescent markers, and enzymes. Most attention has focused on alternatives 
to radioisotopic labels because of the associated problems of safety, stability, and waste 
disposal. From the vast array of non-isotopic labels, no single label has yet emerged as an 
ideal replacement for radioisotopes. 
An ideal label for a DNA probe would have the following properties: 
(a) be easily attached to DNA, 
(b) be detectable at very low concentrations using simple instrumentation, 
(c) produce a signal which is modulated when labelled DNA probe is hybridised 
to its complementary DNA sequence (thus facillitating the development of 
nonseparation. (homogeneous) DNA probe assays, and 
(d) be stable at the elevated temperatures sometImes used ln hybridIsations. 
1.6.1 Labelling of Nucleic Acid Probes. 
Two main types of labelling strategy have evolved: direct and indirect 
labelling, both of 
which have been used in several 
different DNA hybridisation assay designs. (Figure 5.2)"' 
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Figure 5.2- Assay designs in DNA hybridisation assays: (a) The DNA probe is used unlabelled and the target- 
probe hybrid is detected by asing either labelled antibodies againts the duplex or histones (H); (b) 
the DNA probe is directly labelled with a reporter molecule (0); and (c) the DNA probe is 
conjugated to a hapten molecule, and antihapten labelled antibodies are used to detect the hybrid. 
In a variation of this techniqiie, the probe is biotinylated (B) and labelled streptavidin (SA) is used 
as the detection reagent; (d) unlabelled SA is used to bridge a biotinylated probe with a 
biotinylated reporter molecule. 
(a) Indirect Labelling 
Indirect labelling requires the DNA probe to contain a hapten which is detected by using 
a labelled binding protein with specificity for the hapten. Among the indirectly detectable 
markers, biotin has gained the widest use. Biotin can be introduced into DNA 
- enzymatically or chemically, it is detected by labelled avIdIn (or streptavid1n) (Figure 
5.3). 123 The most common signal-generating labels used in indirect detection are enzymes 
such as alkaline phosphatase and horse radish peroxidase. The enzymatic reaction resulting 
in a coloured, chemiluminescent, or fluorescent end product. 
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Many fluorescent dyes such as rhodamine and fluoresceine are also avalible as fluorometric 
reporter groups attached to avidin or streptavidin. But they suffer from low sensitivity due 
to high background fluorescence. 
Similar to the biotin-avidin system, Boehringer Mannheim introduced the Digoxigenin 
(DIG) labelling towards the end of the 1980s (Figure 5.3)"'. The method is based on a 
steroid isolated from the digitalis plants (Digitalis purpurea and Digitalis lanata). These 
plants are the only natural source of digoxigenin, no binding of anti-DIG antibody in other 
biological materials occurs. Detection of hybridised DIG probes is mediated by high 
affinity anti-DIG antibodies conjugated to enzymes or fluorescent dyes. 
An advantage of indirect procedures is the ability to build amplification steps into the 
assay. For example, if biotin is the primary label, it can be bound to one of four binding 
sites on avidin and the three remaining sites can be filled with biotin, thus producing a 
threefold amplification. The use of enzyme-labelled biotin introduces a further amplification 
factor. 
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(b) Direct Labelling 
In direct labelling, the detectable molecule (reporter) is bound directly to the nucleic acid 
probe so that detection can be achieved immediately after hybrid1sation of the probe with 
the target nucleic acid. For such methods it is essential that the probe-reporter bond 
survives the rather harsh hybridisation and washing conditions. More importantly the 
reporter molecule should not interfere with the hybridisation reaction. 
The most common direct nucleic acid labels are radioisotopes, primarily "P and "S, which 
are easily introduced by a variety of enzymatic techniques. They offer the possibility of 
incorporating many labels per probe, thus increasing the sensitivity of detection, in terms 
of which they remain the "gold standard". 
Enzymes such as alkaline phosphatase and horseradish peroxidase can also be used as 
direct labels, as enzyme labelled DNA probes are stable during hybridisation. Although 
enzyme catalysed methods are sensitive, measurements can only be performed once and 
the enzyme activity has to be monitored. 
DNA probes can also be labelled directly with classic fluorochromes, such as fluorescein 
and rhodamine, but this approach suffers from low sensitivity. Recently new directly 
labelled nucleotides have become available, containing resorufin (red fluorescence), and 
hydroxycournarin (blue fluorescence)"'. 
Fluorescein which can be incorporated enzymatically into nucleic acids can also be used 
as an indirect label being detected by anti-fluorescein antibody coupled to an enzyme or 
an unconjugated antibody which can be detected by a secondary antibody labelled with 
fluorescein isothiocyanate 124 . 
By using combinations of digoxigenin-, biotin-, and fluorescence-lab ell ed probes, multiple 
simultaneous hybridisations can be performed to localise different chromosal regions in one 
operation. The availability of three different fluorescent dyes coupled to antibodies makes 
this possible. 
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1.6.2 Nucleic Acid Labelling with Lanthanide Chelates. 
It comes as no suprise that DNA hybridisation assays using the principles of the 
immunological versions of both the DELFIA and Cyberfluor systems have been described. 
Dahlen et aL have described the detection of biotinylated DNA probes using europium- 
labelled streptavidin, both in dot blot and sandwich hybridisation assays"' (Figure 5.4) 
Viral DNA (adenovirus type 2) was detected by attaching the target DNA onto 
microtitration wells before the hybridisation reaction. The detection limit was 10pg of 
target DNA added to the well. The target DNA must be extensively purified before 
immobilisation onto the solid support (overnight procedure). The limitations inherent in 
direct hybridisation formats on plastic surfaces are omitted in sandwich hybridisation. The 
13-lactamase gene was detected by this assay, with a detection limit of 1.9pg of target DNA. 
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Figure 5.4 (A) Dot blot hybridisation. The sample DNA is immobilised on a solid support. A biotinylated 
DNA probe is allowed to hybridise to its target sequences. The bound biotin-probe is detected by 
Eu-labelledstreptavidin. The Eu-fluorescence is developed by adding enhancement solution. (B) 
Sandwich hybridisation. The sample is added simultaneously with the biotinylated DNA probe to 
the hybridisation reaction. The captive probe, which has been attached to the solid support before 
the assay, and the biotinylated probe will hybridise to the target DNA. The bound biotin-probe is 
detected by using Eu-labelled streptavidin. 
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However, the DELFIA assay system is restricted to dot-blot hybridisations, and even here 
it ends up complicating the assay procedure. The essentially non-fluorescent europiurn 
chelate and the procedure of dissociation and enhancement is not suitable for use in 
Southern, Northern and in situ hybridisations, where the label needs to be fluorescent. 
Recently Diamandis and co-workers have described a DNA hybridisation assay (dot-blot 
and Southern blot), based on the detection of biotinylated DNA with a highly fluorescent 
streptavidin based reagent labelled with the europium chelate of BCPDA 126 . This 
streptavidin based macromolecular complex (SBMC), has already been used as a multiple 
fluorescent label in time-resolved fl uoroi mmuno assays (TR-FIA). 
In comparison to other isotopic and nonisotopic methodologies, the system lacks sensitivity 
(detection limit of 4ng of biotinylated DNA on Southern blot). However the SBMC reagent 
is stable for over a year, and signals on nitrocellulose are stable for months and are visible 
on UV illuminators with the possibility of instant visualisation and photography. Also, 
unlike the DELFIA system, the label has the potential to be adapted for both Northern and 
Western blots. 
Mathis et al. have recently reported on the TR-flUOTescent detection of DNA hybrids on 
dot-blots]27 
. 
The Process utilises DNA or oligonucleotide probes labelled with bi0tin, 
followed by recognition by streptavidin conjugated to a europium. (III) cryptate as the 
fluorescent label. The structure of the molecule is shown in Figure 5.5. 
One of the main advantages of the europium cryptate is its exceptional thermodynamic and 
kinetic stability compared with conventional eUTOPIUMchelates, and the shielding provided 
from the solvent molecules means that unlike both the DELFIA and Cyberfluor systems, 
the extra step for the formation of the fluorescent complex is eliminated as the europium 
cryptate is permanently fluorescent. This property of the cryptate allows the direct 
measurement of fluorescence in the medium and solid supports (dot-blots). Measurements 
can be performed several times, the sensitivity reaching 2amol of target DNA. 
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Because of the complexity of indirect hybridisation assays like those described above, 
direct hybridisation assays are preferred. Direct labelling of nucleic acid probes with 
europlurn chelates, apart fron simplifying the assay procedure offers the possibility of 
greater sensitivity. However, direct labelling brings about its own problems besides the 
labelling chemistry, namely the stability of the europium chelate under the demanding 
conditions used in hybridisations. 
Hurskainen et aL have described a simple chemical method for direct labelling of DNA 
with a europium. chelate"""'. The sensitivity of Eu-labelled DNA probes depends on the 
labelling degree and the hybridisation efficiency of the labelled probe. Thus Eu-labelling 
chemistry should allow the incorporation of large numbers of Eu-chelates into DNA 
without sacrificing its hybridisation efficieny. 
Hurskainen's approach was to introduce primary aliphatic amino groups into DNA using 
a transamination reaction. Cytosine bases undergo transamination reaction in the presence 
of sodium bisulphite and an amine. By using ethylene diamine, they were able to 
incorporate free aliphatic amino groups into single stranded DNA, which were subsequently 
reacted with the isothiocyanate derivative of the europium chelate. (Scheme 1.4 ) 
Although the whole process is lengthy, it allows the labelling of large amounts of DNA. 
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Scheme 1.4 Chemical labelling of DNA wiLh a europium, chelate. In the first reaction the cytosine bases in 
DNA are transaminated in the presence of sodium bisulphite and ethylenediamine. In the second 
reaction the modified DNA is reacted with an isothiocyanate derivative of the europium chelate. 
However, europium labelling affects DNA by lowering the thermal stability of the duplex 
and the hybridisation efficiency and although the transamination reaction is a very efficient 
method of modifying DNA, allowing the Eu-labellIng of practically all deoxycytosine 
residues , it needs to be carefully controlled to minimise the extent of labelling. They 
describe the incorporation of 4 to 8 Eu-chelates per 100 bases as the optimum degree of 
labelling that makes sensitive and specific hybridisation assays possible"'. 
These Eu-labelled probes have been used in the detection of adenovirus in clinical 
specimens, fixed onto nitrocellulose and hybridised against Eu-labelled adenovirus DNA. 
Simple and sensitive sandwich and solution hybridisation assays with Eu-labelled DNA 
probes have also been made in microtitration wells for the detection of cytomegalovirus 
and human papillornavirus, detection limit being 5xIO' molecules of target DNA. A 
comparison between the sensitivities of Eu- and "P-labelled DNA probes showed only 
minor differences. 
Europium. labelling of DNA can also be achieved enzymatically by nick translation. Here 
in the presence of all four deoxynucleotide triphosphates, one or more of which carry a 
label, the enzymes DNA polymerase and deoxyribonuclease incorporate the labelled 
nucleotide into double-stranded DNA. An alternative method introduced in 1983 by 
Feinberg and Vogelstein is random priming. 125,129 
The properties and use of enzymatically Eu-labelled DNA probes are identical to those of 
chemically labelled ones. 
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1.6.3 Europium Labelled Oligonucleotides. 
Nowadays, there is a tendency to employ short oligonucleotides instead of longer poly- 
DNA fragments as hybridisation probes. This has come about from the development of the 
polymerase chain reaction (PCR), which by amplifying target sequences by up to 10' times 
before hybridisation has overcome the lack of sensitivity associated with the use of 
synthetic oligonucleotides. 
The advantages of oligonucleotides are that they can be synthesised in large quantities even 
by non-chemists using modem oligonucleotide synthesisers. They are characterised by rapid 
hybridisation kinetics, allowing the assay to proceed at low temperatures and in a much 
shorter time period, high specificity and the denaturation step is eliminated. 
Modem oligonucleotide synthesisers have also meant that the preferred method of labelling 
of oligonucleotides With Eu-chelates is to incorporate primary amino groups into the 
oligonucleotide during synthesis (Figure 5.6). 
By using an amino-modified building block such as diaminohexane modified deoxycytidine 
phosphoramidite, the fuctionalised base can introduced at any position during the synthesis. 
Although it is possible to intoduce up to 50 modified bases to the 5'-end of the 
oligonucleotide, a tail of 15 to 25 modified nucleotides is generally used. After deprotection 
and punfication of the oligonucleotide containing the modified bases, the Eu-chelate 
containing an isothiocyanate is reacted with the primary amino groups avallable. 
Hurskainen et aL have successfully labelled a single oligonucleotide with 35 Eu-chelates, 
although 15-20 Eu-chelates is sufficient for very good sensitivity. 125,130 
Unlike direct labelling, the melting temperature (T. ) and the hybridisation kinetics do not 
seem to be significantly affected by the labelling procedure. 
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Figurc. 5.6 Synthesis of Eu-labelled oligonucleotides. A. The fully protected diaminohexane- 
modified cytidine, is incorporated at the 5' end of the oligonucleotide during synthesis. B. The 
deprotection and purification is carried out standard procedures. C. The isothiocyanate analog of 
the Eu-chelate is reacted to the amino groups avaliable on the modified oligonucleotide. 
By using europiurn labelled oligonucleotides as hybridisation probes, Sund et aL were able 
to achieve a detection sensitivity of 4xI 06 target molecules (200pg), in a direct 
hybridisation format. "' Dahlen et aL have developed a rapid in solution hybridisation assay 
for detecting in vitro amplified nucleic acid sequences (Figure 5.7)"o, "'. 
Two probes complementary to the amplified DNA are allowed to hybridise simultaneously 
with the amplified target sequence. One of the probes is labelled with Eu-chelates, and the 
other is labelled with biotin. The formed hybrid is collected onto streptavidin coated strips 
employing affinity based collection. The bound europium is dissociated with the 
enhancement solution before measurement of the luminescence. 
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This methodology has been successfully applied to the detection of the human 
immunodefficiency virus (MV)-1, with a sensitivity of 10' target molecules. "' 
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Figure 5.7 Schematic presentation of PCR amplification and a solution hybridisation assay employing labelled 
oligonucleotides. The cells are lysed, and the PCR performed on the crude sample. Two probes, one biotinylated and the other labelled with Eu complementary to the amplified fragment, are hybridised to the same target. The hybrids are subsequently collected onto streptavidin-coated 
microtitration. wells. The bound europium is dissociated with an enhancement solution before 
measurememt of fluorescence. 
Europium-labelled allele-specific oligonucleotide probe has been used for the detection of 
a single base change in the human genome. "' The Eu-labelled oligonucleotide probe is 
designed in such a way that the point mutation site is in the middle of the hybridisation 
sequence. By washing under stringent conditions only the perfectly matched probes Will 
remain hybridised. 
Work has also started by the Wallac-Oy group on the application of Eu-labelled 
oligonucleotides in the diagnosis of genetic disease and oncogene detection. 
68 
An earlier approach by Valet et aL to the multiple labelling of ollgonucleotides with 
lanthanide chelates involved the use of psoralen derivatives, """" This chemistry has 
already been used for the photochemical labelling of DNA with biotin and Terbium 
chelates. 
Psoralens undergo photochemical cycloaddition reaction with pyrimidine bases (Thymidine 
in DNA and Undine in RNA). The reaction proceeds in two steps: in the first, the psoralen 
forms an intercalation complex with the duplex, and in the second, light induces the 
cycloaddition reaction between the pyrimidine bases. (Scheme 1.5)' 
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Scheme 1.5 Photocycloaddition of psoralen to thymine 
In Valefs approach (Scheme 1.6), a double stranded poly(A-T) tail is attached to the 5'- or 
T-end of the synthetic oligonucleotide to be labelled. After denaturation, this poly(A-T) tail 
folds back under reannealing conditions to form a partly duplex oligonucleotide (step 2). 
The duplex poly(A-T) tail is then covalently crosslinked by psoralen molecules containing 
reactive thiol or amino groups for the attachment of labels. In Vale6 case, the label 
consists of a terbium chelate of DTPA-pAS, which is attached to the intercalated psoralen 
molecule. The assumed structure of this terbium chelate bound to the psoralen moiety is 
shown in Figure 5.8. 
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Scheme 1.6 The preparation of end-labelled oligonucleotides via functionalised psoralen 
derivatives. R is the deprotected oligonucleotide of ant sequence of interest. P is the psoralen 
moiety, X is the reactive group (either S or NH), and M is the label. The structure in step H 
ensures the most stable loop size of four nucleotides with maximum base pairing. 
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Figure 5.8 Proposed structure of Tb3+-DTPA-pAS attached to 
the primary amino group of one psoralen moiety in an 
oligonucleotide (X-M in Scheme 1.6). 
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Two very recent papers have reported the use of europium chelates as labels for the TR- 
fluorescence detection of polymerase chain reaction (PCR) products, 
In the first, Diamandis and co-workers describe a new method for the quantitative 
assesment of PCR products directly on agarose gels. "' The method involves the labelling 
the 5-end of one PCR primer with the europium chelator 4,7-bis(chlorosulphophenyl)- 1,10- 
phenanthroline-2,9-dicarboxylic acid (BCPDA). After PCR the products are separated by 
agarose gel electrophoresis. The gel is then immersed in to an aqueous Eu 3+ solution. 
During soaking, Eu 3+ diffuses into the gel and associates with BCPDA to form a long lived 
fluorescent complex. The complex is then quantified in the gel with scanning TR- 
fluorometry. A feature of this method is that neither BCPDA nor EU3' are fluorescent by 
themselves, and thus background signals are very low. The detection limit was about 5ng 
of cytornegalovirus DNA. 134 
They also showed that by inimobilising BCPDA labelled PCR products on to nylon 
membranes by blotting, these could be detected using an anti-BCPDA antibody With an 
alkaline phosphatase-based detection system. BCPDA may be a useful hapten for DNA 
labelling and may find applications similar to those of digoxigenin. 
In a more sophisticated approach, Mathis et aL report the detection of DNA PCR products 
by europium. (HI) tris-bipyridine cryptate. 13' This is illustrated in Figure 5.9. The procedure 
is a standard PCR amplification with outer primers (a, b), after the PCR products are diluted 
a second PCR amplification is carried out with inner (modified) primers (c, d). The DNA 
hybrids bearing biotin and 2,4-Dinitrophenol (*) moieties are then affinity collected on 
a streptavidin(SA) coated microtitre plate by their biotin end. Fluorescence detection is then 
carried out at the DNP labelled end by using anti-DNP anti-body labelled with TPB(Eu") 
cryptate 
The procedure was used in the detection of human papillomavirus type 16 DNA in clinical 
cervical smears. 
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Figure 5.9 Detection of DNA PCR products by europium(IH) trisbipyridine cryptate. 
After standard amplification with the outer primers (a, b), the PCR products were diluted and a 
second amplification with the inner (modified) primers(c, d) was performed. The DNA duplexes 
obtained were immobilised by their biotin end (0) onto streptavidin (SA)-coated microtiter plate. 
TbP detection was carried out by the DNP (*)-labelled end using an anti-DNP antibody coupled 
to europium. cryptate (K). 
1.7 HOMOGENEOUS (NON-SEPARATION) DNA ASSAYS. 
that they rely upon binding the The majority of DNA assay formats are heterogeneous, 11 
polynucleotide analyte to an insoluble support material. This 
facilitates the separation of 
hybridised and unhybridised polynucleotide probes so that only labelled probe hybridised 
to the polynucleofide target is measured. Less common are homogeneous or solution-phase 
hybridisation assays. These assays rely upon a labelling strategy in which the measurable 
charecteristic of the label is altered 
by hybridisation between the target and the probe. 
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Potentially fluorescence resonance energy transfer (FRET), sometimes called F6rster energy 
transfer offers the basis for detecting nucleic acid hybridisation under homogeneous 
conditions. F6rster exchange of energy occurs by a dipole-dipole induced mechanism and 
does not require orbital overlap (direct chemical bonding). The efficiency of energy transfer 
is given by equation 2: 
d-'/(d -6 + R. -6) ............................................... 
where d is the distance between the centres of the donor and acceptor molecules and RO 
is a variable depending on factors such as the spectral overlap integral. "', 137 Forster energy 
transfer can occur over relatively long distances, up to 50 or even IOOA, and this means 
that, provided the local concentation is such that the two tags (energy donor and energy 
acceptor) are Within such a distance of each other, energy transfer will occur, creating a 
distinct signal. 
One of the first groups to exploit the FRET principle in the detection of nucleic acid 
hybridisation were Zarnecnik et aL They described three approaches to using the FRET 
principle. (Figure 6.0)6 a 
5 
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Figure 6.0 Strategies for determining nucleic acid hybridisation by FRET. (a) Fluorescent 
probes are covalently attached to the 5' ends of complementary nucleic acids, allowing energy 
transfer to occur between a donor (D) and acceptor (A) fluorophore over the length of the 
hybridised complex. (b) Fluorescent molecules are covalently attached to two nucleic acids, one 
at the 3' end and the other at the 5' end. The fluorophore-labelled nucleic acids are complementary 
to disticnt but closely spaced sequences of longer, unlabelled nucleic acid. (c) An intercalating dye 
is used as a donor for an acceptor fluorophore covalendy attached at the 5' end of one of the 
nucleic aicds. 73 
In the first and second approach, fluorescein (donor) and rhodamine (acceptor) were 
covalently attached either the 5'-ends of two probes or the 5'-end of probe and 3'-end of 
a second probe. Upon hybridisation to the target, where both probes are bound, the two 
labels are brought within short proximity of each other, and on irradiation the excited-state 
energy of the donor fluorophore is transferred by F6rster transfer to the neighbouring 
acceptor fluorophore. The results are a decrease (or quenching) of the fluorescein intensity 
and an enhancement of the rhodamine emission. In the third design, an intercalating dye 
such as acridine orange is the donor fluorophore to a single rhodamine covalently attached 
to the 5-end of one probe. This is a very interesting idea, for only upon hybridisation to 
form the duplex Will acridine orange be able to intercalate and thus be nera enough to the 
acceptor foe energy transfer to occur. 
The findings of Zamecnik et al. have been used in several homogeneous assay designs, 
employing different combinations of energy donors and acceptors. 
Morrison et al. describe a rather complicated competitive hybridisation assay using 5'- 
fluorescein labels whose fluorescence is quenched by either 3'-pyrenebutyrate or 3- 
sulphorhodamine labels. Probes prepared in this manner were able to detect unlabelled 
target DNA by competitive hybridisation producing fluorescence signals which increased 
with increasing target DNA concentration. 7,138 
In another approach, a luminol-labelled probe is hybridised to the target in the presence of 
ethidium bromide. The chemiluminescent emission spectra from luminol overlaps the 
absorption spectrum of ethidium bromide, leading to a fluorescent signal. 
' 
However, all of the above methods by using traditional organic fluorophores suffer from 
low sensitivity of detection due to high background fluorescence. 
It comes as no surprise that efforts to improve the sensitivity of such homogeneous assays 
has concentrated on the use lanthanide chelates . 
In a very recent patent, the ideas of Zamecnik et aL 
for the development of homogeneous 
nucleic acid assays has taken a step 
forward in terms of the sensitivity of detection. 
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Wetmur and co-workers 13' by using a terbium chelate (energy acceptor, E, ) attached to the 
probe oligonucleotide were able to sensitise long lived Tb 3+ fluorescence through 
fluorescence resonance energy transfer from an intercalating dye as the energy donor (EI). 
This process can only occur once probe and target have hybridised to form the duplex. The 
assay they describe is essentially homogeneous, for intercalation is a characteristic property 
of the duplex and thus, there is no need to remove unbound probe molecules. This is dealt 
in more detail in chapter 2. 
A slightly different approach is taken by Oser and Valet but still using terbium as the label. 
They describe a system involving suitable pairs of ollgonucleotides as probes, chemically 
modified to form a ternary Th" complex upon hybridisation with a target nucleic acid. 
(Figure 6.1)140 Upon photoexcitation, the salicylate group of one oligonucleotide, serving 
as a sensitiser ligand is able to transfer the excitation energy to the lanthanide ion of the 
second oligonucleotide, resulting in Th" specific, long-lived fluorescence emission. 
TEMPLATE DNA 
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Figure 6.1 
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The approach of Oser and Valet, although showing only modest differences in fluorescence 
between the hybridised and unhybridised probes, throws up many interesting ideas. The 
oligonucleotide sequences are chosen in such away that after hybridisation to the 
complementary DNA strand, the energy donor (pAS) and energy acceptor (DTPA-Tb") are 
positioned in direct proximity. Compared with ternary complex formation in free solution, 
the formation of a complex between DTPA-Tb'. ' on the one hand and salicylate on the 
other is strongly favoured on the DNA template. 
1.8 RUTHENIUM AS NON-RADIOACTIVE LABELS. 
The considerable problems in using the lanthanides and their complexes as reporter 
molecules in both immuno and DNA assays has forced some people to look at ruthenium 
(H) complexes as potential non-radioactive labels of biolgical molecules. 
One of the biggest advantages of utilising ruthenium (II) is the fact that its chelation 
chemistry is less demanding than those of either europium or terbium, with nitrogen 
containing ligands able to form strong and stable complexes. 
Banwarth et aL have shown that Bathophenanthroline-ruthenium (H) complexes (87) show 
a number of properties which make them ideal non-radioactive labels to the already well 
established Eu" complexes. 141,142 (Figure 6.2). These complexes are thermodynamically very 
stable, and therefore do not dissociate at low concentrations. They are chemically very inert 
and show strong long-lasting fluorescence, allowing detection by time-resolved 
techniques. 
Where L' bore a linker arm with a terminal alkyl carboxy group (88), the corresponding 
RuP(bathophenanthroline) complexes were coupled to 5'-NH2-modified oligonucleotide 
probes through a carboxamide bond. "'Tbe end-specific attachment, coupled with a spacer 
molecule,, ensured minimal interference of the complexes during hybridisation processes 
to target complementary DNA sequence, during which no quenching of the ruthenium 
luminescence was observed. The detection limit corresponded to 10-"mol or 6xlO' 
molecules of target. 
in more recent work Banwarth and Schmidt have been able to couple Ru- 
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bathoPhenanthroline complexes directly to oligonucleotides in the course of their synthesis 
on a solid support by the phosphoramidite procedure. "2 This is made possible by L' 
bearing a hydroxy function (89). 
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By choosing a suitable transmitter molecule as an energy donor, which can be incorporated 
into an oligonucleotide a Iready labelled with the RO-complex, Banwarth et aL were able 
to create a fluoresecence energy transfer system. "' They showed that the chromophoric 
system 6,7-dimethyl lumazine (6,7-dimethylpteridine-2,4(IH, 3H)-dione) (90) is able to act 
as an energy donor, transfering absorbed energy onto bathophenanthroline-Ru(II) complexes 
acting as energy acceptors via the long-wavelength metal-to-ligand charge transfer (MELCT) 
band. (Figure 6-3) 
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By incorporating 6,7-dimethyl lumazine into the Y-end of one oligonucleotide probe and 
Ru(II)-bathophenanthroline at the 5'-end of a second oligonucleotide probe by standard 
solid phase DNA technology, they were able to show by energy transfer measurements that 
a clear differentiation is possible between the hybridised and unhybridised state of two 
complementary and non-complementary oligonucleotide strands. 14' (Scheme 1.7) 
A doubling of the fluorescence intensity was observed in cases where hybridisation- 
mediated energy transfer was possible. 
Energy 
transfer no energy 
5 transfer 
energy acceptor (Ru complex) 
energy donor (lumazine moiety) 
Scheme L7 
They were also able to demonstrate that an arrangement in which two oligomers hybridise 
side by side to a single stranded complementary DNA target ("kissing probes"), resulted 
in energy transfer of the same order of magnitude as observed above. 
In the absence of a 
complementary DNA target, where the side 
by side arrangement is not possible, no energy 
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transfer is observed. "' (Scheme 1.8) 
This method, therefore lends itself to the development of homogeneous DNA assays. 
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Barton et al have developed Ru(phen), 2+ (phen= 1,10-phenanthroline) and its derivatives 
as spectroscopic probes of DNA structure"', based on the well characterised photophysical 
properties of Ru(H)-polypyndyl complexes. "' These complexes are intensely coloured 
owing to the well- charactensed localised metal-to-ligand charge transfer (MELCT) transition. 
Importantly this transition is perturbed on binding to DNA. Extensive photophysical studies 
have indicated that Ru(phen)2', bound to DNA displays an increase in luminescence owing 
to intercalation. Using chiral complexes of Ru(phen)3 2' and Ru(dpp)3 2+ (dpp= 4,7-diphenyl- 
1,10-phenanthroline) they were able to distinguish between right- and left-handed DNA 
helices by observing enantiomeric selectivity in binding to right-handed DNA. 145,147 
(Figure 6.4) 
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More recently, the complex [Ru(bpy)2DPPZ]2' (bpy= 2,2'-bipyri dine, DPPZ= dipyrido[3,2- 
a: 2',, 3'-c]phenazine 91 was shown to be a remarkable luminescent reporter of DNA 
structure. 148 (Figure 6.5) The probe is described as a molecular "light switch" for DNA, and 
shown no photoluminescence in aqueous solution at ambient temperatures , 
but displays 
intense photoluminescence in the presence of double-helical DNA, to which it binds avidly 
by intercalation. By intercalation into the hydrophobic environment of the helix protection 
is afforded to the phenazAne ring from quenching by interaction with water molecules. 
By tethering a dppz complex of Ru(II) to an oligonucleotide probe, a sequence-specific 
molecular light switch to target single-stranded DNA is obtained. (Scheme 1.9)"' 
Little luminescence is apparent for the single-stranded complex. Addition of the 
complementary strand, however yields intense luminescence. In contrast, the addition of 
a noncomplementary strand produces no detectable emission. (Figure 6.6) 
I 
Figure 6.6 Emission spectra of the single stranded metallated complex in the presence of its complementary 
strand (Ru7--), in the absence of added oligonucleotide. (Ru-), and in the presence of a 
noncomplementary strand (R-tr-+-). Excitation is at 440 mn. Intense luminescence is observed only 
in the presence of the complementary strand. For RU7--- (D = 0.007 1, while Ru(phen), dpp2' 
noncovalently bound to oligomer gives (D = 0.0063. 
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2.1 INTRODUCTION. 
Nucleic acid hybridisation with a labelled probe is the only practical way to detect the 
presence of a complementary target in a complex nucleic acid mixture. The aim of this 
work was to develop a new and sensitive detection system for the identification of a target 
DNA sequence in a strand of DNA. 
The range of hybridisation assays are many and varied and the number of such assays 
currently in use has grown tremendously over the last few years. The majority of assay 
formats are heterogeneous (two phase) in that they rely upon binding the polynucleotide 
target to an insoluble support material. This facilitates the separation of hybridised and 
unhybndised polynucleotide probes (usually in excess) so that only the probe hybridised 
to the target polynucleotide is measured. We aimed to develop a homogeneous or (single 
phase) assay method where we eliminate the need to separate target DNA and probe 
system from any excess of reagents. 
Homogeneous hybridisation assays have been few and far between. The problem with 
developing an homogeneous assay has been to find a signalling system where the 
measurable characteristic of the label is altered by hybridisation between probe and target, 
without the generation of signals by the reagents or excess of reagents. The approach 
chosen was to exploit the characteristic of DNA strands to hybridise with complementary 
strands to form a duplex, so that a signal would only be generated when this process had 
occurred. The advantage of this approach is the assurance that the assay system would 
have the appropriate selectivity. 
The rules for complementarity in the hybridisation of DNA strands are reasonably well 
known and the chances of mismatches can be estimated and, by the use of long enough 
probe strands, minimised'. Calculations have shown that the minimum length a synthetic 
oligonucleotide needs to have to recognise a single specific sequence is I 1- 15 nucleotides. 
Tbus short synthetic oligonucleofides can be designed to recognise selectively a target 
nucleic acid. This is a fundamental prerequisite for the design of DNA assays. 
' 
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For the reasons outlined in section 1.2 the luminescent properties of europlum provided 
a suitable approach for the design of a signalling system. In particular the known 
propensity of europium ions only to luminesce when certain conditions are fulfilled, 
including: - 
(1) the exclusion of most of the solvent water from the chelating shell, 
(II) the need for a ligand to act as a photosensitiser to excite the ion, 
(IH) the delayed luminescent properties of the excited europium ions enabling 
the use of time delayed luminescence (gating) techniques, thus minimising 
the problems caused by short-lived background luminescence, and 
the fact that europlum emits in the red region, an area where photodetectors 
are most sensitive. 
Two commercial heterogeneous assay methods utillsing europium luminescence have been 
on the market for a number of years, the DELFL4, ' and CYBERFLUOR' systems. Since 
their arrival on the market many procedures for assaying a wide variety of biological 
molecules based on either method have been patented. All of these are essentially 
heterogeneous assays. For a homogeneous assay the envisaged key components for 
obtaining a luminescent signal are summarised in figure 2.1. Only when the europium ion 
(Eu"), the sensitiser (S) and a shielding ligand (L) come together can light be used to 
generate the characteristic europium emission. 
EU3 ++L Eu 3 +. L+S EU3 +. L 
0,0 0- 
0 0 EU3+ 
(0 
00000 
0 C) 
0= H20 
0 
EU3+ 0 
c 
ELr 
0 
0 
Figure 2.1 
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2.2 APPROACHES CONSIDERED. 
Several schemata were envisaged and are outlined in figures 2.2 and 2.3 
(A) Direct binding of europium to functional groups on the bases. (Figure 2.2) 
Bonding to specific (or modified bases) 
Shielding ligand 
I] Intercalating agent (energy transfer moiety) 
Figure 2.2 Interaction of europium with DNA-modified bases 
The problem With all three approaches is that one has no or little control on the 
photophysical properties of natural bases, which would not be expected to sensitise 
europium luminescence. Also any approach at synthesising chemically modified bases that 
would be capable of strongly binding europlum might negatively affect the ability of the 
polynucleotide probe to hybridise with its target strand. Considering the homogeneous 
nature of the assay that is envisaged, together with the concentration ranges that we hope 
to work in, the possible effects of the bulky labels in preventing hybridisation of the bases 
adjacent to these labels would severely limit the sensitivity and specificity of this 
approach. 
Figure 2.2 (3) illustrates the use of a secondary sensitiser molecule bound as an 
intercalator. This is an interesting approach and will be discussed in the next section. 
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(B) Use of tethered chelates of Europium. (Figure 2-3) 
JL 
-1 
2 
Intercalator (energy transfer moiety) 
Sensitiser attached to intercalator 
Binding ligand 
Sensitising ligand 
Figure 2.3 Tethered chelates of europium 
3 
This approach proved to be the most useful and of the three schemes proposed those 
illustrated by Figure 2.3 (2) and (3) were the most attractive. The approach Illustrated by 
Figure 2.3 (1) was dismissed at an early stage because the requirements for europium 
sensitisation appear to be very specific and at the time this work was started no confirmed 
example of the "through space" (Fluorescence Resonance Energy Transfer, FRET) 
sensitisation of europium luminescence in aqueous solution had been reported; all 
examples involve sensitisation by attached ligands. 
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The ideas embodied in Figure 2.3 (1) using FRET was first explored by Zamecnlk et aP 
(Figure 6.0, Chapter 1), with a practical system appearing in a European Patent6 towards 
the end of our work. 
In their patent Abrahams el al' describe a type Figure 2.3 (1) system for the detection of 
a polynucleotide analyte by means of energy transfer. The presence of the target 
polynucleotide is thus determined by hybridisation with a modified polynucleotide probe 
comprising of bound terbium as the energy acceptor (E2) attached via a short linker arm 
to the probe. The energy transfer moiety (E I) is an intercalating agent such as an aromatic 
dye whose emission spectra ovelaps with the absorbtion spectra of terbium. As the 
intercalation process proceeds along the hybrid, the energy acceptor and emitter fall within 
the F6rster radius resulting in energy transfer and subsequent delayed fluorescence from 
terbium. However, there are no figures as to the sensitivity of the assay or any description 
of using europium as the energy acceptor, although there are claims within the patent 
covering the application of europium. 
In approach Figure 2.3 (2), it was envisaged that a cooperative ligand system was 
required. One in which two different ligands could surround the europlum ion once 
hybridisation between probe and target had taken place, where one of the ligands was an 
appropriate sensitiser attached to an intercalating agent, and one was a tight europlum. 
binder attached by a short flexible chain to the probe strand. On hybridisation with the 
target the europium chelate would be held near the duplex, which would now be capable 
of intercalating with the appropriate sensitiser ligands. The consequence of this overall 
cooperativity is that the local concentration of the components is dramatically increased 
at the target and hence the signal is generated only at this site. The steps leading to the 
final ternary complex around the europlum ion, once hybridisation has taken place is 
shown schematically in Figure 2.4. 
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Target 
Probe 
EU3+ 
ielding ligand 
Tethered handle 
HYBRID 
Sensitiser 
A 
Flexible link 
Intercalator 
+ 
Figure 2.4 Schematic representation of 'our' approach 
The ideas represented in Figure 2.4 were the results of numerous experiments with various 
shielding and sensitising ligands over along period of time, culminating in the design of 
two different, but cooperating ligands for europlum. Each ligand with its own 
predetermined function would, in aqueous solution, encapsulate the metal ion, replacing 
its hydration sphere, and thus prevent the deactivation pathway of the excited state, 
resulting in europim luminescence: in effect an observable switch. 
hv 
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The work can be divided into two different topics: 
A. SYNTHETIC WORK. (Section 2.3) 
(a) A search for non-sensitising or shielding ligands that can be easily attached to 
a polynucleotide chain by variable chain lengths and which can shield the 
europlum ions from the ingress of water but not inhibit the approach of a 
sensitising ligand. 
(b) A search for a range of ligands capable of sensitising europlum luminescence. 
(c) The attachment of the photo sensiti sing unit to the intercalating agent and the 
attachment of the shielding ligands to the polynucleotide strands. These 
represent the components of the actual probe system. 
B. LUMINESCENCE STUDIEES. (Section 2.4) 
(a) Studies on the cooperativity of the sensitiser and neutral shielding ligands and 
the efficiency of luminescence of the ternary system. Modulation of europium 
luminescence by interaction of the non-photosensiti sing (shielding ligand), the 
sensitising ligand and the europium ion was an essential prerequisite for further 
work. 
(b) DNA studies. Studies with oligonucleotides comprising an actual assay system. 
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2.3 SYNTHETIC WORK. 
(a) Shielding ligands. (Non - sensiti sing) 
A fundamental requirement of the basic scheme is the need to select two ligands that by 
acting cooperatively can surround the positively charged europium ion, forming a cage 
in solution. In their complexes the lanthanide cations behave as typical 'hard' acids and 
interact preferentially With hard bases such as fluoride and oxygen rather than with softer 
bases such as nitrogen, sulphur, phosphorus etc. Lanthanide interactions with the softer 
donors can be achieved in organic solvents of low solvating power; however in aqueous 
solutions, the soft base sites can rarely compete with water. Interaction between Ln 3+ and 
nitrogen donor sites occurs in aqueous solutions for ligands such as the 
aminopolycarboxylates. In these complexes, it is likely that the Ln'+-carboxylate 
interactions produce sufficiently strong bonds With the lanthanide ions and that the 
nitrogen ligands are forced into juxtoposition with the ion, with the consequent 
displacement of water molecules. Many polydentate inorganic anions such as N03- or SO, 2 
form stable lanthanide species and can prevent the formation of lanthanide complexes With 
poorly coordinating ligands. The hard acid character of the lanthanides is evidence that 
their complexation in aqueous solution can be interpreted in terms of an electrostatic 
model. The variety of coordination numbers and geometric structures of lanthanide 
complexes is further evidence that there is no limitation due to the necessity to maximise 
orbital overlap between metal and ligand as in the d-transition metal complexes. 
By assuming that purely electrostatic attractive forces will be responsible for the final 
orgarusation of the two ligands around the positively charged metal ion, we were able to 
refine our design criteria for the shielding ligand. 
From the approach outlined in Figure 2.4 the shielding ligand L needs to have certain 
properties. Ideally it should have a very high binding constant for the europium ion such 
that, at the concentTations of the assay (at anything down to 10-"M) the bound state is 
maintained, In order to ensure no exchange of the europium ion with other metals 
occurs, a slow rate of chelation and dissociation is desirable. If this situation can be 
realised, the europium ion being essentially irreversibly bound to ligand L, the rest of the 
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design parameters become relatively easy to explore since one can consider the Eu'-. L 
complex as a single entity. 
2.3.1 Polyazapolycarboxylic Acids. 
Related to the linear arninopolycarboxylic acids as complexing ligands are the macrocyclic 
poly azapoly carboxyli c acids. In these ligands, amine groups are associated in a cyclic 
alkyl system with pendant carboxylate groups attached to the amines. They have large 
stability constants for complexation with rare-earth cations and very slow dissociation 
kinetics. Because of these characteristics, their lanthanide complexes are of interest as in 
vivo NMR imaging contrast agents, where the chelates must be exceedingly stable in order 
to reduce the toxicity of the metal ion. ', ' Kinetic inertness results from shielding the metal 
ion from attack by water as hydration is usually necessary to cause decomplexation. This 
protection from hydration is closely related to the cavity size and rigidity of the aza ring. 
One of the -first group of ligands that we explored as a possible shielding ligand was the 
derivatives of 'cyclen' (5), namely its tetraacid derivative, 1,4,6,1 0-tetrazacyclododecane- 
N,, N',, N", NI"-tetracetate (DOTA) (1). (Figure 2.5) 
The relative stability constants of the lanthanide complexes of DOTA, TETA (2), NOTA 
(3) and EDTA are: 
DOTA > EDTA > TETA > NOTA 
DOTA is known to bind europium at neutral pH with a stability constant Ks in the range 
i o25- i o26 
, this drops to 10" for calcium which being a common biological ion would be 
in competition for any potential binding site. ', " 
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C02H C02H 
,, N N-, ] 
C02H C02H 
(1) 
Figure 2.5 DOTA 
the (Eu DOTA)- complex. 
The extent of DOTA's encapsulation of the Eu" ion is clearly shown by the crystal 
structure of the NaEuDOTA complex. (Figure 2.6)" This shows 9-coordination, the 8 
donor atoms (four oxygen and four nitrogen) in DOTA in a square antiprism geometry 
about the Eu" cation with the aza ring as one square face and one water ligand associated 
with Eu 3+ ; Eu" can accommodate up to 10 solvent molecules. 
+ Ts\ f-ý 
Ts 
+Na-N N N-Na H Ts Ts Ts cN N3 N lýP. A, B (2) 
NN 
CN 
Ts 
Ts 0N oTs T s7 TsH \-/ \--i 
(3) (4) (5) 
Scheme 2.1 A. DMF,, 1100; B. c. H2SO4,, 900 
The standard literature synthesis of DOTA involves the reaction of the parent aza-crown 
cyclen (5) With chloroacetic acid under conditions where the pH of the system is kept 
at around pH 10 throughout the reaction. The initial synthesis of cyclen (5) was attempted 
using pre-tosylated reactants (Rickman and Atkins). " (Scheme 2.1) 
Although this is meant to be a useful and direct method of obtaining tosylated 
macrocycles with yields of 50% or better, it was found that the reaction which is carried 
out in dry DNff is very sensitive to moisture with yields 
depending on the anhydrous 
nature of the solvent. In our hands 23% 
for the tosylated cyclen(7) was the best yield 
obtained. 
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Figure 2.6 The coordination polyhedron of 
A number of procedures exist for the detosylation of these products to give the parent free 
amine crowns; concentated sulphuric acid for several days at 80', 12 a mixture of phenol 
and 32% hydrobromic acid/acetic acid at reflux", LiAlH" or sodium amalgam. " 
However, it was obvious that a higher yielding reaction was necessary to obtain the 
tosylated macrocycle, for detosylation accounts for a large decrease in the molecular 
weight of the desired product and thus the yields obtained. 
Although there are a number of well established procedures for the synthesis of aza- 
crown ethers, there has been a distinct lack of new methodologies for the synthesis of 
polyaza-crowns. One such procedure developed by Bogatsky and co-workers used phase- 
transfer conditions to obtain a number of macrocyclic poly-N-tosylaza-crowns ethers. 16 
(Scheme 2.2). However, because of the need for the protection and subsequent 
deprotection of the nitrogens, this reaction to form aza-crown ethers has largely been 
ignored and surpassed by simpler procedures. These are the reaction of diacid chlorides 
with diamines under high dilution conditions, successfully used by Lehn and co-workers 
to synthesise a variety of aza-crowns ethers and cryptands. " 
Ts-N 0 N-Ts 
H -M H 
(6) 
Br 0 Br 
(7) n 
m 
0 -, 
B Ts N N-Ts 
0 
n (8) 
m 
ro 
HN NH 
0 
4n 
(9) 
Scheme 2.2 A. (nC4H9)4N + Br /NaOH/PhH; B. HBr/AcOH/PhOH 
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A 
10. H2N N NI-12 TsN N NTs 
H Ts 
(10) (12) 
B, /-\ r--\ /1--ý /--\ C 
HO N OH TsO N OTs Nx Ts Ts 
(11) 
D 
- 
T Ts 
CN N 
N ND 
Ts"o \__j \Ts 
(4) 
(3) X= Br, I 
Scheme 2.3 A. p-toluene sulphonyl chloride, NaOH (aq), 0-50C; 
B. p-toluene sulphonyl chloride, (Et)3N, Et20; 
C. NaX. acetone; D, (nC4H9)4N+Br-, NaOH, PhH. 
The methodology of the phase-transfer approach was successfully applied to the synthesis 
of tetra-N-tosylated cyclen (4). This was obtained in high yields by using the appropriate 
fragments, namely tri-N-tosyl diethylene triamine (12) and the nitrogen mustard N-tosyl- 
bis(2-lodoethyl amine) (13). (Scheme 2.3) The reaction, carried out in one-pot, was over 
in two days. The pure tosylated product (4) was simply isolated by separating the benzene 
or toluene layer, drying it over sodium sulphate and removal of the solvent giving a sticky 
residue which was triturated overnight in methanol, to give a white solid, collected by 
filtration in yields approaching 70%, in an analytically pure state, with no 
chromatography being required. The tosylated N-mustards are all solids which makes their 
handling relatively easy and safe. 
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The versatility of the phase-transfer reaction for ring formation has been applied to the 
synthesis of a number of other N-tosylaza macrocycles which are often difficult to obtain 
through other routes. (Scheme 2.4) 
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Scheme 2.4 
However it was soon obvious that from a purely electrostatic approach, our design of 
sensitiser 11gands with two carboxylate binding sites would be unable to approach the 
coordination sphere of a EU3+ ion held tightly in a complex which had an overall net 
negative charge. Also as the crystal structure of EuDOTA complex shows, only one water 
ligand is able to penetrate the cage of 4 carboxylate groups encapsulating the europium 
ion. The approach of a bulky organic figand as sensitiser would almost certainly be 
hindered. 
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2.3.2 Diazacrown Dicarboxylic Acids. 
A search of the literature revealed a class of macrocyclic aminocarboxylic acids that have 
binding selectivity towards the lanthanide ions in general and within this series, towards 
individual lanthanide ions. 
We initialy focused on 7,13-diaza-1,4,10-trioxacyclopentadecane-N, N'-diacetic acid 
(21) (loosely called '221') (Figure 2.7). Studies by Chang et a/18 on the stability constants 
of complexes of 221 With the lanthanides showed that overall the binding constants are 
high and reach a maximum at Eu` (binding constant 10 "). This is in contrast with results 
obtained for a similar ligand of larger cavity size, 1,10-diaza-4,7,13,16-tetraoxacyclo- 
octadecane-N, N'-diacetic acid (22) ('222) (Figure 2.7), where the highest binding constants 
are observed with those lanthanides with the largest ionic radii. " These results show the 
importance of achieving an appropriate match between a metal ion and the cavity size. 
r-ý 
c-, 0 0 "-) 
H02CH2CN N CH2CO2H 
ý, 
o, 
'ý 
12211 (21) 
c0 0-) 
H02CH2C NN CH2CO2H 
-0 oi 
\-i 
'222' (22) 
Figure 2.7 
Recent studies using a combination of laser induced europium ion luminescence and 
NMER spectroscopy have provided detailed analysis of the solution structure of the 
Eu-221 complex. 19 These studies show that 221 forms a 1: 1 metal-ligand complex, with 
complete coordination of all macrocyclic ligating atoms and two coordinated water 
molecules. A proposed possible structure of the complex is shown in Figure 2.8. 
What this shows is that only one of these ligands can surround the europlum. ion at any 
one time. This leaves a cleft around the europium ion which is able to accomodate a 
second (photo senstising) ligand. The approach of a second chelating 
ligand is made 
possible by the overall net positive charge of the 
Eu-221 complex. 
102 
-0 
F-ý\ 
0 
0 
H2/ OH 
Figure 2.8 Possible structure of (Eu 2.2.1) complex. 
The synthesis of '22 F (2 1) was by using literature methods. (Scheme 2.5) 
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The diglycollic acid (23) was converted to the diacid chloride (24) by reaction with PCI, 
in chloroform, and in two simple steps the 1,2-bis(2-chloroethoxy)ethane (25) was 
converted into the bis-amino ethylether (27). The coupling of these two reactive fragments 
were carried out under high dilution conditions, developed by Lehn. 17 This involves the 
slow addition of solutions (in dry benzene or toluene) of both fragments independently 
over 8-12h to a large vigorously stirred volume of either benzene or toluene at 0-5' 
containing an excess of dry triethylamine, with the whole system under dry nitrogen, The 
high dilution conditions are necessary to prevent polymer formation, and the triethylamine 
is present to 'mop up' HCI that is formed as the cyclisation reaction proceeds, to prevent 
protonation of the amine. 
The desired macrocyclic diamide (28) was obtained in reasonable yields as a white solid 
from the reaction of diacid chloride(24) and diamine (27) under the said high dilution 
conditions. 
The amide (28) was smoothly converted into the parent macrocyclic free amine (29) by 
LAH reduction in TBT, which was purified by Kugelrohr distillation to give the amine 
as a white hygroscopic crystalline solid. Alkylation with ethyl bromoacetate and sodium 
carbonate gave the diester as the sodium bromide complex (30). This 'complex' (the 
cryptand replacing the hydration sphere of the sodium bromide) is decomposed by 
Kugelrohr distillation to give the metal free diester (30)". This was hydrolysed by simply 
stirring in hot water overnight to give '221' (21) as a hygroscopic crystalline solid. 
As luminescent studies later showed, '221' successfully fulfilled its designed role as the 
non-sensitising ligand of a ternary complex; binding Eu" tightly to prevent dissociation, - 
but still allowing the approach of a sensitising ligand. The result is a ternary complex in 
aqueous solution where the central Eu" ion is imprisoned in a cage. The formation of the 
ternary complex results in the displacement of coordinated water molecules and leads to 
the first reports of efficient sensitisation of europium luminescence in aqueous solution. 
The luminescence data will be discussed in section 2.4.3. 
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Other synthetic routes to diaza-crowns were also examined, as the nature of high dilution 
cyclisations renders them unsuitable for large scale preparations. These fall into the 
category of methods involving a protection/deptotection sequence, for example using 
either the tosyl or benzyl groups to protect primary amines. 
Synthetic work focused on the use of the benzyl protecting group as used by Gokel el 
al. (Scheme 2.6)" 
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Scheme 2.6 A. 
, 
PhCH2NH2,, Et3N, PhH, 00; B. LiAJH4, THF; 
C. 1,, 2-Bis(2-chloroethoxy)ethane, Na2CO3, Nal, MeCN; 
D, Na/NH3(liq), THF 
The reaction of the diacid chloride (24) with benzylamine proceeds in very high yields, 
to give the desired diamide (3 1) as a white crystalline solid. This was converted aRain in 
high yields to the corresponding secondary amine (32) by reduction using LAH in TBIF 
The cyclisation of this amine fragment with bis-iodoethoxy ether (17) is carried out in 
acetonitrile using sodium carbonate, using conditions which were not 
high dilution to give 
the cyclised N, N'-dibenzyl- 15 -crown- 5 (33) as a clear oil. The 
high yields are due to the 
template effect of the sodium carbonate. This effect has been studied and proved 
for a 
large number of macrocyclic systems of 
differing ring size. 22 
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Although debenzylation of the aza crown (33) by catalytic hydrogenolysis under pressure 
is claimed to work efficiently, 2' this requires access to high pressure hydrogenators. 
Attempts to deprotect the nitrogens using conventional atmospheric hydrogenolysis or the 
use of catalysed hydrogen transfer methods failed to give clean deprotection, reactions 
being slow, only partially complete and with some degradation of the crown system. 
Others methods like the use of sodium in liquid ammonia were studied. Using a solution 
of sodium in liquid ammonia with the absence or addition of small quantities of a proton 
source, such as ethanol, gave poor results. This was found to be due to the virtual 
insolubility of the aza-crown (33) in the solvent! During the reaction the aza-crown 
tended to settle out as a viscous mass on the sides of reaction vessel. This problem was 
readily overcome by using an appropriate mixed solvent system, in this case adding a 
solution of the aza-crown in anhydrous THF to a 2: 1 mixture of liquid ammonia and TBF 
containing the dissolved sodium. Under these conditions a smooth deprotection resulted 
and work-up involving Kugelrohr distillation gave the free 4,1 0-diaza- I 5-crown-5 (29) in 
high yields. This methodology has been successfully used deprotect large quantities > 50g 
of numerous dibenzyl diaza-crowns. 
The initial results from the luminescence studies with '221' (21) encouraged us try and 
attach potential handles to the aza-crown frame work, enabling attachment to biological 
molecules. 
One of the first compounds targetted was the bydroxymetbyl substituted diaza- I 5-crown-5 
(34) (Figure 2.9). The key intermediate in its synthesis is the diacid chloride (3 7). The 
synthetic route to (37) is shown in Scheme 2.7 23 
CH20H 
0 0-- 
HN NH 
0 
(34) 
Figure 2.9 
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Readily available allyl protected glycerol (35) (Aldrich), was the starting point for the 
preparation of diacid chloride (37). Reaction of the diol (35) wi I ith potassium t-butoxide 
and chloroacetic acid in t-butyl alcohol (Williamson Ether synthesis), followed by careful 
workup and the use of high vacuum distillation at low temperatures to prevent acid- 
catalysed polymerisation gave the diacid (36) in good yield. Treatment of (36) with oxalyl 
chloride gave a quantitative yield of the desired diacid chloride (37). 
CH20CH2CH=: CH2 
A 
/--< 
CH20CH2CH=CH2 
H 
10 -0 0 -ý 
HO OH O= >: =o 
(35) OH HO 
(36) 
CH20CH2CH=CH2 
-0 0- 
O= =O ci ci (37) 
Scheme 2.7 A. CICH2CO2H,, KtBUO, tBUOH; B. CICOCOCI 
The synthetic route to the hydroxymethyl diaza-crown (34) is depicted in Scheme 2.9. 
Diacid dichloride (37) was reacted with diamine (42), synthesised by standard literature 
procedures (Scheme 2,8)21, under high dilution conditions in the presence of triethylamine 
to form the (allyloxy)-methyl substituted cyclic diamide (38) in moderate yields. 
Deprotection of (38) by isomerisation of the allyl group with palladium on carbon 
followed by acid catalysed cleavage gave the hydroxymethyl substituted cyclic diamide 
(39). The hydroxymethyl diaza-15-crown-5 (34) was obtained by reduction of (39) with 
LAH in T`BF in good yields. Deprotection and reduction was also achieved in a single 
step by the use of a large excess of LAH in TBF, 
A 
ON. 
Cl o Cl N3 0 N3 
(40) (41) 
H2N 0 NH2 
(42) 
Scheme 2.8 A. NaN3, DMSO; B. LiAIH4,, THF 
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Scheme 2.9 A. [42], Et3N, PhCH3,00, (high dilution); 
B. Pd/C,, HC104, EtOH/H20; C. LiAlH4, THF 
D. LiAlH4 (large excess), THF 
Initial attempts at dialkylation of hydroxymethyl diaza-15-crown-5 (34) with 2.1 
equivalents of ethylbromoacetate in acetonitrile in the presence of anhydrous sodium 
carbonate resulted in alkylation at the ring nitrogens (as expected), and an analytical 
sample of the metal free ligand (43) was obtained after repeated Kugelrohr distillation. 
(Scheme 3.0) 
After successfuly obtaining (43), work was at hand to start functionalisation at the 
hydroxy methyl position in (43), by initially trying to form the active ester, but before 
serious practical work could begin an important discovery was made about 
ethyl enediaminetetraceti c acid (EDTA). 
CH20H 
[34] 
A 
Mo. 
CO 
Et02CH2C NN CH2CO2Et 
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(43) 
Scheme 3.0 A. BrCH2CO2Et, Na2CO3, MeCN 
108 
2.3.3 Linear Amin opolycarboxylic Acids 
Aminopolycarboxylic acids like EDTA (44) (Figure 3.0) form very stable multidentate 
complexes with the lanthanides . 
21,2' Typically, these ligands have at least one secondary 
or tertiary amino function and at least two carboxylates. Because of the weak basicity of 
the carboxylate groups in these compounds , the 
lanthanide aminopolycarboxylates must 
owe their unusually high stability to chelation involving the nitrogen donor sites. The 
involvement of nitrogen in the coordination results in the formation of stable five- 
membered chelate rings. 
The actual structure in solution of a metal - aminopoly carboxyl ate chelate will depend on 
the metal ion as well as on structural and thermodynamic constraints of the ligand. As 
coordination numbers of 8 or 9 are common for the lanthanide cations (Ln 3+), few ligands 
fill the coordination sphere in 1: 1 complexes and water molecules are always present. For 
example, LnEDTA-1 complexes have 3 to 4 hydrate waters in the primary coordination 
sphere. 
H02C----, 1 /-C02H 
N: :N 
H02C--/ ý-C02H 
ED TA (44) 
Figure 3.0 
Although EDTA has a very high binding constant for Eu 3+ ions, initial luminescence 
studies (at pH 8-5) showed little enhancement in europium luminescence on addition of 
the sensitiser (2,9-biscarboxylic acid- 1,1 0-phenanthroline) to Eu-EDTA solution. We 
initially considered that this was because the ion is effectively encapsulated by the ligand 
thus preventing the approach of the sensitiser. 
When EDTA is dissolved in water, it behaves like an amino acid, in this case forming a 
double zwitterion structure (HY) at low pH and the fully deprotonated species y4- at high 
pH (Figure 3.1 A-E). The dissociation constants for the deprotonation of H4Y are pK (ca. 
2.0,2.67ýp 6.16 and 10.26). The relative amounts of each of these species as a function of 
pH is Illustrated in Figure 3.2 
26 
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Figure 3.1 
When studies with the EDTA/Eu"/PDCA system was repeated, but this time varying the 
pH of the solution, to our suprise a significant enhancement in the luminescence was 
observed with the pH/La,, locus occurring at (5.5,308). Although it is difficult to predict 
the effects on both binding and dissociation constants for individual ligands involved in 
ternary complexes, it is reasonable to assume that enhancement we are observing is 
consistent with a definite role for probably two perhaps three of the EDTA carboxylates 
being involved in chelation. To test this idea, a couple of EDTA derivatives were 
synthesised. (Scheme 3.1) 
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Figure 3.2 Composition of EDTA solutions as a function of pH. 
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These EDTA derivatives were simply made by reacting the appropriate amine with 
commercially available EDTA-bisanhydride (45) in dry TBF at room temperature. 
Purification of these compounds involved making the mono-or-disodium salt of the 
appropriate carboxylic acid in situ and extracting With ether to remove any unreacted 
amine. The desired ligands were obtained as their sodium salts on evaporation and these 
were further purified by crystallisation from methanol. 
Solution studies with the monobutyl amide derivative (46) in the presence of Eu" and a 
sensitiser (2,9-biscarboxylic acid-1,10-phenanthroline) showed remarkable enhancements 
with a pH/I,,,,, located at (7.5,453! ) (see section 2.4.3.1) 
These two derivatives of EDTA and their method of formation provided a simple answer 
to the problem of attaching a suitable non-sensitising ligand to the probe strand. 
011gonucleotide probes were supplied by Cellmark Diagnostics functionalised with a 
hexyl-amino group at the 5'-end which was simply reacted with EDTA-bisanhydride. (see 
section 2.5.2) 
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Scheme 3.1 A. R-NH2, THF, r. t 
ill 
Sensitising Ligands. 
So far we have dealt with the photophysically inert part of the generallsed assay system 
as illustrated in Scheme 2.4 
By the choice of suitable ligands like the EDTA -derivatives which are able to bind Eu" 
tightly, we can ensure that the lanthanide ion will remain be bound at the biological target 
at low concentrations. However, to observe lanthanide ion luminescence we have to find 
away of channeling energy in to the europium ion. 
Unfortunately, as explained earlier the lanthanide ions are very poor light absorbers (lack 
of absorption bands),, although direct excitation of these ions using powerful lasers is one 
option, used by Horrocks to study metal ion binding sites in biological materials. 27,2' A 
more practical approach is the use of a photosensitising or 'antenna' ligand, as an indirect 
way of obtaining the excited metal state which precedes luminescence from the metal ion. 
This process of sensitisation occurs as a result of intramolecular energy transfer from the 
triplet excited state of the ligand to the emitting levels of the metal ion (see section 1.3, 
Chapter 1). 
In general it is difficult to predict which organic ligands will make effective sensitisers,, 
although one essential property is to have a triplet state higher in energy than the emitting 
state of the lanthanide ion. Also apart from having the right photophysical properties, the 
sensitiser must be capable of complexing the lanthanide ion (lanthanide binding site), with 
water acting as a competitive ligand. These lanthanide binding sites normally incorporate 
powerful binding groups usually iminodiacetates or carboxylates. However, a complication 
as a result of our approach/design is the need that any potential sensitiser has to be able 
to approach and bind Eu" which is already bound in a complex. 
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Balzani and Lehn chose the bipyridines and phenanthrolines as their lanthanide sensitisers 
incorporating them into cryptands. ", " The encapsulation approach was needed to prevent 
dissociation of the lanthanide ion (due to lack of powerful binding groups on either 
ligand). However this approach by its nature does not allow the approach of a second 
binding ligand and would be useless in our cooperative design, 
2.3.4 Simple 1,10-phenanthroline derivatives 
Our initial approach therefore was to find a suitable lanthanide sensitiser based on simple 
ligands. We focussed on 1,10-phenanthroline and its analogues, namely 1,10- 
phenanthroline-2,9-biscarboxylic acid (PDCA) (48), a derivafive of which (49) is the 
4 
photosensitising component of the Cyberfluor system. (Figure 3.4) 
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Figure 3.4 
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Initial efforts concentrated on the synthesis of 1,1 0-phenanthrollne 2,9-biscarboxylic acid, 
PDCA (48), and its simple analogues. The synthesis of PDCA can be achieved through 
two distinct literature routes, both starting with commercially avallable 2,9-dimethyl- 1,10- 
phenanthroline (Neocuproine) (50). Inital efforts concentrated on the Chandler route. 
(Scheme 3.2)" 
Neocuprolne (50) was oxidised with selenium dioxide to the corresponding dialdehyde 
(51) in high yields, Further oxidation of the dialdehyde (51) with nitric acid gives the 
desired dicarboxylic acid (48) obtained as the monohydrate after recrystallisation from 
TBF/H., O. 
0 
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NN- 
(50) 
N N-= 
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Scheme 3.2 A. Se02, Dioxan; B. c. HN03 
[48] 
Although the dialdehyde (5 1) is a useful intermediate in the synthesis of a number of 
important 2,9-disubtituted phenanthroline derivatives like the dicarbonitrile (53) and the 
bisaminomethyl (54) (Scheme 3.3)", residual metallic selenium contamination was a 
problem since it made the purification of the dialdehyde very difficult, and was carried 
forward to contaminate any subsequent derivative. Thus traces of red metallic selenium 
was observed in the diacid (48) even after several recry stall isations. 
B 
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Scheme 3.3 A. H2NOH. HCI, pyridine, EtOH; B. Acetic an y ri e; 
C. 10%PdlClH2,2% HC104, EtOH 
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An alternative route to PDCA (48) reported by Newkome el al', involved the 
bis(trichloromethyl) derivative (55). This was readily synthesised by free-radical 
chlorination of neocuproine (50) with excess N-chlorosuccinimide inCC14using benzoyl 
peroxide as initiator. Hydrolysis of (55) with concentrated sulphuric acid converted the 
bis(trichloromethyl) derivative to the corresponding acid (48), obtained by quenching the 
reaction with water. (Scheme 3.4) 
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Scheme 3.4 A. NCS, CC14, mCPBA,, B. c. H2SO4,900; 
C. c. H2SO4, MeOH,, reflux; D. NaBH4,, EtOH 
After the acid hydrolysis of (55) if solvolysis With dry methanol was carried out instead 
of quenching With water, the bis(methoxycarbonyl) derivative (56) was obtained in high 
yields. This is a useful intermediate, for it is readily reduced with sodium borohydride in 
ethanol to afford the bis(hydroxymethyl) derivative (57), which can be futher derivatised 
by halogenation. 
Other simple 1,10-phenanthroline derivatives synthesised included the monocarboxylic 
acid (62) and the bis(butylamide) (64). The 2-carboxy-1,10-phenanthroline (62) was 
synthesised by the method of Corey. 
" (Scheme 3.5) 
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Scheme 3.5 A. AcOH/H202; B. PhCOCI; C. KCN; D. NaOH/H20 
34 I O-Phenanthroline- I -oxide (5 9) was prepared by the method of Engbersen , in a slightly 
modified procedure to that reported by CoreY33 , resulting 
in improved yields (>80%) and 
purity. Treatment of the I-oxide (59) with benzoyl chloride and potassium cyanide at 
room temperature afforded 2-cyano-1,10-phenanthroline (61) in excellent yields. It is 
interesting to note that the substitution reaction to form (61) takes precedence over the 
Reissert at C-9., N-10, This would require the attachment of benzoyl chloride to N-10 
which is sterically unfavourable. The parent 1,10-phenanthroline has been found not to 
undergo the Reissert reaction under the conditions useful for quinolines. 33,35,36 
Hydrolysis of 2-cyano- I, I O-phenanthroline (6 1) to 2-carboxy- 1,1 O-phenanthroline (62) was 
achieved under basic conditions using aqueous sodium hydroxide. This hydrolysis reaction 
is strongly promoted by metal ions such as Cu" and Ni2l , 
The mechanism is thought to 
involve attack of hydroxide ions on the metal complexed substrate. 36,37 
The starting point for the synthesis of 2,9-bis(butylamide)-1,10-phenanthroline (64) was 
PDCA (48), which was converted to the d1acid chorlde (63) with thlonyl chloride at 
reflux. This was used without further purification, and reacted with two equivalents of 
butylamide in dry CHC13 to afford the desired compound (64) in high yields. (Scheme 3.6) 
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Scheme 3.6 A. SOC12; B. CH3(CH2)3NH2, CHC13, r. t 
Results from the luminescence studies confirmed PDCA (48), as the sensitiser with the 
necessary physical and photophysical, properties required for its designed role in the final 
ternary complex as an efficient sensitiser of Eu". 
From the general scheme 2.4, we envisage the potential sensitiser being attached by a 
short flexible link to an intercalator. (Figure 3.5) 
INTERCALATOR 
SHORT FLEXIBLE LINKMANDLE 
PDCA 
ý=o 
OH Figure 3.5 
HO 
2.4 INTERACTION OF NUCLEIC ACIDS WITH SMALL MOLECULES. 
Intercalafion and the effects of intercalation has been designed in to the assay as a means 
of- 
discriminating between the hybridised and unhybridised probe and 
(11) providing a local concentration effect of the sensitiser near the reporter molecule 
(bound EU3+) over bulk solution once hybridisation between probe and target strand 
has taken place. 
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Molecules and ions interact with duplex nucleic acids in three primary ways which are 
significantly different: 
(a) binding along the exterior of the helix through Interactions which are 
generally non-specific and primarily electrostatic in origin; 
(b) groove-binding interactions which involve direct interactions of the 
bound molecule with the edges of base-pairs in either of the (major or 
minor) grooves of nucleic acids; and 
(c) intercalation of planar or approximately planar aromatic ring systems 
between base-pairs (Figure 3.6)" 
NH3 
Figure 3.6 The three primary binding modes of B-DNA. 
The first two binding modes do not require a nucleic acid conformational change but may 
induce structural transitions on complex formation. Intercalation requires a change in the 
sugar-phosphate chain torsional angles for separation of adjacent base-pairs by a distance 
(typically 3.4A) sufficient to allow insertion of the intercalating ring system. This can be 
accompanied by other changes in the helical parameters such as unwinding, bending, etc. 
Examples of the types of molecules and ions that bind to nucleic acids by three different 
modes are shown in Figure 3.7. 
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Figure 3.7 Examples of cations which bind by the three primary modes. 
2.4.1 Structure of DNA 
Since the double helical Structure of DNA was first described by Watson and Crick" in 
1953 
, it 
has been clear that double stranded polynucleotides ought to be able to adopt a 
wide family of conformations. These helical conformations can now be classified into 
three general families; the A, B, and Z forms, with the A and B forms being right handed 
and the Z form left handed . 
38,40,41 Although each conformation involves a helix made up 
of two anti-parallel polymer strands With the bases paired through W-C hydrogen bonding, 
the overall shapes of the helices are quite different. (Figure 3.8 )42 
The predominant B-form. is a regular right handed helix, with the base pairs oriented 
essentially perpendicular to the helix. It has well defined major and minor grooves, both 
approximately equally deep but with very different Widths, the minor groove being 
narrow, with the major groove being much more open. A-DNA on the other hand has a 
deep yet narrow major groove which is virtually inaccessible to binding by other 
molecules and a shallow but wide minor groove. The base pairs are tilted and pulled away 
from the helix axis, so that the polymer has a cylindrical hole running down its middle. 
The overall effect is that of a ribbon-like structure wrapped around a pole. The Z-form, 
is a left handed helix with a zig-zag sugar phosphate 
back bone, which is adopted mostly 
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by alternating cytosine/guanine sequences. It has a very deep and narrow minor groove 
with an almost non-existent major groove, making it impossible for intercalating agents 
to bind to Z-DNA. 
major 
groove 
minor 
groove 
major 
groove 
minor 
groove 
groove 
B-DNA A-DNA Z-DNA 
Figure 3.8 Space filling (van der Waals) representations of B, A, and Z DNA's 
2.4.2 External electrostatic interactions 
Nucleic acids are highly charged poly electrolytes whose anionic phosphate groups strongly 
affect their structure and interactions. " It is a polyanion, with one negative charge for 
each nucleotide or a charge of -2 for each step along the helix. The helical column is 
therefore awash in negative charge, and it must 'condense' a significant number of cations 
from solution to exist in stable conformations, Manning" has shown that simple ions such 
as the alkali metals associate with nucleic acids largely as a function of the polymer 
charge density. This association of ions with the polyelectrolyte is called counter-ion 
condensation and causes an unfavourable entropy term in the overall polymer 
conformational free energy summation. This unfavourable term is more than outweighed 
by the numerous favouable interactions in the folded polymer (such as the DNA double 
helix). Partial release of these cations on denaturation or on binding of cationic ligands 
to specific nucleic acid sites accounts for the strong dependence of these processes on salt 
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concentration. Multiply charged simple cations such as Mg2' and cations of simple organic 
amines such as 1,, 3-diaminopropane interact with DNA more strongly than mono-valent 
cations (Ne, K' etc. ) and displace these mono-cations from DNA. " 
Water is also bound along the exterior of nucleic acid structures. Its specific interactions 
with polar groups on bases and sugars as well as with the charged phosphate groups are 
essential for the stability of nucleic acid conformations. 
2.4.3 Groove-binding molecules 
The major and minor grooves tend to differ significantly in electrostatic potential, 
hydrogen-bonding characteristics, steric effects, and hydration. Many protein and 
oligonucleotide molecules exibit binding specificity primarily through major groove 
interactions while small, groove-binding molecules in general prefer the minor groove. 
Typically, minor groove-binding molecules share many structural similarities having 
several simple aromatic rings such as pyrrole, furan, or benzene connected by bonds with 
torsional freedom. This creates crescent shaped compounds which, with the appropriate 
twist, can fit into the helical curve of the minor groove with displacement of water from 
the groove. The interior of the crescent shape tend to contain molecules with hydrogen 
bonding N-H groups. These N-H groups form hydrogen bonding with A: T base pairs in 
the minor groove but are excluded from similar interactions with G: C base-pairs by the 
amino group of guanine. " 
2.4.4 Intercalation 
The foundations of the intercalative mode of binding were laid by Lerman as a result of 
his X-ray diffraction and hydrodynamic studies on the proflavine-DNA complex. " He 
proposed a model of binding in which the planar proflavine molecule (65) becomes 
inserted between the base pairs of duplex DNA. (Figure 3.9) 
The following changes occur upon intercalation 
47,48 : 
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(a) Unwinding and lengthening of the DNA helix. 
Intercalation produces an extension (by 3AA) , unwinding, and stiffening of the 
DNA helix. These structural distortions are a consequence of the untWisting of 
the base pairs and helical backbone needed to accomodate the intercalator. 
(b) Electronic interaction of the intercalat-or "ithin the helix. 
Intercalation results in an ordered stacking of the bound species between the 
base pairs at 3AA separation. The intercalating surface is sandwiched tightly 
between the aromatic, heterocyclic base pairs and stabilised electronically in 
the helix by 7c-n stacking and dipole-dipole interactions. 
(c) Rigidity and orientation of the intercalator within the DNA helix. 
Upon intercalation at the unwound site, there is substantial structural overlap 
between the base pairs and the intercalator. The intercalator becomes rigidly 
held and oriented with the planar moiety perpendicular to the helical axis. 
The above physical and electronic changes form the basis of experimental methods used 
to establish intercalation: 
(b) 
Figure 3.9 The intercalation model: (a) is a representation of B-DNA; 
(b) shows the same molecule containing intercalated drug molecules. 
This mode of binding has been established for a large number of planar polycyclic 
aromatic cations. These in general contain a planar chromophore with 
two to four rings 
with an optimum of three, groups avallable 
for hydrogen bonding and a positive charge. 
47 
(Figure 4.0) Typical binding constants for these complexes are K -10' to 
106 IM-1 47,49 
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However, the description of intercalative binding is clouded by the fact that many 
intercalators have also been found to be groove-binders. ", " This is not suprising looking 
at the physical make-up of many intercalators (Figure 4.0). What is not clear are the 
factors that determine which process predominates at the surface of the helix or whether 
surface binding is the first step towards intercalation. Temperature-jump relaxation 
measurements have shown that proflavine intercalates via a mechanism involving initial 
fast bimolecular attachment to the surface of the helix, followed by one or more slower 
insertion steps. ", " It appears that the intercalation event does not require preopening of 
the duplex, and at equilibrium a proportion of the ligand remains externally bound. 
However, similar studies with ethidium have revealed quite a different mechanism 
involving direct intercalation with no externally bound intermediates. " 
- 
El 
Br + N-- 
roo, 
H2N-o-&NH2 
-NH H2N 2 
X- H 
(65) (66) 
Figure 4.0 
Recent studies by Lowe et aL using a newly developed indirect assay for unwinding of 
linear DNA have provided further strong evidence of intercalative binding by a range of 
simple quatemised phenanthridines and acridines. 
", " (Figure 4.1) 
In terms of the intercalating component of our assay design, it was decided to employ 
either unsubstituted phenanthridine or acridine, with the sensitiser being attached through 
a quaterniSed link to the ring nitrogen of either intercalator. 
This would provide the 
neccessary positive charge on the intercalator. The absence of substituents on either 
intercalator also meant we avoided lengthy protection/deprotection steps 
before and after 
quatemisation- 
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Figure 4.1 
2.5 MULTIFUNCTIONAL 1,10-PHENANTHROLINIES. 
The phenanthrolines have been known for over one hundred years, with the parent 1,10- 
phenanthroline being synthesised by Blau" in 1898. Their discovery as metal complexing 
agents and subsequent use in many analytical applications provided the impetus for an 
extensive study of procedures for their synthesis. " The last ten years has seen a 
resurgence in the chemistry of phenanthrolines, particularly the parent 1,1 0-phenanthroline 
and its derivatives. This has followed closely the rapid development of macrocyclic 
chemistry, with the phenanthrolines as metal recognition centres in a host of macrocyclic 
frameworks. 56,57,58 (Figure 4.2) This latter period of research has seen the synthesis of a 
whole host of 1,10-phenanthroline derivatives, particularly those functionalised at the C- 
2,9 position, like PDCA, where the two carboxylates provide additional chelation sites. 
However, little new work appears to have been carried out on the synthesis of 
multifunctional phenanthrolines. 
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Thus a synthetic scheme to the IýI 0-phenanthrollne framework was required whIch would 
provide substituents next to the heteroatoms (at C2 and C9) for conversion into the 
carboxylic acid, and a functionality to allow attachment of potential "handles". The 
synthetic scheme needed to be flexible enough to allow easy variations in the chain length 
of the handle, which inturn needed to possess some funtionality (an alkyl halide or 
tosylate) which could be used for attachment to different intercalators through 
quaternisation. 
The original synthesis of 1,10-phenanthroline by Blau was by a double Skraup reaction 
on o-phenylenediamine using glycerol and sulphuric acid in the presence of an oxidising 
agent". This quickly evolved into the single step Skraup ring closure reaction starting 
from 8-aminoquinoline, which proceeds in higher yields, To this day 8 -amino quinolines 
remain the starting materials of choice for the synthesis of 1,1 0-phenanthrolines. Case and 
co-workers were able to prepare numerous methyl and polymethyl derivatives of 1,10- 
phenanthrolines by treatment of various substituted 8-aminoquinolines under Skraup 
condifionS59,60,61,62 (Scheme 3.7) using: 
(a) (x, 13-unsaturated al dehydedi acetates, intoducing methyl groups into the oc- and 
B-positions in the ring formed. 
(b) Ketals, e. g 1,3,3-trimethoxybutane, introducing a methyl group in to the 
position of the ring formed. 
(c) (x, B-unsaturated ketones, e. g methylvinyl ketone, again introducing a methyl 
group into the y-position of the ring formed. 
(d) Oxoalcohols, e. g 4-hydroxy-3-methyl-2-butanone, enabling the intoduction of 
two methyl groups (B and y) into the ring formed. 
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By choosing appropriate reactants we would end up with methyl groups at the desired 
positions in the ring (C-2,9), and a third methyl group somewhere on the phenanthroline 
backbone as the functional group anchor for the attachment of potential handles. 
The methodology of alkylating methyl groups has already been successfully applied in the 
corresponding 2,2'-bipyridine series by Sauvage et al. in their synthesis of 4,4'-bis(4- 
bromobutyl)-2,2'-biyri dine (73) (Scheme 3.8) . 
6' The treatment of 4,4'-dimethyl-2,2'- 
biyridine (71) with lithium diisopropylamide (LDA) followed by quenching of the 
CH3 
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resulting dianion with THP-protected bromopropanol gave the desired alkylated bipyridine 
(72). Deprotection followed by bromination of the resulting alcohol gave the 
corresponding alkyl halide (73) as a very usefull reactive fuctionality. 
THPO 
H3C CH3 
A 
T 
ON/) 
OT14P 
XT -KT 
(71) 
Br 
114 114 
(73) 
IIII 
(72) 
Br 
Scheme 3.8 A. (i) LDA/THF, 00 (ii) Br(CH2)30THP; 
B. (i) p-TsOH, EtOH, (ii) HBr (48%), H2SO4 
The viability of this approach has recently been demonstrated by the synthesis of 4,7- 
dialkylated-1,10-phenanthroline (75), by the lithiation of commercially available 4,7- 
dimethyl-1,10-phenanthroline (74) using LDA followed by alkylation of the dilithiated 
intermediate. ' (Scheme 3.9) 
Ll- Li R -R H30 CH3 
I KI 
x 
KI h 
AB 
xK 
KI K 
KI NNNN NN 
(74) (75) 
R= Et ,i Bu ,i Pr 
PhCH2, C12H25 
Scheme 3.9 A. LDA/'II-IF, -78OC; B. RI, r. t 
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However, the choice of polymethyl pherianthrolines with a methyl group anchor were 
ruled out at an early stage due to the lack of discrimination, in terms of reactivity that 
exists between methyl groups in the ring. The 2,4-position of 1,10 -ph enanthro line are the 
most reactive and with little or no difference in reactivity followed by the other positions 
which are relatively unreactive. This difference in reactivity was clearly demonstrated by 
Katritzky et aL in their alkylation. of 3,4,7,8 -tetram. ethyl - 1,1 O-ph enanthroline (76) using 
LDA to give exclusively the 4,7-dialkylated phenanthroline (77). " (Schem e 4.0) 
H3 %C C Hrj 3 
CH H3C 3 
N XT x N 
(76) (77) 
Scheme 4.0 A. (i) LDA/THF, -780, (ii) CH3(CH2)3I 
A different and successful approach was provided by the Conrad-Limpach synthesis of 
quinolines. " O-Keto esters react with primary aromatic amines in two ways: at low 
temperatures under acid catalysed conditions, reaction occurs at the keto group to give the 
imine (or enamine) (78), at high temperatures reaction occurs at the ýester group to give 
an amide (79) (The Knorr quinoline synthesis). " The resulting compounds can each 
be 
cyclised to quinolines, with the acid catalysed cyclisation of the amide (79) with H2SO4 
at 100' yielding 2-hydroxyquinoline (81) where as the imine (78) is converted into 
4- 
hydroxyquinoline (80). (Scheme 4.1) 
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(81) 
By reacting 8-aminoquinoline with ethyl aceto acetate, followed by cyclisation in paraffin 
oil at 2700C, Hazelwood et aL were able to obtain 4-hydroxy-2-methyl-1,10- 
phenanthroline (82). (Scheme 4.2)" 
The yield of the thermal cyclisation was later improved by substituting boiling diphenyl 
ether for the hot parafin oil. 
:: Oe rool 
Zs. N N 
NH2 A 
nN 
B 
NH NN 00 
-CH3 H Et02C-C": C 
-10KýOEt 
H 
(82) 
Scheme 4.2 A. dil. HCIII 1000; B. Parafin oil, 2700 
From the work of Hazelwood, 4-hydroxy-2,9-dimethyl-1,10-phenanthroline (83) was 
identified as potentially possessing the correct functional groups to enable the synthesis 
of a new class of EU31 sensitiser which could function under our 
homogeneous assay 
conditions according to the general scheme 2.4. 
2500C,, DPE 
(80) 
H+, I OOOC 
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This initial target (83) was synthesised according to the method of Case" by a Conrad- 
Limpach reaction of ethyl acetoacetate with 2-methyl-8-aminoquinoline (85). (Scheme 4.3) 
N 
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A 9%N. 1 
NH2 
N 
NH 
1 
Et02C-C=C-CH3 
H (84) (85) 
(86) 
0 
N 
PH 
(83) 
Scheme 4.3 A. Hydrazine hydrate, 10%Pd/C, MeOH; 
B. Ethyl acet oacet ate, H+ý, PhH; C. Diphenyl ether, 2550 
2-Methyl-8-aminoquinoline (85) was obtained in almost quantitative yield by reduction 
of 2-methyl-8-nitroquinoline (84) by catalytic transfer hydrogenation using hydrazine 
hydrate and 10% Pd/C in methanol. This was then reacted with ethyl acetoacetate in 
refluxing dry benzene with a trace of acetic acid as catalyst, removing the water as 
formed. No attempt was made to purify the intermediate enamine (86), obtained as a 
brown solid following the removal of excess benzene. Thermal cyclisation of the 
intermediate enamine (86) was carried out in boiling diphenyl ether at 255'C. The desired 
product, 4-Hydroxy-2,, 9-dimethyl-1,10-phenanthroline (83), was obtained as an off-white 
powder by precipitation from the cooled diphenyl ether solution on addition of a large 
volume of 100-120 Petroleum Ether. The last traces of diphenyl ether could be removed 
from the product by repeated boiling in petroleum ether. Spectroscopic analysis of the 
pure product obtained by recrystallisation from water clearly showed this compound to 
exist mainly in the tautomeric pyridone form, the NH group being strongly hydrogen 
bonded to the heterocyclic ring nitrogen. Although this was expected, there was concern 
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that attempts to attach a handle to the phenanthroline framework at the 4-OH position via 
O-alkylation, using a simple alkyl dihalide would be complicated as the N-alkylation of 
pyri ones is much more favoured. 
(87) 
However, our fears proved to be groundless, and selective O-alkylation of (83) with 1,4- 
dibromobutane in acetonitrile using potassium carbonate proceeded smoothly, giving the 
alkyl ether (88) in over 70% yield after chromatography. (Scheme 4.4) 
Yield of the O-alkylation was further increased to above 80% by using caesium carbonate 
as the base. 
[83] 
PV\tABr 
N 
Scheme 4.4 A. Br(CH2)4Br, Cs2CO3, MeCN 
The two stage route to the diacid (90) (Scheme 4.5), involved hydrolysis of the bis- 
trichloromethyl derivative (88), which was obtained in excellent yields by the 
hexachlorination of the dimethyl derivative (83), using N-chlorosuccinimide in dryCC'4 
with m-CPBA as initiator. However, the second stage involving the hydrolysis to the 
diacid (90) caused many problems. Hydrolysis of tri-chloromethyl derivatives to the 
corresponding acids is normally achieved by heating in concentrated sulphuric acid 
(see Scheme 3.4). This was not successful with the acid sensitive alkyloxy side chain 
present, hydrolysis being accompanied by degradation of the side chain. 
Attempts at reducing the reaction time of the hydrolysis reaction to less than Ih was only 
partially successful with the mono aci d-monotrichloromethyl derivative (89),, with its 
alkyloxy side chain intact, isolated by chloroform extraction as a mustard coloured fine 
powder in 50% yield. The problem appeared to be the HCI that is produced during the 
course of the hydrolysis of the trichloromethyl groups. After several attempts we found 
that hydrolysis of (88) could be achieved in buffered acetic acid (glacial acetic 
acid/sodium acetate), to give the required diacid 
(90) as an off-white solid. 
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However, the yield of the pure diacid (90) after co-solvent recrystalisation from THF/H, O 
was very dissapointing. 
10 A 
[87] _A Br w- 
B 
PVVBr 
-N N 
C13C 
(88) 
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-N N -: -- 
OH HO 
(90) 
Cl3C ; ý=o 
HO 
(89) 
Scheme 4.5 A. NCS, CC14, m-CPBA; B. c. H2SO4, Ih; 
C. AcOH/NaOAC 
It was heartening to discover towards the end of our work that the problem of 
synthesising the 1,1 0-phenanthroline nucleus containing both the alkoxy link and the bis- 
2,9-carboxcylic acid funtionality had posed similar problems to others. 
In their synthesis of potentiometric sensors based on 4-octyloxy-1,10-phenanthroline-2,9- 
dicarboxcylic acid (93), Deady and co-work ers" initial approach to the acid (93) was 
through a standard two-stage oxidation by way of the aldehyde (92). But the second stage 
involving the oxidation of the aldehyde (92) to the acid (93) using concentrated nitric acid 
was not successful with the alkoxy link present. The oxidation was finally performed at 
room temperature in high yields by using the mild oxidant sodium chlorite in aqueous 
tert-butyl alcohol with 2-methyl-2-butene as a chlorine scavenger. (Scheme 4.6) 
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Scheme 4.6 A. Se02, Dioxan; B. NaC102, tBuOH, isobutene 
An initial attempt at attaching the intercalator to the sensitiser was carried out with 4- 
bromobutyloxy-2,9-bistrichloromethyl-1,10-phenanthroline (88). Quaternisation reactions 
are normally carried out in solvents like nitrobenzene or where the alkylating agent also 
acts as the solvent. Attempts to react phenanthridine and (88) in nitrobenzene at 1400C 
failed with no sign of reaction. The N-alkylation of phenanthridine was eventually 
achieved in good yields by carrying out the reaction as a neat melt, using excess 
phenanthridine as the reaction medium at 115', to which the alkylated phenanthroline (88) 
was added portionwise with stirring. (Scheme 4.7) The reaction is over within two hours 
and once allowed to cool , it sets into a very 
hard mass which is initially stirred with 
diethyl ether and filtered to give a fine light-brown powder. Final purification is achieved 
by dissolving the crude quaternised material (94) in CHC13 and adding it dropwise to 
stirred diethyl ether, precipitating the product as a pale yellow solid. Attempts at 
alkylating phenanthridine with the biscarboxylic acid derivative (90) failed giving an 
intractable material which could not be identified. 
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Although, by the use of glacial acetic acid/sodium acetate modification we were able to 
effect the hydrolysis of the bi s(tri chl orom ethyl) derivative (88) to the corresponding 
bis(carboxylic acid) (90), the persistent low yields combined with failures in the 
quatemisation reaction convinced us of the need for a better synthetic approach to our 
desired target. 
In amongst a rather long winded synthetic approach to 2-m ethyl - 1,1 0-phenanthrol ine, 
Heindel et aL reported the synthesis of 2-carboxymethyl-4-hydroxy-9-methyl-1,10- 
phenanthroline 
69 (95). This compound was obtained by a modified Conrad-LImpach 
procedure employing 8 -amino -2-methy I quinolin e (85) and dimethyl 
acetyl enedicarboxy late. (Scheme 4.8) 
w 
N NA 
NFý H3CO2C 
H 
(85) (95) 
Scheme 4.8 A. Dimethylacetylenedicarboxylate, MeOH 
It became obvious that by reacting an appropriately functionalised aminoquinoline, namely 
8-amino-2-carboxymethylquinoline (99) with dimethyl acetylenedicarboxylate we should 
obtain 4-hydroxy-2,, 9-bis(carboxymethyl)- 1,10-phenanthroline (10 1), following the thermal 
cyclisation of the corresponding enamine derivative (101). 
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The synthesis of 8- amino- 2 -carbo xy methy I quinoline (99) was reported in the early 1950s 
by Roth and Erienmeyer". Their synthesis starts from commercially avaliable 8-nltro-2- 
methylquinoline (84). (Scheme 4.9) 
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Scheme 4.9 A. AcOl-L NaOAC, Br2; B, 20% H2S04,80OC; 
C. MeOK Ht; D. Cyclohexene, I O%Pd/C, MeOH 
The tribromomethyl derivative (96) was obtained in excellent yields by the bromination 
of 8-nitro-2-methylquinoline using acetic acid, sodium acetate and bromine. Hydrolysis 
to the corresponding monocarboxylic acid (97) was achieved using 2M sulphuric acid at 
reflux, the acid being obtained as a white solid in high yields. Suprisingly, the use of 
standard hydrolysis conditions of concentrated sulphuric acid at 90T failed completely 
with the starter being recovered unchanged. 
Following esterification of the acid (97) in methanol, alternative methods of reduction to 
that reported by Roth and Erlenmeyer of the corresponding nitroester (98) to 8-amino-2- 
carboxymethylquinoline (99) were investigated. The best of these was again catalytic 
transfer hydrogenation with 10% Pd/C in methanol, this time using cyclohexene as the 
hydrogen source; under these conditions it is converted to benzene, thus providing the 
hydrogen source necessary to effect the reduction". Under these conditions the reduction 
of the nitro group proceeds smoothly and in very high yields. Isolation is simply by hot 
filtration over celite, followed by removal of the solvent in vacuo. 
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By reacting 2 -carboxymethyl -8 -amino quinol ine (100) with dimethyl acetylenedi carboxyl ate 
under reflux in dry methanol, the intermediate enamine derivative (100) was obtained as 
a bright yellow solid after removal of solvent. This was used without further purification. 
The thermal cyclisation was carried out in boiling diphenyl ether at 2550 , with the 
enarnine derivative (100), being added portion wise over 15 minutes to the boiling 
diphenyl ether solution. After approximately 30 m inutes of reaction time, the solution was 
allowed to cool before the addition of a large volume of 100-1200 Petroleum ether 
resulting in the precipitation of 4-hydroxy-2,9-bis(carboxymethyl)-1,10-phenanthroline 
(101) 
, isolated by filtration in 60% yield. (Scheme 5.0) 
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Scheme 5.0 A. Dimethylacetylenedicarboxylate, MeOH; 
B. DPE,, 2550C 
Attempted O-alkylation of (10 1) under conditions used previously for the 0-alkylation of 
4-hydroxy-2,9-dimethyl- 1,1 0-phenanthroline (83), namely caesium carbonate in acetonitrile 
gave very poor results with tlc [silica gel: 5%MeOH/CHC'3 or neutral alumina: CHC13 
showing a multitude of fluorescent spots. Studies by Hopkins et al on the alkylation of 
4-hydroxypyridones and the factors in determining the proportion of either N-or 0- 
alkylation identified the effects of the nature of the alkylating agent, the solvent and the 
base employed". By variation of the solvent and metal Ion, virtually exclusive nitrogen 
or oxygen alkylation could be obtained. 
In the end O-alkylation to give 4-(5-lodopentyloxy)-2,9-biscarboxymethyl-1,10- 
phenanthroline (102) was achieved by the use of anhydrous silver carbonate in benzene 
with 1,, 5-diiodopentane as the alkylating agent, the reaction mixture being protected from 
light during the course of the reaction. (Scheme 5.1) 
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Scheme 5.1 A. I(CH2)51, AgC03, PhH 
Isolation and purification of the O-alkylated phenanthroline (102) proved to be a major 
problem with extensive degradation being observed on attempts at column 
chromatography using either silica or neutral alumina. However, we were able to isolate 
some of the O-alkylated product (102) (, -28% yield), although an analytically pure sample 
was never obtained. This material was subsequently used for the quaternisation of 
phenanthridine, the reaction being carried out as a neat melt with excess phenanthridine 
as the reacfion medium. (Scheme 5.2) The desired quatemised phenanthridine (103) was 
obtained in an analytically pure state as pale yellow microcrystals by slow precipitation 
from a solution in chloroform by the controlled addition of diethyl ether, However, the 
overall yield turned out to be very poor (<15%), and this coupled with the problems we 
encountered in the final step involving hydrolysis of the ester functions to give the desired 
biscarboxcylic acid as our target compound (104), forced us to search for other approaches 
prefeably those involving a more stable link between the sensitiser and the intercalator. 
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Scheme 5.2 A. Phenanthridine, ll-, PC 
In recent years oligonucleotides carrying reactive groups have been developed to direct 
specific reactions at preselected sequences on single-stranded nucleic acids. One such 
group are the Cu-phenanthroline chelates, recently reported by Helene et aL", " 
(Scheme 5.3). 
NH2 
A 
bo b 
NN 
(105) 
00 
H 11 11 N-C-(CH2)5-S-P' 
0 
D 
(107) 
(106) 
3 
Scheme 5.3 A. Br(CH2)5COCI, (lPr)2NEt, MeCN; 
B. Pharmacia automatic synthesiser 
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Covalent linkage of the phenanthroline derivative to the 5'-end of the 
oligodeoxynucleofide was achieved via reaction of the thiophosphate group with 5- 
(halogenoalkylamido)-1,10-phenanthroline (106). This derivative (106) is easily prepared 
from 5 -amino- III 0-phenanthroline (105) by reaction with the appropriate acid halide. 
Thus, the 5-amino functionality represents, potentialy a very convenient anchor with 
which to attach alkylhalide handles for subsequent reaction with potential intercalators via 
quatemisation. 
Our initial target was the synthesis of 5-nitro-2,9-dimethyl-1,10-phenanthroline (108). 
Electrophilic substitution of the electron-deficient phenanthrolines requires drastic 
conditions and occurs preferentially in the benzene ring. 
The nitration of 2,9-dimethyl-1,10-phenanthroline (neocuproine) (50) was achieved using 
fuming nitric and sulphuric acid at 1400C. (Scheme 5.4) The desired 5 -nitro- 2,9- dimethy I- 
1,10-phenanthroline (108) was isolated and purified by first neutralisation of the reaction 
mixture by the addition of solid sodium carbonate, resulting in the precipitation of the 
crude nitrated product, and subsequent purification by reprecipitation from dilute sulphuric 
acid solution. The overall yield of the pure nitrated product (108) was 60%. The dione 
(109) which is a useful by-product of the nitration was isolated by extraction of the total 
aqueous residue with chloroform, and purified by chromatography to give the pure dione 
as a bright yellow solid in 13% yield. 
Attempts at nitration of neocuproine using concentrated nitric and sulphuric acid failed 
with the starter being recovered. 
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Scheme 5.4 A. c. HN03 c. H2S04 
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Our next envisaged target was 5-amino-2,9-bis(carboxymethyl)-1,10-phenanthroline (113). 
The synthetic route to this derivative is outlined in Scheme 5.5, and contains many of the 
synthetic transformations already carried out on earlier phenanthrohne systems containing 
the 2,9-dimethyl functionality. 
Hexachlorination of 5 -nitro -2,9-dimethyl - 1,10 -ph enanthrol ine (108) to 5-nitro-2,9- 
bis(tTichloromethyl)-1,10-phenanthroline (110) was readily achieved by . reaction with 
excess N-chlorosuccinimide (7 equivalents) in carbontetrachloride/chloroform solution 
with 3-chloroperoxybenzoic acid as initiator. The chloroform was neccessary as the 
nitrated material (108) had limited solubility in carbontetrachloride. The crude yields were 
excellent (>95%) and purification was readily achieved by column chromatography using 
chloroform as the eluent. 
Hexachlorination is in fact a convenient way to separate the crude products of the 
nitration of neocuproine, and both the nitro-hexachloromethyl derivative (110) and the 5,6- 
dione-2,, 9-bis(trichloromethyl)-1,10-phenanthroline derivative, can be isolated in high 
yields by column chromatography. 
Conversion of the hexachloride (I 10) to the corresponding 5-nitro-2,9-dicarboxylic acid 
(I 11) was again carried out in concentrated sulphuric acid at 90'C for 5 hours. The crude 
product was obtained as a yellow solid after quenching by addition of the reaction mixture 
to crushed ice. The pure diacid was obtained in high yields after recrystallisation from hot 
water/tetrahydrofuran as a pale yellow solid. 
Fluorometric studies with this compound in the presence of Eu" and an EDTA derivative 
indicated that the electron withdrawing nitro group has a detrimental effect on the 
luminescence properties of the ligand. These results back the general findings of Mukhala 
et aL that the best relative luminescence yields are obtained for sensitising ligands with 
electron donating substituents (Me, Ph), electron withdrawing subtituents (NO,, COOH) 
having a reverse effect (Chapter 1, Table 1.5). 
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By quenching the hydrolysis reaction of the hexachlorlde derivative (110) with dry 
methanol instead of water 5-nitro-2,, g-bis(carboxymethyl)-1,10-phenanthroline (112) is 
obtained. The yield of the pure product after recrystallisation from hot 
methanol/chloroform is >80%. 
Reduction of the nitrodimethyl ester (112) to the corresponding amine, 5-amino-2,9- 
bis(carboxymethyl)-1,10-phenanthroline (113), was again performed using catalytic 
transfer hydrogenation with 10% Pd/Carbon as catalyst and cyclohexene as the hydrogen 
source. The reaction was carried out in methanol and was over within 3 hours. The crude 
product was obtained as a bright yellow solid after hot filtration over celite and removal 
of solvent. This compond is amenable to column chromatography, and purification was 
readily achieved by silica gel chromatography using 10% methanol in chloroform as the 
eluant. 
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In the initial reduction attempt using 10% Pd/Carbon and cyclohexene, ethanol was the 
used as the solvent. This resulted in complete trans-esterifi cation and the 5-amino-2,9- 
bis(carboxyethyl)-1,10-phenanthroline derivative is obtained. 
The final set of reactions to the desired target compound (116) is outlined in Scheme 5.6). 
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AB [113 
H3C02C C02CH3 H3C02C 
0 
H ii 
N-C-(CH2)5 
(116) 
(114) 
Br 
-N 
ý(I 15) 
C02CH3 
Scheme 5.6 A. Br(CH2)5COCI, (iPr)2NEt, MeCN; 
B. Phenathridine, II 50C, C. H2OMr, pH 4 
The amine diester (113) was reacted with commercially available 6-bromohexanoyl 
chloride in dry chloroform at room temperature. The reaction mixture also contained an 
excess of diisopropyl ethyl amine, added as a base to scavenge the HCI liberated during the 
reaction. The reaction, which was easily monitored by t1c (silica gel: 15% MeOH/CHC'3) 
was -over within the hour and after work-up, the crude product was purified by column 
chromatography (silica gel: 10% MeOH/CHC'3). The desired alkylated product (114) was 
isolated as a viscous oil, and the pure product was only obtained as a solid in 80% yield 
after trituration with diethyl ether. 
The proton-nmr of compound (114) (Figure 4.3) clearly shows the all the peaks that we 
would expect; the methylene protons next to the bromine appear as a triplet at 3.46ppm 
while the protons next to the amide link appear as a triplet upfield 
from TMS at 2.6ppm. 
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In between these two signals reside the signal due to hydrate water at 3.21ppm. This is 
present even after drying in a vacuum oven, and confirms that the product exists as the 
hydrate. The six protons of the alkyl chain appear as a complex set of overlapping signals 
between 2.1-1.55ppm. Downfield from TMS the singlet associated with C-6 of the 
phenanthroline ring at 7.0 pprn (in the amine diester) (113) appears to have shifted into 
the group of signals associated with the ring protons around 8. Oppm. Also visible in the 
proton-nmr is the amide proton, a broad signal at 9.2ppm which is exchangeable with 
D20- 
0 ppm 
Figure 4.3 The proton nmr of (114) (20OMHz; CDC13). 
The penultimate step involved a quaternisation reaction between the alkyl bromide handle 
of (114) and the ring nitrogen of our heterocyclic intercalator, phenanthridine, to give the 
corresponding phenanthridinium compound (115), as the bromide salt. Like previous 
quaternisations, the reaction was carried out as a neat melt, using an excess of 
phenanthridine. A large excess of phenanthridine ensures that the reaction mixture does 
not become too viscous to stir before the reaction has proceeded to completion. The alkyl 
bromide phenanthroline (114) was added portionwise to liquid phenanthridine stirred at 
115', the quaternisation reaction is over within 1.5 hours. 
After cooling, the reaction mixture sets into a hard red/brown solid which is stirred with 
diethyl ether and filtered to give exclusively the desired product (115), which unlike 
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recry stall 1 sation. from hot water but the recovery was very poor (<10%). On exposure to 
air it tended to become sticky. 
The proton-nmr of the phenanthridinium salt (115) is shown in Figure 4.4. Although we 
appear to have lost some of the fine structure, probably due to the presence of charged 
species, the signals are still clearly visible and discemable. 
What we were looking for in the proton-nmr was evidence of quaternisation. This is 
clearly shown by the shift in the signal due to the terminal methylene group of the alkyl 
chain from 3.45ppm in (114) to 5.2ppm in the phenanthridinium species (115), as a result 
of replacing the bromine with the electron-Withdrawing quaternary nitrogen, Further 
evidence is provided by the large shift down-field from TMS of the proton on C-6 of the 
phenanthridine ring (next to N), from around 9. Oppm to over I I. Oppm in the 
phenanthridinium salt (115). 
10.0 5.0 
Figure 4.4 The proton nmr of (115) (20OMHz; CDC13). 
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The final synthetic step was the hydrolysis of the two methyl ester groups of 
(115), to 
give the desired target molecule as the 
dicarboxylic acid (116). Base catalysed hydrolysis 
was ruled out as the phenanthridinium system is sensitive 
to nucleophilic attack at the 
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carbon attached directly to the electron-withdrawing quaternary nitrogen. However, these 
quatemised phenanthridines have been shown to be very stable to even very strong acids 
at reflux. 
Initial attempts centred on hydrolysis in water at pH7 at 100T, however, after 16 hours 
there was no indication of any significant reaction that could be observed by tlc (alumina: 
10% MeOH/CHC'3). By dropping the pH of the solution to pH I by the addition of 
concentrated HBr gave reaction overnight; indicated by the disappearance of the diester 
and appearance of a baseline spot by t1c. 
However, analysis of the bright orange solid isolated by proton-nmr indicated that some 
degradation of the product at the alkyl chain had taken place. Hydrolysis at pH 4 gave 
much better results, and a bright orange solid was isolated by simply removing the solvent 
under high vacuum. Analysis by proton-nmr showed the characteristic signals of the 
phenanthridinium group were still present at 10.7 and 5.2ppm, and that the two singlets 
due to the methyl ester groups at around 4. Oppm had virtually disappeaTed. Attempts at 
obtaining an analytically pure sample of (116) by recrystallisation have been unsuccessful, 
and analysis by tlc on both normal and reverse phase systems have failed been 
unsuccessful. However, the match of the molecular ion peak was well within the required 
5ppm limits for calculated mass. 
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2.6 LUMINESCENCE STUDIES 
The key to our approach and design for a homogeneous DNA assay was whether- 
(1) we could enhance europlum ion luminescence in aqueous solution using 
cooperative ligands viz. a three componenet system; the LIA ternary complex 
composed of the europium ion, a sensitising ligand and a separate non-sensitising 
ligand, 
(ii) the same ternary complex could be made to assemble once hybridisation 
between probe and target strand to form the duplex had taken place. 
Our initial efforts concentrated on trying to understand how to prepare such ternary 
complexes in solution, and the effects of pH and concentration on the relative 
lurninesecence intensities. 
The photoactive component of the temary complex is the sensitiser, and initial studies 
(binary solution studies) concentrated on finding the best overall sensitiser from our the 
simple 1,10-phenanthroline derivatives synthesised and the optimum conditions for 
maximum energy transfer to the europlum ion. (section 2.4.2) 
Studies involving the ternary sysytem were initially carried out with '221' as the non- 
sensitising ligand and phenanthroline diol (57), monocarboxcylic acid (62) and PDCA (48) 
as sensitisers. From these studies PDCA was identified as the sensitiser with the best 
'cooperative properties' resulting in large enhancements in the luminescence. When studies 
were repeated, but this time using the mono-and-bis butylyamide derivatives of EDTA with 
PDA as sensitiser, the highest enhancements were observed at a pH ideal for subsequent 
biological studies. (see sections 2.4.3 and 2.4.3.1) 
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2.6.1 General Procedures 
Luminescence spectra were determined on a Perkin Elmer LS50 spectrometer fitted with 
a red-sensitive photomultiplier. The solvent of choice for spectroscopic studies was high 
grade water (Elgastat). Solutions were buffered using 5mM tris(hydroxyethyl)aminomethane 
(Gold label, Aldrich) ('tris') in the presence of 50mM sodium chloride (Analar, BDH). 
Preliminary studies showed that the luminescence of the europium. ion was not affected by 
the presence of air; solutions were not routinely degassed. 
The protocol for cleaning cuvettes was as follows: At the start of a run they were washed 
with sulphuric acid/hydrogen peroxide (1: 1 v/v, Care! ) mixture, allowing them to stand for 
full 30 min.; rinsed with high gradýe water until the washings were neutral; rinsed with five 
lots of Analar methanol and air dried. 
After each measurement, the cuvettes were washed with three lots of 3M hydrochloric acid, 
four lots of water, and, finally, five lots of methanol before air drying. 
The procedure for adjusting the pH was as follows: a 30 ml solution of the concentration 
to be studied was prepared using the relevant stock solutions and 5mM tris and 50mM 
NaCI buffer. The solution was then adjusted in pH using concentrated Analar HCI and/or 
KOH and the solutions left for 15 min. to stabilise. Luminescence measurements were 
made on 2 ml samples; each being returned to stock before further manipulation. Total 
changes in concentration were <10%. 
2.6.2 Solution Studies - Binary Systems 
Direct studies in aqueous solution proved to be a quick method for screening luminescence. 
These solution studies were conducted varying two main parameters, either the pH or the 
concentration. The pH used in these studies is critical because europium solutions are 
extremely pH sensitive. At high pH (>6) hydroxide ions can form and these bind more 
strongly to the metal ion than water, eventually leading to precipitation of the insoluble 
hydroxide. This tendency to bind to water and hydroxide ion is also reflected in the 
speciation behaviour of this element; europium 
behaves some what like aluminium in its 
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chemistry and increasing concentrations leads to the formation of aggregates of the ions 
71 bound by either water or hydroxyl bridges. Such aggregation could impair the 
luminescence behaviour leading to non-linear responses with concentration changes. 
The buffer chosen for the solution studies tris [2-amino-2-(hydroxymethyl)propane- 1,3 -diol] 
was found the prevent the formation of europlum-hydroxy species in the pH range 7-8; 
such solutions were stable for days, whereas, in the absence of this buffer, precipitates 
started to form Within a few hours. Tris is commonly used as a buffer in DNA studies at 
pH 7-8, since it buffers around this important range. Control studies showed that the 
addition of tris to solutions of photosensitising ligands and europlum gave no luminescence 
enhancements, indicating that it does not interfere. These same conditions (5m. M tris and 
50mM NaCl) are also used by other groups, such as Barton' S76, when studying metallo- 
complex - DNA interactions. 
Studies on luminescence versus pH are shown for the phenanthroline diol (57), 
monocarboxyclic acid (62) and dicarboxcyclic acid (48) in the presence of excess 
europium; With no sensitiser no luminescence is observed (Figures 4.5 - 4.7). 
These results show that as expected the diol (57) shows the lowest enhancement in 
luminescecnce and the dicarboxylic acid (48) the most. As expected the diol shows the 
lowest variation with pH, the broad hump showing a maximum at pH 6.7 (23.4 intensity 
units). This suggests a relatively weak affinity of the diol for europium; that some 
luminescence is observed does confirm that some interaction does occur between the ligand 
and metal. 
The results for the monocarboxylic acid (62) and dicarboxylic acid (48) are more 
instructive. The enhancements both show a strong pH dependence. At low pH the carboxyl 
group Will be protonated and coordination of this group Will have to compete with solvent 
water. As the pH is increased the carboxylate anion is generated and this appears to 
coordinate strongly with the metal. However, as the pH is 
further increased the intensity 
rapidly falls away and this is explained 
by competition with hydroxyl ions. Finally, at 
pH's above 10.5, the carboxylate group can no 
longer compete for binding sites and 
formation of europiurn oxide occurs. The dicarboxylate shows 
both higher enhancements 
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than the monocarboxylate (72.1 versus 42.8) and peaks at a higher pH (9.0 versus 8.7); a 
higher pH allows both carboxylate groups to ionise and hence compete more effectively 
againts the ingress of hydroxide ions. The presence of the two, carboxylate groups has the 
effect of holding the europium closer to the sensitiser with the corresponding increase in 
the efficiency of energy transfer. 
The binding constant for the Eu": di, carboxylic acid (48) was determined to be ;: tIO' by 
luminescence versus concentration studies. However, the low quantum efficiency of 
luminescence of these binary systems made it very difficult to carry out these studies on 
a conventional fluorometer, and more detailed studies are needed. 
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2.6.3 Ternary Systems using [2.2.11 (21). 
Since the europium ion behaves as a highly charged sphere, our approach to forming 
ternary complexes in solution was to try and exploit electrostatic field effects. Thus, 
choosing ligands that do not completely saturate the positive charge on an europium ion 
allows the initial 1: 1 complex to retain a positive charge so that a second negatively 
charged ligand can be attracted into its coordination sphere. 
Luminescence studies were repeated in the presence of a third component, the non- 
photo sensiti sing ligands, based on [2-2-1] (21) and EDTA and its derivatives. 
Earlier we mentioned that the bis-acetic acid derivative of 1,7-diaza-4,10,13- 
trioxacyclopentadecane [2.2.1] (2 1) forms tight complexes with europium ions (K,. > 10") 
and molecular models have shown that this is achieved whilst leaving a cleft suitable for 
occupation by water molecules or another hgand, which in our case will be the 
photosensitiser. 
The luminescence results for the diol (57), monocarboxylic acid (62) and the diacid (48) 
are shown in Table 2.1, additionally luminescence results for the dicarboxylic acid (48) are 
shown graphically in Figure 4.8. 
Equimolar quantities of Eu" to [2.2.1 ] were used , the ratios 
being kept constant to ensure 
a 1: 1 complex and avoid 2: 1 complexes involving these species. The concentrations used 
of both Eu" and [2.2.1] were a 100-fold excess to the sensitiser concentration (10-'M). 
Since the [2.2.1] in the pH range 7-9 has an association constant for EU3+ > 10", no free 
europlum should exist in solution under these conditions. 
The most exciting results were obtained for the diacid (48). As expected , the Eu". 
[2.2.11 
complex shows no luminescence when irradiated at 300 nm [Figure 4.8(a)]. However, as 
soon as the diacid (48) was added a large enhancement of the luminescence was observed 
[Figure 4.8 (c)]. As predicted, in the absence of the shielding [2.2.1 ] ligand, the diacid. Eu" 
complex (K., ca. 106) only showed a weak luminescence [Figure 4.8 (b)]. 
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Table 2.1 Ternary system enhancements' with [2.2.1] (21). 
LIGA; ND Without [2.2.1 
Imax pH,,, ax 
With [2.2,1 
pH 'max max 
7 il( Diol (59 22 (4-8) 95 10 
Mm onoacid (64) 43 9,0. 46 7.5 
Diacid (50) 70 8.7 257 8.0 
'Concentration of ligands: [(59)], [(64)], [(50)]= 10-6M 
[(21)]= 104M 
[Eu3+]M 
%ex at maximum M the region 280 - 290mn. 
Xem 615mn. 
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Figure 4.8 Variation of luminescence with changing pH (a) x EU3+ 
(10-4), [2.2.1] (10-4); (b) ---x-- EU3+ 
(10-4), PDA (10-6); (C) --o- 
Eu3+ (10-4), [2.2.11 
(10-4), PDA (10-6 mol dm-3). Aqueous 
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ments; graphs are average of triplicates; 
615 nm. 
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The diol (57) was also shown to enhance luminescence, although not to the same extent 
as the diacid, but to our initial surprise the mono carboxylic acid showed little increase in 
luminescence. 
The luminescence curves for the diacid. Eu". [2.2.1] complex show an interesting pH 
dependence. At high pH the europium complexes decompose by hydroxide attack, 
formation of europium oxides being observed. At lower pH protonation of the carboxylate 
groups occurs, thus lowering their affinity for the metal ion. The luminescence peak for the 
ternary complex {Figure 4.8 (c)] occurs at pH 8.0 as compared to that of the binary 
complex (pH 9.2): over a sixfold enhancement in luminescence is observed at pH 8.0. 
These results were very heartening as it demonstrated one of our key postulates, that a 
ternary complex can be made to assemble in solution around a europium ion resulting in 
large modulations of the metal ion luminescence. 
The results also suggested that to achieve maximum 'ligand cooperativity' at least two 'hard' 
centres are required for tight binding of the sensitiser molecule to the [2.2.1 ]. Eu" complex. 
Thus, the monocarboxylic acid is only able to bind weakly to the europlum complex, 
probably via the single carboxylate group, the nitrogen centres being, in themselves, rather 
weak ligands to the europium ion compared to water and, and as a consequence, are unable 
replace solvent molecules from the coordination sphere of the metal. Although the hydroxy 
groups of the diol are able to compete with solvent water molecules for coordination sites, 
this only occurs at high pH (I,,,, maximum at pH 10), when they are fully ionised 
However, since this pH was outside the range we were aiming for , no 
further work with 
the diol was carried out. 
The formation of both the 1: 1 diacid. EU3, complex and the 1: 1: 1 ternary complex occurs 
rapidly upon the addition of the diacid (48) to the other components, as reflected 
by the 
rapid onset of the observed luminescence. In contrast, addition of 
[2.2.1 ] to the diacid. Eu" 
complex results only in a slow increase in the 
luminescence to the full value (half-life ca. 
3h. We were able to explain this by the fact that the organisatlon of the more mobile 
[2.2.11 ligand about the europium ions is a far more demanding process, in terms of the 
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conformational. reorganisation and displacement of water, " than that of, the diacid with 
europium. However, the reverse is also true and, once formed, unravelling of the [2.2.1] 
ligand (total dissociation) from the europium ion is also expected to be slow. 
2.6.3.1 Ternary systems using EDTA and its Derivatives. 
Although we were aware that EDTA has a very high binding constant for Eu" ions. An 
initial screen (at pH 8.5) showed little enhancement and we initially considered that this 
was due to over zealous encapsulation of the ion by the ligand, making it hard for the 
sensitiser to approach the bound metal ion. However, further consideration of the pK values 
of EDTA (ca. 2.0,2.67,6.16 and 10.26) suggested that, at lower pH (pH< 6.16) only 2 
carboxylates groups should be present and, at this point EDTA may mimic [2.2.1]. This 
prediction was demonstrated by the enhancement of luminescence observed with the 
dicarboxylic acid (48), with the maximum observed luminescence (1m ax 308) occurring 
between pH 5.5-6.0 (Table 2.2). The increased 1,., x 
is explained by a combination of less 
steric crowding in the complex allowing closer approach of the phenanthroline 
dicarboxylate resulting in fighter coordination. 
By repeating these experiments with the monobutylamide derivative of EDTA (46) (Figure 
4.9), a very high increase in the luminescence Omax 540) was observed over a broad pH 
range (pH 7-8) , ideal 
for assays of biological materials. Under these conditions we may 
assume that at least one of the two EDTA carboxylates is ionised (maybe, both) and at 
least one of those from the phenanthroline groups (again maybe both) so that very tight 
coordination occurs around the metal ion. 
Luminescence half-time measurements have shown that in this ternary complex only one 
water molecule is able to coordinate to the encapsulated europium ion, (CH20 ca. 0.75 
msecs. ) 
It is worth noting that in our ternary systems the problem we face is the fact that the 
binding constants of the various species present will be interdependent. For example, the 
binding constant of the photosensitiser PDCA for europium in aqueous solution would be 
different from the association constant of PDCA for the europium-EDTA complex 
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Eu 3+ EDTA and, also, these association constants will vary with pH. Thus, we would expect 
the presence of the EDTA ligand to result in a decrease in the binding constant of the 
phenanthroline dicarboxylic acid (48). In order to work out respective binding constants 
detailed concentration -fluorescence studies would be needed. 
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2.7 STUDIES WITH SYNTHETIC OLIGONUCLEOTIDES. 
Our approach to a direct M situ (homogeneous) identification of target DNA strands is 
illustrated in Figure 2.1 and Scheme 2.4. The probe is linked to a chelator to which is 
strongly coordinated a europium. ion. The probe is then hybridised to the target DNA to 
form a double stranded segment of DNA. In this situation, where there is no sensitiser 
present neither the probe nor its duplex with the target gives a signal under irradiation with 
light. The europium ion has a very weak absorption coefficient since the excitation process 
is formally spin forbidden". 
The initial excited state of europium is only efficiently reached by a ligand-to-metal 
sensitised energy transfer process Involving a triplet sensitiser like PDCA (48). Such energy 
transfer requires very close contact between sensitiser and the metal ion. We have shown 77 
that under certain conditions, chelates of europium can accept a second ligand, such as 
III 0-phenanthroline-2,9-dicarboxylic acid (48), which acts both as a sensitiser and shielding 
agent to displace solvated water molecules; solvated water inhibits europium. luminescence. 
This is a key feature of our assay design; the need for cooperation between the europiurn 
ion and two different ligands to form a ternary complex (a three component cooperative 
system) in which the sensitiser is able to both approach and bind tightly to the already 
coordinated metal ion. This assembly process occuring once probe and target have 
hybridised to form the duplex. 
As mentioned earlier the non-sensitising ligand L needs to have a very high binding 
constant for the europium ion (K.., > 10") so that once attached to the oligonucleotide 
probe the bound state will be maintained and we can consider the euopium. ligand complex 
[EU3+ L] as a single stable entity. 
In contrast, one does not want a very high binding constant of the photosensitiser S for the 
ing together in bulk solution Eu 3+ L entity; as this would result in the components comi 1 
rather than at the target DNA site, 
leading to high background counts. The binding constant 
of the sensitising ligand 
for the chelated europlum is in the range K., 106 _ 10' and thus, 
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at concentrations of the two components at < 10-' M little association between the reagents 
occurs. This ensures the background signal for europlum luminescence is small and is 
expected to fall away rapidly upon dilution. The success of our system relies upon an 
enhancement of the signal for europium luminescence once the probe strand has met the 
target strand of DNA. This is achieved by making use of intercalation using a positively 
charged aromatic species such as the phenanthridinium group linked to the sensitiser. 
Intercalation is a characteristic property of the duplex and the binding constant of such 
species for double stranded DNA is in the order of K., 10'. Intercalation has the effect of 
increasing the local concentration of the sensitiser and this works in cooperation with the 
binding costant of the sensitiser to the metal ion. As a consequence the overall binding 
constant of the sensitiser to the metal ion is increased andl results in the enhancement of 
the europium signal. Since, in the presence of the target strand the signal is generated in 
a cooperative, Intramolecular manner, the relative strength of the signal is expected to fall 
away less rapidly upon dilution. 
2.7.1 Oligonucleotide Test System. 79 
The only way to test our approach was to actually perform a DNA assay under 
homogeneous conditions. This was carried out using an oligonucleotide probe (24mer) and 
two strands of target oligonucleotide; one complementary to the probe (R) and the other 
a complete mismatch (Q). (Figure 4.3) 
PROBE: H2N-(CH2)6-0-AA. GAT. GAT. ATT. TTC. TTT. AAT. GGT. G 
(5') (3') 
TARGET R (MATCH): TT. CTA. CTA. TAA. AAG. TTA. CCA-C 
(3') 
TARGET 
(5') 
(WSMATCH): GTýC. CAT. TAA. CAT. CTG. TCT. TCC. ACT. AAG. GGG 
(3') 
Figure 5.0 
(5 t) 
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2.7.2 Preparation of the EDTA adduct of the 24mer. 
The 5'-aminohexyl group of the oligonucleotide probe was reacted at room temperature 
with 25 fold excess of the anhydride of ethyl enedi aminetetraaceti c acid in 10 mM TRIS 
buffer at pH 9.0, followed by saturation with europium (111) chloride overnight to give the 
chelate derivative (117) (Scheme 5.7). The chelate was adequately purified by passing the 
whole solution through a short Sephadex G25 column (NAP 5) using 10mmol TRIS/HCI 
at pH 7.5 as the eluent, taking ca. 20gl fractions. All the collected fractions were subjected 
to UV analysis at 260nm, With those fractions showing a strong absorption at ýInm260 nm 
being combined. The presence of tagged europium. could be checked by stimulating 
europium. luminescence using a solution of PDCA as the sensitiser. 
The final concentration of the tagged oligonucleotide probe (117) in the combined fractions 
was determined by O. D. measurements using a Pharmacia Gene-Quant automated analyser. 
HN 5' 31 2 AA. G AT. GAT, ATT. T TC, TTT. AAT. G GT. G 
A 
3 
uH 
00 
05 
00 -AA. 
GAT. GAT 
00N 
(117) 
3' 
ATT, TTC. TTT. AAT. GGT. G 
Scheme 5.7 A. (i) EDTA bisanhydride, THF, NaOH 
(") EuCl3 
2.7.3 Hybridisation Experiments. 
Hybridisation experiments were carried out With Mr I Coates (Brunel University) using 
the general procedures of L6vgren et aL", 150pl of target oligo was made up to the 
approximate concentration of the probe 
(IxIO-'M) diluting with TRIS/HCl buffer. 
Hybridisation of target oligo's with the tagged probe (117) were carried out in a mixture 
of Denharts solution (25pl), and 
60OW1 of buffer (OAM Tween 20,1M NaCl, O. IM MgCJ2 
and I omM HEPES) at 42T 
for 3 hours, giving a concentration of 5xI 0-'M for the duplex. 
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After hybridisation was complete, solutions of the sensitiser (116) (5xI 0-6M) from a stock 
solution (I xI 0-'M) of the sensitiser (116) made up in TRIS/HCI buffer were added, and 
the solutions left to equilibrate. The luminescence of each solution was then measured 
exciting at 298nm. Then a series of dilutions were performed on both targets (Q and R), 
ending up with a final concentration of 2.6xI 0-'M (I 12x dilution), the results are illustrated 
in Table 2.3 and luminescence spectra of both the matched and un-matched in Figure 5.1. 
Table 2,2 Luminescence results from the hybridisation of both matched and mismatched 
oligonucleotide targets With the labelled probe. 
gColntration 
(M) OLIGO R/INTENSITY' OLIGO Q/INTENSITY 
3 ()X 1 ()-6 140 60.5 
1.5x1 ()-6 86 39 
3. gxl ()-7 30 15 
1.3x1 0-7 9 3 
5.4x10-' 3 0,4 
2.6x 10-' 
IL- 
1 
1.12 0.05 li 
X,, = 298nni, ?,,, = 615nm 
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From these results we can clearly see that as predicted, there is a distinct difference in the 
luminescence intensities between R (matched) and Q (mismatched), with a stronger signal 
being observed in the presence of the matching target R as compared to that observed with 
the mismatch target Q. Also, upon dilution, a more rapid decrease in the intermolecular 
(background) signal is observed than for the cooperative (intramolecular) signal observed 
in the presence of the matching target. All the results were reproducible. 
1.12 
1.1 
Il 
OA 
0.1 
a: 
al 
OJ 
CLI 
W 
3.: 
0.1 
0. DO 
Figure 5.1 Emission in range 550 - 750 nm observed on mixing reagents 117 and 116 with 
(a) target R (match) and (b) Target Q (mismatch). Buffer as in text; initial 
concentrations on mixing 5x 
10-6M 117,5 x 10-'M 116 and 5x 
10-6 M Target, 
followed by xI 12 dilution. Delay time 0.1 ms, slit Widths 10 nm. 
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550. 
,0- 750.0 
2.8 CONCLUSIONS. 
With the aim of developing new homogeneous assays for DNA, various strategies have 
been listed, all making use of the characteristic property of the lanthande ion, europiurn, 
to luminesce when certain conditions have been satisfied. The most important of these 
being the need for a suitable sensitiser which possess: (1) the correct photophysical 
properties to enable it to excite the europium ion by ligand-to-metal triplet energy transfer, 
and (ii) 'hard' binding sites to enable tight binding of the europium ion; and also a way of 
preventing or limiting the coordination of water molecules to the europium ion, which have 
been identified as the main culprits in deactivating the excited state of the europlum ion. 
We have found and demonstrated a new method for the cooperative binding of ligands to 
Eu" ions which works like a switch turning on the luminescence of the Eu" ion in aqueous 
solution. 
The main components of this cooperative binding have been identified as 1,10- 
phenanthroline-2,9-biscarboxylic acid (PDCA) (48) as the most efficient sensitiser of 
eur, opium luminescence and both linear and cyclic derivatives of EDTA as ligands with the 
necessary high binding constants for Eu", (termed non-sensitising ligands). 
Our approach, making use of the cooperative binding ('ternary complex) principle has 
involved the successful synthesis of a new class of phenanthroline sensitiser (116). 
H0 Br- 4, 
PN-6-P'05 
- 
(116) 
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We have been able to tag appropriate DNA probe strands with an EDTA derivative and 
initial assay results using a tagged probe strand of oligonucleotide and two target strands; 
one complementary (matched) and the other a complete mismatch under homogeneous 
(non-separating) conditions has given very encouraging results, with clear discrimination 
in the modulated luminescence where a match has occured between target strand of DNA 
and it's complementary probe strand and a complete mismatch. 
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3.1 EXPERIMENTAL 
The following abbreviations for reagents have been used in the experimental section: 
AcOH (acetic acid); t-BuOH (tertiary butanol); CDC13 (deuteriated chloroform); CHC13 
(chloroform), DCM (dichloromethane); ME (dimethyl sulphate); DMSO (dimethyl 
sulphoxide); DMSO-d6 (deuteriated dimethyl sulphoxide); D20(deuteriated water); EDTA 
(ethylenediaminetetraacetic acid); EtOH (ethanol); HCI (hydrogen chloride); HN03 (nitric 
acid); H, SO, (sulphuric acid); KX03 (potassium carbonate); LiAlH, (lithium aluminium 
hydride); MgS04 ((magnesium sulphate); MeCN (acetonitrile); MeOH (methanol); NaCl 
(sodium chloride); NaC03 (sodium carbonate); NaHC03 (sodium hydrogen carbonate); 
Na2S04 (sodium sulphate); TIIF (tetrahydrofuran). 
Purifications by column chromatography were performed on either silica gel (Sorbsil C60) 
or aluminium oxide (neutral; Brockmann grade 1), using redistilled solvents. Thin layer 
chromatography (tlc) was performed on either Whatman 2.5 x 7.5 cm glass-backed plates 
with a 0.25 mm layer of silica gel 60 F254, or on Merck E-type aluminium backed sheets 
with a 0.2 mm layer of aluminium oxide 60 F254 (neutral). 
Melting points were measured on a Reichert-Jung Thermovar hot-stage microscope melting 
point apparatus and are uncorrected. 
Bulb-to-bulb distillations were conducted in a Kugelrohr apparatus and the temperatures 
quoted refer to the oven temperature. 
Microanalysis were performed by MIEDAC Ltd., Brunel University, on a Carlo Erba 1106 
elemental analyser (dynamic combustion system) or a Control Equipment Corporation 
Model 240 XA (static combustion system). 
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Proton nuclear magnetic resonance (nmr) spectra were recorded on a Varian CFT-20 (90 
MHz), or a Bruker AMX 200 (200 M7Hz nmr spectrometer. Resonances are reported as 
(frequency, solvent), 8= shift in ppm from tetramethylsilane at 0 ppm and the multiplicity 
of signals as s, sizglet; d, doublet; dd, double doublet; q, quartet; t, triplet; in, multiplet, - br, 
broad; J values are in Hz) 
Mass spectra were recorded either on an AEI MS902 spectrometer or at the SERC facility, 
Department of Chemistry, Swansea College, University of Wales for fast atom 
bombardment (FAB) and accurate mass measurements. 
Infrared (ir) spectra were measured on a Perkin Elmer 1420 Ratio Recording 
spectrophotometer as KBr discs unless otherwise stated. 
3.2 Luminescence measurements 
Phosphoresence excitation and emission were recorded on a Perkin Elmer LS50B 
Luminescence spectrometer at room temperature with the following parameters; 
Excitation spectra- Slit Width 10.0 nm 
Gate time 1.0 ms 
Excitation spectra were determined by exciting from 200-450 nm whilst monitoring at 
615 nm. 
.4.. Sht W*dth 10.0 nm Emission spectra: 11 
Gate time 1.0 ms 
Delay 0.1 ms 
Emission spectra were run from 550-800 nm. 
All luminescence measurements were run using 2ml quartz cells having aI cm path length, 
Excited state lifetimes were determined in both H20 and D20 by utilising the Short-Term 
Phosphoresence Decay program on the LS 50B spectrometer. 
The number of coordinated water molecules was 
determined by the method of Horrocks 
and Sudwick (Chapter 1, p. 10), using experimentally 
determined excited-state lifetimes. 
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N, 0,0'-Tris(p-toluenesulphonyl)-bis-(2-hydroxyethyl)amine (3 )'2' 81 
An ether solution of tosyl chloride (28.6g, o. 15 mole) in ether (150 ml) was added slowly 
to a stirred solution of bis(2-hydroxyethyl)amine (5.3g, 0.05 mole) in triethylamine (52 ml). 
The reaction was carried out in an open beaker; after stirring for Ih, water was added to 
dissolve unreacted materials, and the reaction mixture left standing overnight. A white solid 
was isolated by filtration which was then purified by recrystallisation from hot absolute 
ethanol to give 3 as a white solid (I 6.7g, 5 8%), m. p. 66-67C (lit. '12 
65-67'C) (Found: C, 
52.89; H, 5.43; N, 2.72. Calc. for C2 5Hq N 08 S3: C, 52.89, H 5.15; N, 2.47%); 5H (90 
Nfflz; CDC13) 2.43 (9H, s, Ar-CH3), 3.3 5 (4H, t, J5.8, N-CHA 4.09 (4H, t, J5.8, O-CHA 
7.18-7.76 (12H, m, Aromatic-H). 
N, N'ýN"-Tris(p-toluenesulphonyl)diethylenetriamine (12)12,82 
To a cold vigorously stirred solution of 3-aza-hexane-1,3-diamine (3.2g, 0.013 mole) and 
sodium hydroxide (3.7g, 0.092 mole) in water (30 ml), a solution of toluene-p-sulphonyl 
chloride (17.5g, 0.092 mole) in ether (150 ml) was added dropwise over a period of 4h, 
followed by an additional Ih stirring. A white solid was collected by filtration, washed well 
with water and dried. The crude product 12 was purified by dissolving it in the minimum 
of hot DMF and precipitating it out by the addition of a large volume of water. The desired 
product 12 was isolated as a white solid by filtration, washed well with cold water and 
dried (I 1.4g, 41 %), m. p. 174-1750C 
(Ilt., 12 172-174'C) (Found C, 53.14; H, 5.57; N, 7.42. 
Calc. for C25H3, N3 06 S3; C, 53.08; H, 5.52; N, 7.42%); 5H (90 M11z; DMSO-d6) 2.38 
(9H, s, Ar-CHA 2.8 9 (1 OH, br s, N-CH2 an d NH), 7.5 0 (6H, d, J8.0,2,6 -ArH), 7.6 8 (6H, 
d, J8.0,3,5-ArH). 
The disodium salt of NN', N"-Tris(toluene-p-sulphonyl)diethylene triamine (2) 12 , 82 
To a stirred refluxing suspension of 12 (10g, 0.018 mole) in absolute ethanol (700 ml), 
freshly prepared sodium ethoxide (2.72g, 0.04 mole) was added in one go. The mixture was 
refluxed for 24h, after which the excess ethanol was removed by evaporation in vacuo to 
give an off-white sticky solid. This was stirred with dry ether and filtered to give the 
desired product 2 as a very fine crystalline solid (10.0g, 91%) (Found C, 49.03; H, 5.085 
Ný 6.64. Calc- forC25H29 N3Na2 
06 S3: C, 49.25; H, 4.79; N, 6.89%). This salt was used 
immediatelY in the preparation of 4. 
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1,4,7,10-Tetrakis-(p-toluenesulphonyl)-1,4,7,10-tetraazacyclododecane (4) 12 
To a stirred solution of 2 (10,0g, 0,016mole) in DM[F (200 ml) at 1000, a solution of the 
tosylated diol 3 (9.1g, 0,016 mole) in DMF (100 ml) was added drop wise over 2h. The 
solution was then cooled to room temperature at which point a large volume of water was 
added and the resultant white precipitate collected by fitration. This was dissolved in 
boiling benzene (900 ml), and the resultant solution washed well with water, dried 
(MgSOA filtered and the filtrate reduced in volume to approximately 100 ml before the 
addition of absolute ethanol (200 ml). The solution was allowed to stand overnight in a 
refigerator resulting in crystallisation of the desired macrocycle 4 as a white solid (2.7g, 
23%), m. p. 292-2930C (lit., " 2920C) (Found: C, 54.76; H, 5.66; N, 7.00. CaIc. forC36H44 
N4 )8 S4- C, 54.80; H, 5.62; N, 7.10%); 8H (90 Nfflz; CDC13) 2.35 (12H, s, Ar-CHA 3.32 
(16H, s, N-CHA 7.20 (8H, d, J9.0,2,6-ArH), 7.63 (8H, d, J9.0,3,5-Ar-H). 
N-(p-toluenesulphonyl)-bis-(2-iodoethyl)amine (13)" 
To a solution of 3 (5.0g, 0.082 mole) in acetone 150 ml) sodium iodide (3.3g, 0.022 mole) 
was added, and the mixture refluxed for 8h. Solid material was removed by filtration and 
the filtrate evaporated to give an oil which was dissolved in ethyl acetate (100 ml) and 
washed with brine (2x 100 ml), dried (MgSO, ), filtered and evaporated in vacuo to give 
a clear oil which immediately solidified on standing to give the bisiodo derivative 13 (3.5g, 
83%), 8H (200 MHz; CDC13) 2.42 (3H, s, Ar-CHA 3.27 (4H, t, J7.0, N-CH2), 3.50 (4H, 
t) 17.0ý I-CHA 7.33 (2H, d, J8.3,2,6-ArH), 7.69 (2H, d, J8.3,3,5-ArH); m/z 479 (M', 
3.9%), 352 (M' - 1,7%), 324 (M' - Ts, 2%), 155 (Ts, 62%), 91 (ArCH3,, 100%). 
1,4,7,10-Tetrakis-(toluene-p-sulphonyl)-1,4,7,10-tetraazacyclododecane (4) 
To a vigorously stirred refluxing mixture of tetra-n-butyl ammonium iodide (0.60g, 0.0016 
mole (25% mole)) in an aqueous solution of sodium hydroxide (5% w/v, 34 ml) and 
benzene (34 ml), a solution of the tritosylated ethylenediamine 12 (3.7g, 6.5 mmole) and 
the bisbromo derivative 13 (2.5g, 6.5 mmole) in benzene (194 ml) was added quickly 
through an addition funnel. The mixture was refluxed with stirring for 2 days after which 
it was allowed to cool, the benzene 
layer separated and the aqueous layer reextracted with 
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a single portion of benzene (50 ml), the combined organic phases was washed with water, 
dried (MgSO, ), filtered and evaporated to give a sticky residue which was triturated 
overnight with methanol and filtered to give the desired macrocycle 4 as a white powder 
(3.55g, 69.5%), m, p. 292-2930C (lit., " 292T) (Found: C, 54.89; H, 5.66; N, 7.00. Calc. for 
C36 H44 N4 08 S8: C, 54.80; H, 5.62; N, 7.10%); 8ff (90 MHz; CDC13) 2.42 (12H, s, 
ArCHA 3.40 (16H, s, N-CH. ), 7.26 (8H, d, J9.0,2,6-ArH), 7.64 (8H, d, J9.0,3,5-ArH); 
m/z FAB 789 (M+H). 
Bis-(2-iodoethyl)ether (14)'0 
Bis-(2-chloroethyl)ether (7.0g, 0.05 mole) and sodium iodide (I 6.5g, 0.11 mole) in acetone 
(50 ml) was refluxed for 24h and the inorganics filtered. The filtrate was evaporated and 
the residue dissolved in ether, washed with water then with a dilute solution of sodium 
thiosulphate (3M) to remove iodine. The ether phase was then dried (MgSOA, filtered, 
evaporated and the crude residue distilled at reduced pressure (123-124'C @ 10mm Hg) 
to give 14 as a colourless liquid (13.3g, 86%), (lit., 'O b. p. 123.5-124'C @ 10 mm Hg); 
8H 
(90 NlHz; CDC13) 3.23 (4H, t, J7.0, I-CHO, 3.45 (4H, t, J7.0, O-CH2); m/z 326 (NI', 
0.2%), 199 (M' - 1,0.5%), 171 
(M+ 
- 
CAL 12%), 155 (W - OCAL 32%), 155 (CAL 
100%). 
1,4,7-Tri-(p-toluenesulphonyl)-1,4,7-triaza-10-oxa-cyclododecane (15). 
To a vigorously stirred refluxing mixture of tetra-n-butyl ammonium iodide (0.19g, 0.5 
0 
mmole (25% mole)) in an aqueous solution of sodium hydroxide (5% w/v, II ml) in 
benzene (I I ml), a solution of the tritosylated ethylene diamine 12 (1.2g, 2 mmole) and 
bis-(2-iodoethyl)ether 14 (0.62g, 2 mmole) in benzene (70 ml) was added quickly through 
an addition funnel. The mixture was refluxed with stirring for 24h after which it was 
allowed to cool., the benzene layer separated and the aqueous layer reextracted with a single 
portion of benzene (50 ml), the combined organic phases was washed with water, dried 
(MgSOJý filtered and evaporated to give a sticky white residue which was triturated 
overnight with methanol and filtered to give the desired macrocycle 15 as a fine white solid 
(0.83g, 65%), m. p. 203-204T (lit., " 200-204T) (Found: C, 54.64; H, 5.81; N, 6.09. Calc. 
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for C., g 
H37N3 07 S3: C, 54.78; H, 5.86; N, 6.60%); 8.11 (90 MHz-, CDC13) 2.41 (9H, s, - 
CHA 3.16-3.68 (16H, m, N-CH2, O-CH20.2-7.82 (12H, m, ArH); m/z FAB 636 (M+H). 
N., N'-(p-toluenesulphonyl)ethylenediamine (16)'2 
To a cold vigorously stirred solution of ethylene diamine (3.0g, 0.05 mole) and sodium 
hydroxide (4.0g, 0.1 mole ) in water (30 ml), a solution of p-toluenesulphonyl chloride 
(I 9.7g, 0.1 mole) in ether (100 ml) was added drop wise over 2h, followed by an additional 
1h stirring. A white solid collected by filtration was purified by dissolving It in the 
minimum of hot DNff and precipitating the product by the addition of a large volume of 
water. The desired product 16 isolated as a white solid by filtration was washed well with 
water and dried (10.3g, 56%), m. p. 163-1640C (lit., 82 163-1640C); 5H (90 NMz; DMSO-d6) 
2.36 (6H, s, Ar-CHA2.77 (4H, s, N-CH2), 7.3 5 (4H, d, J8.0,2,6-ArH), 7.64 (4H, d, J8.0, 
3,5-ArH), 7.69 (2H, br s, NH); m/z 368 (M, 0.2%), 213 (M' - Ts, 11%), 155 (Ts, 100%). 
1,2-Bis-(2-iodoethoxy)ether (17)20 
A mixture of 1,2-bis-(2-chloroethoxy)ethane (20.0g, 0.11 mole) and sodium iodide (36.0g, 
0,24 mole) in acetone (100 ml) was refluxed with stirring for 48h. The solution was then 
filtered to remove inorganics, the filtrate evaporated and the residue dissolved in ether, this 
was then washed with water then with an aqueous solution of sodium thiosulphate to 
remove iodine, dried (MgSOA filtered and evaporated in vacuo to give a brown oil. This 
was distilled at reduced pressure (126T @ 0.5 mm Hg) to give the product 17 as a clear 
oil (25.5g, 63%), (lit., 
20 b. p. 126-1290C @ 0.5 mm Hg); 51, (90 MHz; CDC13) 3.21 (4H, t, 
X7.0., I-CH. ), 3.61 (4H, s, I-CH2CH2), 3.72 (4H, t, J7.0, O-CH. ); m/z 3 70 (M, 0.3 %), 199 
(W - OCH2CH21,18%), 155 (W - (OCH2CH2)21,100%)- 
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1,4-Di-(p-toluenesulphonyl)-1,4-diaza-7,10-dioxa-cyclododecane (18). 
To a vigorously stirred mixture of tetra-n-butyl ammonium iodide (0.37g, I mmole (25% 
mole)) in an aqueous solution of sodium hydroxide (5% w/v, 13.7 ml) in benzene (13.7 
ml), a solution of the tosylated ethylene diamine 16 (1.5g, 4 mmole) and 1,2-bis-(2- 
iodoethoxy)ethane 17 (1.5g, 4 mmole) in benzene (115 ml) was added quickly through an 
addition funnel. The mixture was refluxed for 24h, allowed to cool, the benzene layer 
separated and the aqueous phase reextracted with a single portion of benzene (50 ml), the 
combined organic phases washed with water, dried NOW, filtered and evaporated in 
vacuo to give a white sticky solid. This was triturated overnight with MeOH and filtered 
to give the ditosylated macrocycle 18 as white solid (1.5,65%), m. p, 224-226'C (lit., 85 220- 
2260C) (Found: C, 54.69; H, 6.19; N, 5.90. Calc. forC22H30 N2 06 S2: C, 54.75; H, 6.26; 
N, 5,80%); 5H (90 "ýMZ; CDC13) 2.41 (6H, s, ArCHA 3.25 (4H, m, N-CH. ), 3.50 (8H, s, 
N-CH2, O-C"2), 3.65 (4H, m, O-CH2); m/z FAB 483 (M+H). 
1,2-Bis-(2-iodoethoxy)benzene (19) 
To a solution of 1.2-bis-(2-0,0'-p-toluenesulphonylethoxy)benzene (2.0g, 3.9 MmOle) in 
acetone (100 ml), sodium iodide (1.48g, 9.88 mmole) was added and the mixture refluxed 
for 12h. The mixture was filtered and the filtrate evaporated in vacuo to give a dark brown 
residue which was dissolved in ether and then washed with water then with a dilute 
solution of sodium thiosulphate (3M) to remove iodine. The ether phase was then dried 
(MgS04),, filtered and the filtrate evaporated in vacuo to give an off-white solid (1.32g, 
. 
), 4.28 (4H, t, J7.0,0- 80%), m. p, 60-61'C; 5H (90 'ý'MZ; CDC13) 3.41 (4H, t, J7.0, I-CH2 
CHA 6.90 (4H, s, ArH); m/z 419 (M'+I, 3.9%), 418 (M+, 3 8%), 262 (Nl+ - C2H4', 48%), 
155 (CAL, 100%)* 
1,4-Di-(p-toluenesulphonyl)-1,4-diaza-7,10-dioxa-(8,9-benzene)-cyclododecane (20). 
To a vigorously stirred refluxing mixture of tetra-n-butyl ammonium Iodide 
(0.37g, I 
mmole (25% mole) in an aqueous solution of 
NaOH (5% w/v, 13.7 ml) in benzene (13.7 
ml), a solution of the tosylated ethylene 
diamine 16 (1.5g, 4 mmole) and 19 (1.67g, 4 
mmole) in benzene (115 ml) was added quickly 
through an addition funnel. The mixture 
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was refluxed for 24h, allowed to cool, the benzene layer separated and the aqueous phase 
reextracted with a single portion of benzene (50 ml), The combined organic phases was 
washed with water, dried (MgSO, ), filtered and evaporated in vacuo to give a sticky white 
solid. This was triturated overnight with MeOH, filtered and dried to give the macrocycle 
20 as a white solid (1.25g, 59%), m. p. 181-182T (Found: C, 58.77; H, 5.61 - N, 5.19. Calc. 
for C, H.,, N,, 0 C, 58.85; H, 5.69; N, 5.28%); 5 (90 Nfflz; CDC13) 2.40 (6H, CH -6 
S2: 
HA 
3.39-3.5 (8H, rn, N-CH2), 4.24 (4H, t5 A. 1, O-CH2), 6.83 (4H, s, ArH), 7.31 (4H, d, J8.4, 
Ts-2,6H), 7.68 (4H, d, J8.4, Ts-3,5H); m/z 531 (M+H). 
1,2-Bis(2-azidoethoxy)ethane (26)20,21 
1,2-Bis(2-chloroethoxy)ethane 25 (20.0 g, 0.107 mol) and sodium azide (13.9 g, 0.214 mol) 
in DMSO (100 ml) were reacted and worked up as for 41 to give the desired bisazide 26 
as a clear yellow oil (16.4 g, 77%), 2930-2880 (C-H), 21 10vs (N 1150 (C-0- A 
Q; 5H (90 MBZ; CDC13) 3.31 (4H, t, J5.0, N3-CH2), 3.50 (4H, s, N3-CHCH. ), 3.5 5 (4H, 
t, J5.0, O-CH2); m/z 200 (M, 2.3%), 116 (M' - 
3N3) 14.7%), 74 (116 - OCA, 63 %). 
1,8-Diamino-3,6-dioxooctane (27)20,21 
The reduction of 1,2-Bis(2-azidoethoxy)ethane 26 (10.0 g, 0.05 mol) with LAH (5.0 g, 0.13 
mol) to the corresponding bisamino compound 27 was carried out as for 42, to give the 
desired compound as a clear yellow oil (7.2 g, 97%); umaý, cm-' 3420,3340 (NH2), 3000, 
2920 (C-H), 1150 (C-0-C); 51, (90 XMz; CDC13) 1.70 (4H, br s, D20 exchangeable NH2). 
2.84 (4H, t, J5.0, N-CH2), 3.50 (4H, tý J5.0ý O-CH2), 3.61 (4H, s, N-CH2CH. ); mIz 147 
(M', 1.5%), 117 (M' - CH21'ýH2,65%), 87 (M'- OCH2CH2NH2,, 38 %), 44 (CH21ý-H21100%)- 
Diglycollic acid dichloride (24) 17 
To a stirred mixture Of PC15 (91.5,0.44 mole) in CHC13 (300 in]) at room temperature 
under nitrogen, diglycollic acid (26.8g, 0.2 mole) was added in small portions. This 
resulted in the formation of a slurry, however, the addition was continued over I hour. 
After addition of diglycollic acid the slurry was kept stirring overnight resulting in an 
almost clear solution being formed. The remaining insoluble material was removed 
by 
filtration, and the filtrate evaporated in vacuo to give the crude diglycollic acid dichlorlde 
as a dark oil, This was purified 
by fractional distillation (64'C @ 2.0 mm Hg), to give the 
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pure diacid chloride 24 as a clear oil (24.3 a, 71%), u cm-1 -2980-2900 (C-H), 18OOvs It) m ax 
(C-0), 1150 (C-0-C), 6H (90 MHz, CDC13) 4.65 (4H, s, O-CH, -CO). 
5,9-Dioxa- 1,7,13-trioxo-4,1 0-d iazacycl open tad ecane (28) 17 
To a 2L three-necked round-bottom flask equiped with a mechanical stirrer, toluene (800 
ml) was added and the flask and its contents cooled to 0-5'. Under a nitrogen atmosphere, 
the diarnine 27 (7.0g, 0.047 mole) and triethylamine (10.4g, 0.1 mole) in toluene (200 ml) 
(solution A) and the diglycollic acid dichloride 24 (8.2g, 0,048 mole) in toluene (200 ml) 
(solution B) were added dropwise simultaneously to the vigorously stirred toluene solution 
over a period of 8h. Once addition was complete, the resulting mixture was stirred at room 
temperature overnight and filtered to remove salts. The filtrate was evaporated to give a 
white sticky solid, this was taken up in chloroform/benzene (50: 50 v/v) and the resulting 
solution passed through a short column of neutral alumina eluting with the same solvent 
mixture. After evaporation of the solvent the macrocyclic diamide 28 was obtained as a 
white solid (6.3g, 54%), m. p. 149-150'C (lit., 17 149-150"C); u,,,,,, cm-' 3420 (NH), 1690s 
(C=O), 1115 (C-0); 81, (90 M14z; CDC13) 3.54 (8H, rn, N-CH2CH. -O), 3.62 (4H, s, 0- 
CH2CH2-0); 4,01 (4H, s, CO-CH2-0); 7.15 (2H, br s, NH); m/z 247 (M+I), 246 (M', 3%), 
216 N+ - "ýH2=: CH2,5%), 30 QýH2=CH21 100%)* 
1,7,13-Trioxo-4, I O-d iazacycl open tad ecan e (29)'7 
To a cooled suspension of lithium aluminium hydride (5,0g, 0.13 mole) in dry THF (200 
ml) under nitrogen, the diamide 28 (5.0g, 0.02 mole) was added portionwise in solid form 
over 30 minutes (vigorous reaction! ). After addition was complete the mixture was refluxed 
for l2h, allowed to cool when excess LAH was destroyed by the dropWise addition of 5% 
sodium hydroxide solution. The resulting white solid of hydroxide salts was 
filtered and 
the filtrate evaporated in vacuo to give an off-white solid. This was recrstallised 
from light 
petroleum ether, to give the title compound 29 as a white 
hygroscopic solid (3.6,82%), 
m. p. 89-900C (11t. '17 
89_900C); 5H (90 M"Z; CDC13) 2.30 (2H, br s, D., O exchangeable NH), 
2.76 (8H, t, J4.8, N-CH2), 3.53-3.66 (12H, m, O-CH2); m/z 217 (M" 2.3%), 173 (16.9%), 
150 (80%), 132 (89,7%), 83 (50.3%), 44 (26.9%), 18 (100%). 
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Ethyl- (1,7,13-trioxo-4,, 10- d iazacycl open tad ec an e)-NýN'- di acetate (30)21 
To trioxodiazacyclopentadecane 29 (1.0g, 4.6 mmole) in anhydrous acetonitrile (50 ml) was 
added sodium carbonate (5.0g, 0.046 mole) and ethy lbro mo acetate (1.7g, 0.01 mole) . 
The 
reaction mixture was refluxed under nitrogen for 18h, cooled and filtered. The filtrate was 
stripped of solvent to give 30 as its NaBr conplex. The title compound 30 was isolated 
from the resulting solid complex by bulb-to-bulb distillation (150' @ 10-' mmHg), giving 
30 as a clear oil (0.91g, 51%); u.,,., cm-' 3000-2940 (C-H), 1740s (C=O), 1190-1120 (C-0); 
8H (90 MHz; CDC13) 1.24 (6H, t, J7.1, -CHO, 2.93 (8H, m, N-CH2), 3.60 (16H, in, O-CH2. 
N-CR2-C02), 4.12 (4H, q, J7.2, m/z390(M', 12%), 359(M'-CH 21%), C02-CH2)5 30 
317 (M' - C02CH2CH3.100%), 303 (317 - 
CH2) 19%), 230 (303 - 
C02CH2CH3,8%), 216 
(230 - 
CH2ý 17.2%). 
1,7,13-trioxo-4,10-diazacyclopentadecane-NýN'-diacetic acid (2 1)20 
To ultra pure water (25 ml), the diester 30 (0.15g, 0.38 mmole) was added and the mixture 
refluxed for 16h. The water was evaporated under high vacuum and the resulting residue 
recrystallised from 80% ethanol to give the title diacid 21 as white crystals (77mg, 60%) 
(Found: C, 49.96; H, 8.05; N, 8.07. Calc. for C, 4H26N2 07: C, 50.29; H, 8.05; N, 8.07%); 
5H (90 MHz; D20/TSP) 3.57 (8H, m, N-CH. ), 3.81 (16H, m, N-CH2-CO2,, 
O-CH2); M/Z 
290 (W - C02,6%), 246 (W - 2CO2,32%), 44 
(C021,1 ()0%)' 
1,7-Dibenzyl-2,6-dioxo-4-oxa-1,7-diazaheptane (3 1). 
21 
A solution of benzylamine (19.3g, 0,18 mole) and triethylamine (18.2g, 0.18 mole) in 
benzene (100 ml) was slowly added to a stirred solution of diglycollic acid dichloride 24 
(13.0g, 0.076 mole) in benzene (100 ml). The temperature of the reaction was kept at 0-8' 
during the addition with the aid of an ice/water bath. After addition the reaction mixture 
was allowed to warm up to room temperature where it was kept for 2h, before being 
concentrated by evaporation. The residue was dissolved in chloroform 
(200 ml) and 
consecutively washed with 3M HCI (20 ml), IM NaOH 
(20 ml), and water (100 ml), The 
organic phase was dried (NaýSO, 
), filtered and evaporated in vacuo to give the crude 
product as an off-white solid. 
Recystallisation fron benzene gave pure 31 as a white 
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crstalline solid (I 3.9g, 51 %), m, p, 124-125T (lit, 21 124-125T); umaxcm" 3380 (NH), 1650s 
(C=O), 1560,1530,1465 (C=C), 1150 (C-0-C), 710 (NH); 8H (90 MHz, CDC13) 4.05 (4H, 
O-CH2-CO), 4.44 (4H, d, J5.9, PhCH2), 7.16 (2H, br s, NH), 7.24 (1 OH, s, PhH); m/z 
312 (M, 91.7%), 294 (30%), 205 (35.8%), 149 (38.6%), 106 (92.9), 91 (PhCH., 100%), 
1,7-Dibenzyl-4-oxo-1,7-diazaheptane (32)21 
A solution of 31 (10,0g, 0.028 mole) in dry TBIF (50 ml) was slowly added to a stirred 
slurry of lithium alurniniurn hydride (8.0g, 0.21 mole) in dry THF (200 ml) at 0'. After 
addition was complete, the reaction was stirred at reflux for 21h. The reaction was cooled 
to 0', and excess LAH destroyed by the consecutive addition of water (6 ml), 15% NaOH 
(6 ml), and water (18 ml). The white precipitate was removed by filtration, the filtrate 
evaporated in vacuo, and the residue dissolved in chloroform (200 ml), washed with brine 
(30 ml) and water (30 ml). The organic phase was dried (Na2SOJ, filtered and evaporated 
in vacuo to give 32 as a clear yellow oil (6.1g, 77%); u,,,, 
_, 
cm-' 3320 (NH), 2890s (C-H), 
1510,1450 (C=C), 1120s (C-0-C); 5H (90 MHz; CDC13) 1.83 (2H, br s, DO exchangeable 
NH), 2.75 (4H, t, J5.4, N-CHA 3.53 (4H, t, J5.4, O-CH2), 3.75 (4H, s, PhCH2), 7.23 
(I OH, s, PhH); m/z 284 (W, 2%), 193 (M' - PhCH2-, 18%), 91 (PhCH2.100%). 
N, N'-Dibenzyl-1,7,13-trioxo-4,10-diazacyclopentadecane (33)21 
A solution of 1,7-dibenzyl-4-oxa-1,7-diazaheptane 32 (4.3g, 0.015 mole), 1,2-bis-(2- 
iodoethoxy)ethane 17 (7.4g, 0.02 mole), sodium carbonate (10.6g, 0.1 mole) and sodium 
iodide (1.5g, 0.01 mole) in dry acetonitrile (400 ml) was heated at reflux under nitrogen 
for 24h, The reaction mixture was cooled, filtered to remove inorganics and evaporated. 
The residue was dissolved in chloroform (100 ml) and extracted with 6M HCI (2 x 50 ml). 
The combined aqueous phases were then adjusted to pH 8-10 With the addition of solid 
sodium carbonate, before being extracted with chloroform 
(2 x 100 ml). The combined 
organic phases was evaporated in vacuo to give a clear red/brown oil, which was punfied 
by column chromatography [neutral alumina: 
10% ethyl acetate/hexan es], to give the title 
compound 33 as a clear oil 
(3.9g, 65%); 5H (90 "ýVMZ; CDC13) 2.80 (8H, t, J5.6, N-C]ErA 
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3.53-3.67 (16H, m, O-CH2 and PhCH2), 7.24 (1 OH, s, PhH) -, m/z 399 (M-, 2.3 %), 307 (M- 
- PhCH., 14%), 176 (16%), 164 (32%), 91 (PhCH2,100%). 
1,7,13-Trioxa-4,10-diazacyclopentadecane (29) 
To a stirred solution of liquid ammonia (100 ml) kept at reflux at atmospheric pressure, dry 
THF (50 ml) was added followed by freshly cut sodium (4.14g, 0.18 mole). To this blue 
solution ,a solution of 33 
(3.0g, 7.54 mmole) in dry TFIF (50 ml) was added dropwise. 
Stirring was continued for a further 2h, after which the reaction was quenched by the 
addition of absolute EtOH (10 ml), The reaction mixture was left overnight at room 
temperature (to evaporate off the ammonia), and filtered to remove inorganic materials. The 
filtate was evaporated in vacuo and the residue dissolved in water (40 ml), extracted with 
CHC13 (2 x 50 ml). The combined organic extracts were dried (NaýSOJ and the solvent 
removed in vacuo to yield a red/brown oil. This was purified by bulb-to-bulb distillation 
(110-120' @ 10-' mmHg) to give 29 as a waxy solid (1.3g, 79%), m. p. 88-890C (lit. '17 
89- 
90 0 C); 8H (90 MHz; CDC13) 2.24 (2H, s, D20 exchangeable NH), 2.76 (8H, t, J4.8, N- 
CH2), 3.54-3.66 (12H, m, O-CH2)' 
3,6-Dioxa-4-(allyl)oxymethyl-1,8-octanedioic acid (36). 23 
To a solution of potassium t-butoxide (34.3 g, 0.036 mole) in t-butyl alcohol (230 ml) 
under a blanket of nitrogen was added 3 -(allyl)oxy- 1,2-propane diol (3.10 g, 0.076 mole). 
After stirring at room temperature for I h, a solution of chloroacetic acid (14.4 g, 0.152 
mol) in t-butyl alcohol (58 ml) was added dropWise over Ih at reflux. The mixture was 
stirred and refluxed for 18 h and the solvent removed in vacuo. 
The solid off-white residue 
obtained was dissolved in the minimum of water and the aqueous solution extracted with 
diethyl ether (2x 100 ml) and acidified with 6M hydrochloric acid. 
This was then extracted 
with ethyl acetate (5x 100 ml) saturating the aqueous 
layer with solid sodium chloride 
wi I between extractions. The combined organic extracts were washed th 
brine (100 ml), dried 
(MgS04) and the solvent removed in vacuo to give the title compound 
36 as a pale yellow 
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oil (13.0 g, 69% ), 811(90 Nffiz, CDCI 3) 3.5-4.7 (11H, m, OCH, ), 5.1-5.4 (2H, m, C= CH, ), 
5.6-6.1 (1H, m, CH=C), 11.2 (2H, s, COOH); vm., /cm-1 (film) 3700-2300 (COOH), 1760 
1130 (C-0). 
3,6-Dioxa-4-[(allyloxy)methyll-1.8-octanedioic acid dichloride (37). 23 
A solution of the diacid (7.0 g, 2.8 mol) in oxaly choride (35 ml) was refluxed with stirring 
under nitrogen for 1.5 hours, after which excess oxaly chloride was removed by 
0 evaporation to give 37 a light yellow oil (8.0 gý 100 /0); 5, (90 Nfflz; CDC13) 3.5-4.0 (1 IH, 
OCH2), 5.0- 5.6 (2H, m, C=CH2), 5.7-6.3 (1 H, m., CH=C); v .. a. 
/cm-1 (film) 1810 (C=O), 
1160 (C-0). This was used without further purification. 
2,13-Dioxa- 1,7,13-tri oxo- 15- [ (allyl o xy) meth yl 1 -4,10- d iazacycl open tade cane 
(38). 23 
Bi s- 1,2-(amino ethyl) ether 42 (1.56 g, 15 mmol) and triethyl amIne (4.13 g, 41 mmol) in 
toluene (100 ml) (Solution A), and the diacid dichloride 37 (4.28 g, 15 mmol) in toluene 
(100 ml) (Solution B), were added simultaneously to a vigorously-stirred toluene (500 ml) 
at 0-5'C over 8 hours under nitrogen. After the addition was complete, the mixture was 
stirred ovemight at room temperature. The mixture was filtered to remove insoluble 
material, and the filtrate evacuated in vacuo to give a light brown oil which was purified 
by column chromatography on neutral alumina with CHC13 as eluant to afford pure 38 as 
a colorless hygroscopic oil (1.9 g, 40%); 8H(90 TýMZ; CDC13) 3.1-4.6 (19H, m, O-CH2, N- 
CHA 5.1-5.4 (2H, m, C=CH2), 5.6-6.1 (IH, m, CH=C), 7.1 (2H, br s NH); vmýx/cm` (film) 
3422 (NH), 1685 (C=O), 1120 (C-0). 
2,13-Dioxa- 1,7,13-trioxo- 15-(hydroxymethyl)-4,1 0-diazacyclo pentad ecan e (39). 23 
To a solution of the (allyoxy)methyl diamide 38 (100 mg, 3.2xlO-' mmol) in a 1: 1 (v/v) 
mixture of water and ethanol (I ml) was added 5% Pd/C (9 mg) and perchloric acid 
(0.007 
ml). The mixture was heated with stirring at 80' 
for 24 hours, The catalyst was removed 
by filtration and the filtrate made basic by the addition of aqueous ammonium hydroxide. 
The solvent was removed in vacuo without 
heating (CARE! Perchlorates), to leave a sticky 
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oil. Purification by column chromatography [silica: 10% MeOH/CHCI_, ] gave the desired 
product 39 as a white hygroscopic solid (61 mg, 69%), m. p. I 10-111T (ht., " 110-11 I'C)5 
8H(90 MHz; CDC13) 2.9-4.5 (18H, m, O-CH, N-CH, ), 7.1 (2H, br s, NH); v,,,,, /cm-' (KBr) 
3400 (NH, OH), 1670 (C=0), 1125 (C-0). 
1,7,13-Trioxo-15-(hydroxymethyl)-4,10-diazacyclopentadecane (34 ). 23 
To a cooled suspension of lithium aluminium hydride (0,11 g, 2.79 mmol) in THF (2 ml) 
under nitrogen, a slurry of the hydroxmethyl diamide 39 (0.1 g, 3.64xl 0-4 mol) was added 
and the mixture was refluxed for 24 hours. After cooling, excess LAH was destroyed by 
the addition of 5% NaOH solution. Solid material was filtered and washed several times 
with hot TIHF, and the combined filtrate and washings evaporated in vacuo and the residue 
purified by column chromatography on neutral alumina with chloroform-ethanol (25: 1) to 
give the title compound 40 as an off-white hygroscopic solid (65 mg 73%), m. p. 47-490C 
(lit., 23 47-49'Q5 8H(90 ýMZ; CDC13) 2.4 (2H, br s, D20 exchangeable NH), 2.6-2.9 (8H, 
rn, NCH2), 3.2-4.0 (13H, m., OCH2); v.,,, /cm-' (film) 3310,3180 (NH, OH), 1112 (C-0); 
m/z 217 (Mý - CH20H, 22%), 180 (46.5%), 162 (100%), 100 (49.3%), 88 (65%), 85 
(58.5%), 83 (82%), 44 (43.5%). 
1,7,13- Trio xo- 15- (hyd roxymethyl)-4,10- d iazacycl open tadecane (34). 
A solution of the (allyloxy)methyl diaza-15-crown-5-diamide 38 (1.5 g, 4.8 mmol) in TFIF 
(40 ml) was slowly added to a stirred solution of LAH (6.1 g, 0.16 mol) at 0-5' under 
nitrogen. The mixture was refluxed for 36 hours after which tlc [silica: 10% MeOH/CHCI31 
showed the disappearance of starter. The mixture was allowed to cool and excess LAH 
quenched by the addition of water (5 ml), 3M NaOH (5 ml) and water (5 ml). Work-up as 
for 34 and chromatography using neutral alumina with chloroform- ethanol (25: 1) gave the 
desired product 34 as an off-white hygroscopic solid 0.8 g, 67%), ni. p. 47-49'C. Other 
physical properties were identical to those already reported. 
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Ethyl- (1,7,13-trioxo- 15- (hyd roxymethyl)-4,10-diazacy clo pen tadecane-NN; - diacetate 
(35). 
To a solution of hydroxymethyl-diaza- 15 -crown- 5 34 (0.08g, 0.32 mmole) in MeCN (16 
ml), anhydrous NaC03 (0.07g, 0.65 mmole) was added followed by ethy lbromo acetate 
(0.11 g, 0.65 mmole). The mixture was refluxed under nitrogen for 24h, allowed to coool 
to room temperature, filtered and the filtrate evaporated in vacuo to give 35 as its NaBr 
complex. The title compound was isolated from the resulting complex by bulb-to-bulb 
distillation (140'C @ 10-3 mmHg), giving 35 as a clear hygroscopic oil (83 mg, 59%) 
(Found: C, 53.13; H, 8.68; N, 6.52. Calc. for C19 H36N2 08 
. 
0.5H20: C, 52.92; H, 8.59; N, 
- CDC13) 1.25 (6H, t) J7.2, -CH A CH20H), 2.86- 6.58%); 5H (90 MHZ) 3), 2.17 (2H, s, H 
2.96 (8H, m, N-CH2), 3.45-3.89 (17H, m, N-CH2CO. 0-CH2), 4.1 (4H, q, J7.2, Co2CH2-); 
m/z FAB 421 (M+H). 
Bis-1,2-(azidoethyl)ether (41). " 
To a stirred solution of sodium azide (18.8 g, 0.28 mol) in DMSO (100 ml) at 90', b's-1,2- 
(chloroethyl)ether (20.0 g, 0.14 mol) was added dropWise under nitrogen. The mixture was 
refluxed at 90'C for 4 hours, allowed to cool before being added to a large volume of 
water. This was then extracted with diethyl ether (5x 100 ml), dried and evaporated in 
vacuo to give 41 as a clear yellow oil (18.8 g, 85%), v. aý, 
/cm-' (film) 2950-2890 (C-H), 
21OOvs (NA, 1120 (C-0-C); 5H (90 M1-1Z; CDC13) 3.36 (4H, t, J5.0, N3-CH2), 3.68 (4H, t, 
J5.0, O-CH2); m/z 157 (M+ + 1,0.96%), 72 (M+ - 3N2,8%), 44 (72 -C2H4,23.6%), 28 (72 
OCA, 54.5%). 
Bis-1,2-(aminoethyl)ether (42). 21 
To a cooled suspension of lithium aluminium hydride (7.2 g, 0.189 mol) in TBF (3 00 ml) 
under nitrogen, a solution of the bis azide 41 (10.0 g, 0.071 mol) in TBF (30 ml) was 
added dropwise over I hour (vigorous reaction! ). After addition the mixture was refluxed 
for a further 18 hours, allowed to cool when excess LAH was quenched 
by the addition 
of 5% NaOH. The resulting white solid, was 
filtered and the filtrate evaporated in vacuo 
1 -' (film) 3420- to give the title compound as an almost colourless oil 
(5.38 g, 73%); u,, a., crn 
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3340 (NH2), 2990-2920 (C-H), 1650 (N-H), 1150 (C-N); 6H (90 MHz, CDC13) 1,64 (4H, 
br s, D, O exchangeable NH, ), 2.84 (4H, t, J5.5, N-CH-,, ), 3.47 (4H, t, J5.5, O-CHA m/z 
103 (M+, 0.5%), 74 (M' - CH., NH 72.8%), 44 (CH, NH 100%). 
N-(butylacetamido)-ethylenediamine-N, NýN'-triacetate (sodium salt) (46). 
To a slurry of ethyl enediaminetetraaceti c acid dianhydride (2.0g, 7.81 mmole) in dry THF 
(40 ml), n-butylamine (0.57g, 7.81 mmole) was added and the reaction mixture stirred at 
room temperature under nitrogen for 24h. The solvent was removed in vacuo to give a 
white solid residue, which was dissolved in aqueous NaOH (0.94g, 0.024 mole) (15 ml), 
and extracted with diethyl. ether (2 x 15 ml). The aqueous layer was evaporated to give a 
sticky residue which was dried under high vacuum, and recrystallised from hot methanol 
to give the monobutylamide 46 as a white solid (2.6g, 79%), m. p. >300'C dec. (Found: C, 
40.40; H, 5.72; N, 10.05. CaIc. forC, 4H22N3Na3 07 H,, O: C, 40.49; H, 5.82; N, 10.11 %); 
5,, (20OMfIz; D20/TSP) 0.95 (3H, t, J7.3, CHA 1.34-1.49 (4H, m, -CH2-), 2.52 (1 H, s, 
N-CHA 2.69 (3H, s, N-C'12), 3.2 (1 OH, m, N-CH2CO); m/z FAB 414 (M + H). 
N, N'-bis-(butylacetamido)-ethylenediamine-NýN'-diacetate (sodium salt) (47). 
To a slurry of ethyl en edi amin etetraac eti c acid dianhydride (2.0g, 7.81 mmole) in dry THF 
(40 ml), n-butylamine (1.14g, 0.016 mole) was added and the reaction mixture stirred at 
room temperature under nitrogen for 24h. The work up was identical to that used for 46 
apart from the residue was dissolved in two equivalents of NaOH (0.63g, 0.016 mole) in 
water (15 ml). Recrystallisation from hot methanol gave the bis-butylamide 47 as a white 
solid (2.4g, 69%), m. p. 173-174'C (Found: C, 46.41; H, 7.2311-1 N, 11.85. Calc. for C,, 
H32 
N4Na2 06. H20: C, 46.55; H, 7.38; N, 12.06%); 
5H (200 MHz D20/TSP) 0.97 (6H, t, J7.3, 
CHA, 1.30-1.48 (8H, m, -CH2-), 2.7 (4H, s, 
N-CH2), 3.18 (4H, s, N-CH2CO), 3.2 3 (8 H, 
- m1z FAB 447 (M + H). m, N-CI12CO)., 5 
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1,10-Phenanthroline-2, 
ý9-dicarboxaldehyde (51)" 
To a solution of 2,9-dimethyl-1,10-phenanthrollne 50 (6.0g, 0.03 mole) In d'Oxan 
containing 4% water (200 ml) was added selenium dioxide (15. Og, 0.14 mole). The solution 
was heated under reflux for 4h and then filtered hot through celite. The crude dialdehyde 
53 separated from the cold filtrate as yellow crystals. Further purification was achieved by 
recrystallisation from TFIF/water to give 51 as an off-white crystalline solid (5.2g, 73%), 
m. p. 231-232'C (11t., 3 1 231-232'C); umax/cm-1 2853 (aldehydic C-H), 1709 (C=O), 1595, 
1552 (C=C), 869,815 (C-H); 81, (90 MHz; DMSO-d6) 8.17 (2H, s, 5,6H-phen), 8.26 (2H, 
d, J9,3,8H-phen), 8.82 (2H, d, J9,4,7H-phen), 10.31 (1 H, s, CHO); m/z 23 7 (M', 19%), 
236 (M' - 1,66%), 208 (236 - CO, 74%), 180 (208 - CO, 100%). 
1,10-Phenanthroline-2,9-dicarboxylic acid (48)" 
The dialdehyde 51 (0.5g, 2.1 mmole) was added to 80% nitric acid (10 ml) and the 
resulting solution heated under reflux for 3h. The solution was cooled, poured onto ice and 
the precipitated solid recrystallised from methanol and dried to give the diacid 48 as the 
mon ohydrate (0.30g, 55%), m. p. 237T dec. 
(Ilt., 3 ' 238'C dec. ); u,. /cm-' 3600-2800 
(0-); 5H (90 NMz; DMSO-d6) 8,20 (2H, s, 5,6H-phen), 8.40 (COOH), 1735 (C--: ý0), 880 
(2H, d, J8.3,3,8H-phen), 8.73 (2H, d, J8.3,4,7H-phen); m/z 224 (M' - C02,4%), 180 
(M' -2C02,55%), 44 (CO, 100%). 
2,9-Bis-(trichloromethyl)-1,10-phenanthroline (55)32 
To a solution of 2,9 -dim ethyl - 1,1 O-phenanthroline 50 (5.0g, 0.024 mole) in carbon 
tetrachloride (200 ml), N-chlorosuccinimide (19.2g, 0.144 mole) was added followed by 
a catalytic ammount of 3-chloroperoxybenzoic acid to initiate the reaction. The reaction 
was heated at reflux for 12h, cooled to room temperature when precipitated succinimide 
was filtered off and the filtrate concentrated in vacuo to give a yellow solid. The solid was 
dissolved in chloroform (150 ml), this was then washed with a saturated solution of 
NaýC03, dried (Na2SOA filtered and evaporated to give crude 55 a pale yellow solid. This 
was purified by column chromatography 
[silica gel: benzene/acetone (9: 1)] to give 55 as 
a white solid (8.57g, 
86%), m. p. 212-2140C (lit., 32 212-214'C); 8H (90 1ý11_'Z; CDC13)7.90 
180 
(2H, s, 5,6H-phen), 8,25 (2H, d, J8.6,3,8H-phen), 8.40 (2H, d, J8.6,4,7H-phen); m/z 414 
(M +' isotopic cluster), followed by a complex isotopic pattern in accord with the sequential 
loss of chlorines; 380 (M+ - Cl, isotopic cluster), 345 (380 - Cl, isotopic cluster), 308 (345 
- Cl, isotopic cluster), 273 (308 - Cl, isotopic cluster), 237 (273 - Cl, isotopic cluster). 
1,10-Phenanthroline-2,9-dicarboxylic acid (48)11,. 
12 
A solution of the hexachloride 55 (2.0g, 4.82 mmole) in 98% sulphuric acid (10 ml) was 
heated at 80-90T under nitrogen for 6h (evolution of HCI gas! ). The resulting dark-brown 
solution was allowed to cool to room temperature and the viscous solution was then slowly 
poured over crushed ice/water. The crude diacid 48 precipitated as an off-white solid, it 
was collected, washed well with cold water and recrystallised from hot water/TBF to give 
the desired pure diacid 48 as a creamy white solid ( 1.1 8g, 91 %), m. p. 23 8'C (lit., 31 238Q 
(Found: C, 58.55; H2 3.46; N, 9.82. Calc. for C14H8 N2 04 R20: C58.5 5; H 3.3 6; N 
9.82%); u.,, /cm-1 3600-2600 (COOH), 1720 (C=O), 1290-1200 (C-0), 870 (0-H); 81, (90 
MHz; DMSO-d6) 3.17 (S3, H20) 8.21 (2H, s, 5,6H-phen), 8.41 (2H, d, J8.4,3,8H-phen), 
8.74 (2H, d, J8.4,4,7H-phen); m/z 224 (M' - C02,7%), 180 (M' - 2CO2,52%), 44 (CO, 
100%). 
2,9-Bis(methoxycarbonyl)-1,10-phenanthroline (56)" 
A solution of 2,9-bi s(tri chlorom ethyl)- 1,1 0-phenantholine 55 (2.0g, 4.82 mmole) in conc. 
sulphuric acid (5 ml) was heated at 90' under nitrogen for 2h. During the course of the 
reaction HCI gas is liberated. After cooling the mixture (ice/water), methanol (5.0 ml) was 
cautiously added with rapid stirring, and the solution refluxed for a 
further 1h. The solution 
was cooled to room temperature, and poured over crushed 
ice. The precipitated solid was 
collected by filtration, washed several times with ice-cold water, then with cold methanol 
and dried. Recrystallisation from MeOH/CHC13gave 
56 as a white solid (I. I 8g, 83 %), m. p. 
213-214T (lit., 32 213-214'C); u,,. /cm-1 1730 (C=O), 1280 (C-0), 1020 (0-CH3); 
5H (90 
MHz; DMSO-d6) 4.01 (6H, S, C02CHO, 8.19 (2H, s, 5,6H-phen), 3.3 9 (2H, d, J8.3,3,8H- 
phen), 8.74 (2H, d, J8.3,4,7H-phen); m/z 
296 (M% 7%), 265 (M' - CH30,7%), 23 7 (Mý - 
COOCH3ý I oo%), 178 (M' - 2COOCH3)- 
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2,9-Bis(hydi-oxymethyl)-1,10-phenanthroline (57 )32 
To a stirred solution of the diester 56 (2.8g, 9.5 mmole) in absolute EtOH (300 ml), 
sodium borohydride (1.4g, 0.039 mole) was slowly added portionwise under nitrogen. The 
solution was refluxed for 3h, cooled, and concentrated in vacuo to give a solid which was 
stirred 'Mth water (100 ml), before being filtered to give a solid. This was recrystallised 
from water to give the dialcohol 57 as light yellow needles (1.82g, 79%), m. p. 197-198'C 
dec., (lit., 31 197-198'C dec. ) (Found C, 64.91; H, 5.22; N 10.64. Calc, forC14 
Iý HI, N,. H,, O: 
C) 65.10; H, 5.46; N, 10.84%); umaxem-' 3600-3100 (0-H), 1190 (0-H), 880 (C-0); 8H (90 
MHz; DMSO-d6) 3.2 (H20), 5.0 5 (4H, d, J7.1, CH2-OH), 5.69 (2H, t, OH), 7.95 (4H, m, 
3,8,5,6H-phen), 8.50 (2H, d, J8.6,4,7H-phen); m/z 240 (M', 17%), 239 (M' - 1,23%), 
223 (M' - OH, 100%), 209 (M' - CH30,25%), 194 (223 - COH, 94%). 
1,10-Phenanth ro line -1-oxide (59)", "' 
To a stirred solution of 1,1 0-phenanthroline 58 (4,7g, 0.026 mole) in glacial acetic acid (3 0 
ml), hydrogen peroxide (30% solution in water) (3 ml) was added and the temperature 
raised to 72'C were it was carefully maintained for 2.5h, after which an additional 
ammount of hydrogen peroxide (3 ml) was added. Heating at 72'C was continued for 3h, 
after which the mixture was allowed to cool when a final portion of hydrogen peroxide was 
added (2 ml), and the mixture kept at room temperature overnight. The solution was 
concentrated in vacuo to ; 05 ml, when water (45 ml) was added and evaporation 
continued to a volume of ; ýd 5 ml. To this remaining dark-brown oil, solid NaýC03 (;: zl25g) 
was added and the mass extracted with hot chloroform (Soxhlet ). The chloroform solution 
was stirred for Ih with decolourising charcoal and MgSO,, filtered and evaporated in vacuo 
to give 59 as an off-white solid which was recrstallised from chlorobenzene to give pure 
59 as needle-like crystals (2.9g, 57%), m. p. 181-182T (lit, 34 180-181T) (Found: C, 67.11; 
H7 4,60; N, 12,91, Calc- forC, 2H8N 20 
H20: C, 67,28; H, 4.70, N, 13.08%). 
2-Cyano-1,10-phenanthroline (6 
1)33 
A solution of 59 (0,98g, 5 mmole) and potassiun cyanide 
(1.0g, 0.015 mole) in water (20 
ml) was stirred at room temperature while 
benzoyl chloride (LO ml, 8.6 mmole) was added 
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dropwise over 10 minutes. The reaction mixture was stirred for a further 30 minutes and 
the precipitated solid collected by filtration, washed with water and dried to give a tan 
coloured solid, This was recrystallised from EtOH to give 61 as a light brown fluffy solid 
(0.52g, 54%), m. p. 238-2390C (I it. '33 237-2380C) (Found: C, 75.86; H, 3.45; N, 20.18. Calc. 
for C 
3H7N3: C, 76.09-, H, 3.41; N, 20.48%); UmaxCM-1 2230 (C=-=N), 8,4 (90 MHz, CDC13) 
7.60-7.75 (IH, m, 8H-phen), 7.85 (2H, d, J3.2,, 5,6H-phen), 7,91 (1H, d, J8,3H-phen), 
8.26 (IH, dd, JI. 7 and 4.4,7H-phen), 8.35 (IH, d, J8,4H-phen), 9.22 (IH, dd, A. 7 and 
4.4,9H-phen); m/z 205 (M', 100%). 
1,10-Phenanthroline-2-carboxylic acid (62)" 
To a solution of 61 (0.5g, 2.5 mmole) in absolute ethanol (10 ml), an aqueous solution Of 
sodium hydroxide (0.4g, 0,01 mole) (5 ml) was added and the mixture refluxed for 2h. The 
solution was cooled and acidified to pH -1 with the dropwise addition of conc. HCI, and 
the precipitated product isolated by filtration, washed well with cold ethanol and dried to 
to give 62 as the hydrochloride salt of the acid as a white solid (0.45g, 80%), m. p. 263- 
2650C (lit., " 262-2650C) *(Found: C, 57.20; H, 3.62; N, 10.25. CaIc. for C 13 H9 
N2 0. C' 
. 
0.70 H20: C, 57.12; H, 3,80; N, 10,25%); m/z 224 (MH+ (free acid), 17%), 180 (MIR 
C02-) 100%); 
* The characterisation as a hydrate is consistent with previous work" which report the 
hygroscopic nature of 1,10-phenanthroline-2-carboxylic acid. 
1,10-Phenanthroline-2,9-dicarbonyI chloride (63)87 
1,10-Phenanthroline-2,9-dicarboxylic acid 48 (0-6g, 2.2 mmole) In redistilled thlonyl 
chloride (15 ml) was refluxed with stirring under nitrogen until dissolution occurred, --2h. 
The clear yellow solution was evaporated in vacuo to give the diacid chloride 63 as a 
yellow solid (0.63g, 94%), m. p. 226-228'C 
dec. (lit., 87 227-2280C); i).. xcm-' 
1770 (C=O); 
5H (go MHz; CDC13 ) 8.02 (2H, s, 5,6H-phen), 8.39 (4H, s, 3,4,7,8H-phen); m/z 305 (M', 
jostopic cluster, 25%), 
178 (100%). This compound 63 was used without further 
purification. 
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1,10-Phenanthi-oline-2,9-bis(butylamide) (64) 
To a stirred solution of n-butylamine (0.38g, 51 mmole) in dry CHC13 (50 ml), asolution 
of 63 (0.4g, 1.3 mmole) in CHC13 (10 ml) was added dropwise and the reaction stirred at 
room temperature, under nitrogen for lh. The chloroform solution was washed with 
water, then with a saturated solution of NaC03, dried, (NaS04), evaporated in vacuo and 
the residue purified by column chromatography [silica gel: 5% MeOH/CHC131, to give the 
title compound 64 as an off-white solid (0.38g, 75%), m. p. 179-1800C (Found: C, 69.71; 
Hý 6.80; N, 14.76. Calc. for C22H26N4 022: C, 69,82; H, 6.92; N, 14,80%); 5H (90 MHz, 
CDC13) 0* 91 -1 * 
91 (14H, m, -(C'E'2)2-CH.. ), 3.60 (4H, m, N-CH2), 7.87 (2H, s, 5,6H-phen), 
8.32-8.61 (6H, rn, 3,4,7,8H-phen and NH); m/z 379 (M' + 1,16.2%), 378 (M', 59.5%), 
335 (M +-C Aý 100%), 279 (72%), 179 (77.9%). 
2-methyl-8-aminoquinofine (85) 
To a solution of 2-methyl-8-nitroquinoline (10.0 g, 0.053 mol) dissolved in boiling 
methanol (200 ml), hydrazine hydrate (15.9 g, 0.138 mol) was added followed by 10% 
Pd/C (200 mg). The mixture was refluxed for I hour or until effevescence had ceased, at 
which point a further amount of 10% Pd/C (200 mg) was added and the mixture refluxed. 
This procedure was repeated once more, to give a total reaction time of 3 hours. After hot 
filtration through celite, the solution was concentrated under reduced pressure and 3M 
hydrochloric acid (100 ml) added. The resulting orange precipitate was made basic by the 
addition of 3M NaOH with cooling to give a light-brown solid which was collected by 
filtration and washed well with water. The crude product was recrystallised from ligroin 
to give pure 85 as pale yellow crystals (8.0 g, 95%). m. p. 56-57'C; 5IJ90 MHz; CDC13) 
2,67 (3H, s, C113), 4.0-5.5 (2H, br s, D20exchangeable NH2), 6.7-8.0 (5H, m, 3,4,5,6,7H- 
quinoline); m/z 158 (M% 100%), 157 (M +-Iý 20%), 130 (M' - HCN, 17%). 
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4-H yd roxy-2,9-d im ethyl- 1,10- ph enan th roline (83). "' 
A mixture of 2-m ethyl -8-arn Inoquinoline 85 (4.0 g, 0,025 mol), ethyl acetoacetate (3.6 g, 
0.028 mol) and glacial acetic acid (0.6 ml) in benzene (60 ml) was refluxed using a Dean- 
Stark apparatus for 12 hours. Excess benzene was taken off and the resultant brown oil 
dried in vacuo to give the enamine 86 as a light-brown solid (6.7 g, 99%). This was used 
without further purification in the thermal cyclisation step. 
The enamine 86 (6.75 g, 0,025 mol) was added portion-wise to a solution of boiling 
diphenyl ether (240 g) at 2550C this was followed by an additional 30 minutes at reflux. 
The mixture was then allowed to cool resulting in some precipitation which was enhanced 
by the addition of a large volume of 100-120' Petroleum ether. The desired product was 
isolated by filtration as a dark-brown powder. At this point the product contained a large 
amount of diphenyl ether, this was subsequently removed by repeated washing of the solid 
with hot 100-1200 Petroleum ether to give the crude product as a light-brown solid. 
Recrystallisation from water gave the desired product 83 as the hydrate as a white solid 
(4.3 g, 77%), m. p. 237-2380C (11t., 
67 237-238T) (Found: C, 67.93; H, 5.73;, N, 11.27. Calc. 
for C, 
4H, 2N. . 
1.25H20: C, 68.14; H, 5.72; N, 11.35%); 8H (90 M14z; CDC13) 1.98 (H20)-) 
2.52 (3H, s, 9-CHA 2.76 (3H, s, 2-C"3), 6.30 (IH, s, 3H-phen), 7.31-7.49 (2H, dd, J8.9, 
6,8H-phen), 8.04-8.23 (2H, dd, J8.9,5,7H-phen), 9.81 (IH, br s, NH); m/z 224 (M', 
100%). 
4-(4-Brom obu tyl) oxy-2,9-d im ethyl- 1,1 O-ph en an th roline (87) 
To a solution of 4-Hydroxy-2,9-dimethyl-1,10-phenanthrollne 83 (0.25 g, 1.12 mmol) in 
acetonitrile (50 ml), caesium carbonate (1.1 g, 3.35 mmol) was added and the mixture 
stirred at room temperature before the addition of 1,4-dibromobutane (0.72 g, 3.3 5 mmol). 
The mixture was refluxed under nitrogen for 5 hours, cooled, filtered and the filtrate 
evaporated in vacuo to give a brown solid. The solid was taken up into chloroform and this 
was washed with water, dried (NaSO, ), and evaporated in vacuo. 
The residue was purified 
by column chromatography [silica gel: 
benzene/acetone (L 1)], to give the alkylated 
pherianthroline 87 as a white solid 
0.28 g (70%), m. p. 100-102'C dec. (Found: C, 55.74; 
HýI 5.55; N, 7.25. Calc. for C,, H19 N20 Br. 1.5H20: C, 55.97; H, 5.74; N, 7,25%); 5H (90 
185 
Mliz; CDCI 3) 1.73 (3H, H, 0), 2.15 (4H, m, CH2-C"-», 2.87 (3H, S, 9-CH3), 191 (3H, s, 
2-CH3), 3.54 (2H, t, J6, Br-CH2), 4.24 (2H, t, J6, O-CH2), 6.82 (IH, s, 3H-phen), 7.42- 
7.61, dd, J9.1, "6,8H-phen), 8.01-8,12 (2H, dd, J9, *5,7H-phen); m/z 360 (M + 2,4.8%), 
358 (M, 4.7%), 278 (M' - Br, 20%), 224 (278 - C4H6> 100%), 196 (224 - CO, 33%). 
* The absolute assignment of these signals are not possible without detailed nmr studies and 
have been based on previous work by Deady et. aL". Their assignment of the position of 
H5,7 as compared to H6,8 have been based on simple electronic arguments; (1) H5 as 
compared to H6 is closer to the electronegative oxygen and is therefore slightly more 
deshielded and (ii) positions 2,9,4,7-on the phenanthroline ring tend to be more deshielded 
as compared to positions 3,8. 
4-(Bromobutyl)oxy-2,9-bistrichoromethly-1,10-phenanthroline (88) 
To a refluXing solution of 4-(4-bromobutyl)oxy-2,9-dimethyl-1,10-phenanthroline 87 (0.4 
g, 1.11 mmol) in carbon tetrachloride, N-chlorosuccinimide (0.98 g, 7.3 3 mmol) was added 
followed by a catalytic ammount of 3-chloroperoxybenzoic acid as initiator. 'The solution 
turns a clear yellow immediately the initiator is added. The solution was refluxed for 5 
hours, after which it was allowed to cool to room temperature, resulting in the precipitation 
of succinimide which was removed by filtration. The filtrate was evaporated under reduced 
pressure to give a yellow solid. This was purified by column chromatography [silica: 
benzene/petroleum ether (6: 4)], to give the title 88 compound as a white solid (0.41 g, 
65%), m. p. 171-172T (Found: C, 38.38; H, 2.53; N, 4.86. Calc. for C, 8H13N2Br C16 0: 
C, 38.20; H, 2.32; N, 4.95%); 8H (90 M11Z; CDC13) 2.19 (4H, m, -CH2-CH2-), 3.52 (2H, 
m, Br-CH2), 4.37 (2H, m, O-CH2), 7.57 (IH, s, 3H-phen), 7.85 (IH, d, J7.0,8-phen), 8.33 
(3H, m, 5,6,7H-phen); m/z 566 (M', isotopic cluster, 1%), 530 (M' - Cl, isotopic cluster, 
5%), 485 (M' - Br, 1.9%), 450 (485 - Cl , isotopic cluster, 
1.7%), 395 (485 - CH6 and Cl, 
isotopic cluster, 1.4%), 359 (385 - Cl, isotopic cluster, 2.8%), 36 (Cl, 100%). 
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4-(4-bi-omobutyl)oxy-2-cai-boxylic acid-9-trichloi-omethyl-1,10-phenanthi-oline (89) 
To a stirred solution of concentrated sulphuric acid (1.0 ml) under nitrogen, the 
bis(trichloromethyl derivative 88 (0.3 g, 5.3xlO-' mol) was added portion-wise. After 
addition the temperature was raised to 90', where it was kept for I hour. On cooling, the 
dark solution was added drop-wise to crushed ice, resulting in copious preci II 'p'tat'on. The 
precipitate was collected by filtration and dissolved in CHC13which was then washed with 
water (2x), dried over anhydrous sodium sulphate, filtered, and the resultant filtrate 
evaporated in vacuo to give a mustard coloured powder (0.1 g, 50%), m. p. 1730C dec. 
(Found: C, 43.64; H, 2,85; N, 5.54. Calc. for C1, H, 4BrCl3N2 03: C, 43.89; H, 2.86; N, 
5.68%); u,,, a,, cm-' 
3 600-2900 (COOH), 173 0 (C=O), 1150 (C-O-C), 860 (OH); 8H (90 MHZ; 
CDC13) 2.22 (4H, m, -CH2CH2-), 3.48 (2H, m, Br-CH, -), 4.41 (2H, m, O-CH2-), 7.72 (1 H, 
s, 3H-phen), 7.89 (IH, d, J9.0,8H-phen), 8.32 (IH, d, J9.0,7H-phen), 8.47 (2H, s, 5,6H- 
phen); m/z 449 (M+ - C02ý 1.9%), 311 (449 - C4HqBr, 29%, isotopic cluster), 278 (311 -Cl, 
20.4%, isotopic cluster), 91 (100%), 44 (C02,42.5%) 
4-(4-bromobutyl)oxy-2,9-dicarboxylic acid- 1,10-phenanthroline (90). 
To an acetic acid/water (4: 1) mixture (50 ml) was added the bls(trlchloromethyl derivative 
89 (0.4 g, 0.7 mmol) and the mixture brought to reflux. At intervals of 1/2 hour, anhydrous 
sodium acetate (0.35 g, 4.24 mmol) was added in three equal portions. Hydrolysis was 
continued for a further 2 hours after which no front running material could be detected by 
tlc [silica: toluene/acetonitrile/formic acid (5.0/4.5/0.5)]. The solvent was removed by high 
vacuum and the residue recrystallised from water/TI-IF mixture to give a mustard coloured 
powder (80 mg, 27%), m. p. >250'C dec. (Found: C, 49.31; H, 3.68; N, 6.93. Calc. for C,, 
H15 Br N2 05. H20: C, 49.45;, H, 3,92; N, 6.91%); u,,,, cm-' 3600-2900 (COOH), 1720s 
(C=O), 1290-1220 (C-0), 1130 (C-0-C); 8H (90 MHz; DMSO-d6) 2.28 (4H, m, -CH2CH2), 
3.49 (2H, m, Br-CH, -), 4.3 8 (2H, m. O-CH. ), 8.21-8.3 6 (3H, m, 3,6,8-H-phen), 8.66 (2H, 
d, J8.4,5,7H-phen); m/z 331 (M' - 2CO2,44%), 251 (3 31 - Br, 12%), 44 (CO27 100%). 
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4-(Phenan th ridiniu rn)oxy-2,9-bis-t6chIo ro rn ethyl- 1,10- phen an th i-ofine (94). 
Phenanthridine (1.0g, 5.59 mmole) was heated to 115T in a pear-shaped flask, under 
nitrogen. To this melt the bis(trichloromethyl) derivative 88 (0,25g, 0.44 mmole) was added 
portionwise over 10 minutes. The reaction mixture immediately turns dark red/brown in 
colour and becomes very viscous and difficult to stir. The reaction was monitored by tlc 
[silica gel: benzene/ 40-60' Petroleum ether (6: 4)] and was complete after 3h, at which 
point it was allowed to cool to room temperature. The reaction mixture which had now set 
solid was dissolved in CHC13 (8 ml), and this solution was added dropwise to a stirred 
diethyl ether, precipitating the product as a pale yellow solid, This was collected by 
filtration and further purified by repeating the reprecipitation step with fresh solvents; the 
desired quaternised product 94 as an off-white solid (0.23,69%), m. p. 180'C dec. (Found: 
M'+H, 746.1625. C31 H23BrCl6N30 requires 746.1642); 51j (90 MHz; CDC13) 2.07 (4H, 
M, -CH2CH2-), 4.45 (2H, m, O-CHA 5.70 (2H, m, N-CH2), 7.53-8.67 (13H, m, 
3,4,5,6,7,8,9, IOH-phenanthridine and 3,5,6,7,8H-phenanthroline), 12.04 (IH, s, 2H- 
phenanthridine); m/z (FAB) 746 (M+H). 
2-Tribromomethyl-8-nitroquinoline (96)70 
To a solution of 2-methyl- 8 -nitro quinoline 84 (5.0 g, 0.027 mol) in glacial acetic acid (100 
ml), sodium acetate was added until a saturated solution was formed. To this stirred 
suspension, bromine (5 ml) in glacial acetic acid (35 ml) was added dropwise, after 
addition the mixture was refluxed for I hour, allowed to cool and then added to a large 
volume of ice/water with stirring. This results in the immediate precipitation of a solid, 
which is collected by filtration, washed well with water and dried to give the title 
compound as a yellow solid (10.6 g, 92%), m. p. 130-131' (lit., " 130-131T); 81, (90 MHz; 
CDC13) 7.7-8.11 (3H, m, 3,6,7H-quinofine), 8.31 (2H, s, 4,5H-quinofine); m/z 425 (M', 
1.85%), 378 (M' - 
N02) 1.2%), 355 (M' - Br, 100%), 265 (355 - Br, 58.5%). 
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2-Carboxylic acid-8-nitroquinoline (97 )70 
A slurry of the 2-tribromomethyl-8-nltroqulnollne 96 (7-0 g, 0.16 mol) In 20% sulphur1c 
acid solution (250 ml) was refluxed for 48 hours, or until very little suspended material 
remained. The dark red solution was then filtered and its pH adjusted to pH 3 by the 
addition of 3M NaOH solution. This results in the precipitation of a solid which is 
collected by filtration washed well with water and dried to give the title compound 97 as 
a light brown solid (1.5 g, 42%), m. p. 180-1820C (lit., 70 181-182"C); 8H (90 MHz; DMSO- 
d6) 7.90 (1H, d, J7.8,3H-quinoline), 8.35 (3H, m, 4,5,6H-quinoline), 8.76 (1H, d, J8.4, 
7H-quinoline); m/z 218 (Mý, 34.6%), 174 Q**ý C02,100%), 127 (174 - N02,36%), 44 
(13%, C02)- 
2-Carboxymethyl-8-nitroquinoline (98)' 
A slurry of the acid 97 (2.0 g, 9.17 mmol) in methanol (100 ml) was heated to reflux at 
which point concentrated sulphuric acid (1.0 ml) was added dropwise, resulting in instant 
solubilisation. Mixture was refluxed overnight, allowed to cool and excess MeOH 
evaporated under vacuum. The remaining residue was dissolved in DCM and washed well 
with sodium bicarbonate solution (2x), followed by water (Ix) and finally dried over 
sodium sulphate before filtration and evaporation to give the desired compound 98 as an 
off-white solid (1.65 g, 79%), m. p. 125-126T (lit., 70 125-126C); 8H (90 'VMZ; CDC13)4.02 
(3H, s, C02CHA 7.57-8.33 (5H, m, 3,4,5,6,7H-quinoline); m/z 232 (W, 19.1%), 202 
- CH30,49.3%), 174 (W - 
C02CH31,100%)) 127 (174 - N02,25.7%) 
2-Carboxymethyl-8-aminoquinoline (99)'o 
To a stirred solution of 2-carboxymethyl -8 -nitro quinoline 98 (2.0g, 8.6 mmole) in ethanol 
(100 ml) cyclohexene (4.2g, 0.052 mole) was added followed by 10% Pd/C (0.2g) and the 
solution brought to reflux under nitrogen. The mixture was refluxed for 24 hours with 
monitoring by tlc [silica: DCMJ5%EtOAc] during which time a further 0.2g portion of 
10%Pd/C was added. On the dissapearance of the starting material the mixture was filtered 
hot through celite and the filtrate run down to give the desired product 99 as a 
orange/yellow solid solid (1.67g, 98%), m. p. 
98-99'C (lit., 'o 97-99'C); 5H (90 Nfflz; CDC13) 
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4.0 (3 H, S, C02CHA 4.99 (2H, s, D., O exchangeable NH2), 6.86-7.38 (4H, m, 3,5,6,7B- 
quinoline), 8.08 (IH, s, 4H-quinoline)-, m/z 202 (M', 4,9%), 171 (M+ - CH30, 51%), 143 
0 (M+ - COXH35 
100/0)- 
4-Hydroxy-2,9-bis-(methoxycarbonyl)-1,10-phenanthroline (101). 
To a solution of 2 -carboxymethy 1 -8 -amino quInol in e, 99 (1.4g, 6.93 mmole)'n dry methanol 
dim ethyl acetyl enedi carboxylate (1.03g, 7.28 mmole) was added in one go and the mixture 
refluxed under nitrogen for 12 hours. Evaporation of the solvent under vacuum gave the 
enamine 100 as a bright yellow solid (2.4g, 100%). This was used without further 
purification in the thermal cyclisation. 
The enamine 100 (2.0g, 5.81 mmole) was added portionwise to a solution of refluxing 
diphenyl ether (150g) at 250T. After addition was complete the mixture was refluxed for 
a further 30 min., then allowed to cool to room temperature before the addition of a large 
volume of 60-80' Petroleum ether to precipitate the desired product as a fine light-brown 
powder. The product was collected by filtration and washed several times with hot 
petroleum ether to remove last traces of diphenyl ether and dried to give 101 a light-brown 
powder (1.08g, 60%). An analytically pure sample was obtained as the hydrate by 
recrytallisation from hot water, m. p. 2200C dec. (Found: C, 60.57; H, 3.81; N, 8.53. Calc. 
for C16HI2 N, 05 . 0.25H20: 
C, 60: 66; H, 8.82; N, 8,84%); uný,., cm-' 3350 (NH), 1760 
(C=O), 1690 (C=O), 1170 (C-0-C); 5H (90 MHz; CDCIJ 1.82 (H20), 4.0 8 (6H, s, 
C02CH3), 7.18 (IH, s, 3H-phen), 7.66 (IH, d, J9.0,8H-phen), 8.34 (2H, s, 5,6H-phen),, 
8.41 (IH, d, J9.0,7H-phen); m/z 313 (M+I, 13%), 312 (M+, 100%), 252 (NT' - 
C02CHA 
36%), 194 (253 - 
COSH33ý 17%). 
4-(5-1o d open tyl)oxy-2,9- bis- (m eth oxycarb onyl)- 1,1 O-phen an th roline (102). 
To a stirred solution of 101 (0.2g, 0.64 mmole) in benzene (50 ml), silver carbonate 
(0.088g, 0.32 mmole) was added followed by 1,5-dliodopentane (0.42g, 1.28 mmole). The 
reaction mixture which was protected 
from the light, was refluxed under nitrogen for 36h, 
whilst being monitored 
by tlc [neutral alumina: CHC'31, It was allowed to cool to room 
190 
temperature, filtered, the filtrate evaporated in vacuo to give a brown oil which was 
triturated overnight with 60-80 Petroleum Ether to give a light-brown solid. This was 
purified by column chromatography to give 102 as a light mustard coloured solid (92 mg, 
28%); UmaxCM-' 2990-2920 (CHA 1720 (C=O), 1280 (CO)5 1025 (0-CH3); 8H (90 ýVMZ; 
CDC13) 1.91 (6H, in, -CH2-), 2.06 (H20), 3.26 (2H, t, J6.8, I-CH2), 4.08 (3H, s, COXHA 
4.11 (3H, s, CO, CH. ), 4.3 5 (2H, m, O-CHA 7.78 (IH, s, 3H-phen), 7.92 (IH, d, J9.0,8- 
phen), 8.35 (IH, d, J9.0,7H-phen), 8.36 (2H, s, 5,6H-phen); m/z 380 (M' - 1,3.9%), 322 
(380 - 
C02CH3,60.5%), 263 (322 - 
C02CH3ý 8%), 44 (100%). 
4-(5-Phenanthridinium)oxy-2,9-bis-(methoxycarbonyl)-1,10-phenanthroline (103). 
Phenanthridine (0.18g, 0.98 mmole) was heated to 1150C in a pear-shaped flask, under 
nitrogen to melt it. To this melt 102 (0.05g, 9.8 x 10-5 mole) was added portionwise over 
5 minutes, the reaction mixture immediately turned a dark red/brown colour and became 
very viscous, The mixture was heated for lh and allowed to cool to room temperature. 
Once cold the reaction mixture set solid, this was stirred with benzene (10 ml) and filterd 
to give a light-brown solid; this procedure was repeated twice with fresh solvents to 
remove last traces of both phenanthridine and 103. Final purification was achieved by 
dissolving the crude material in CHC13 and adding the minimum volume of diethyl ether 
to slowly precipitate the desired quaternised material 103 as straw coloured microcrystals 
(12 mg, 15%), m. p. 2030C dec. (Found: M-1,560.6180. C34 H30 N3 05 requires M, 
560.6281); 5H (200 NMz; CDC13) 1.96 (6H, m, _CH2_), 2.14 (H20), 4.08 (6H, s,, C02CHA 
4.34 (2H, m, O-CHA 5,23 (2H, m, N-CH. ). 9.12-7.3 (13H, m, 3,4,5,6,7,8,9, l0H- 
phenanthridine and 3,5,6,7,8H-phenanthroline), 11.61 (IH, s, 2H-phenanthridine); m/z 
FAB 560 (M - 1). 
5-Nitro-2,9- dim ethyl- 1,1 O-phen an th roline (108). 
Neocuproine 50 (109,0.048 mole), was added portionwise to cold fuming sulphuric acid 
(45 ml) after which fuming nitric acid (50 ml) was added, and the solution heated at 140'C 
under nitrogen for 1 hr. The reaction mixture was then allowed to cool to room temperature 
and then poured over crushed ice/water 
(CARD). The resulting solution was then 
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neutralised to pH 6 by the addition of solid sodium carbonate and the yellow solid 
produced collected by filtration and purified by reprecipitation from 3M sulphuric acid 
solution by neutralising with NaOH, to give the desired nitrated product 109 as a mustard 
coloured solid (6.6g, 50%), m. p. 177-180T dec. (Found: C, 62,05; H, 4.59; N, 14.99. Calc. 
for C14H, I N, 02 HO: C, 61.99; H, 4.83; N, 15.48%); umaxcm-' 3500-2900 (OH), 1520 
(ArNO2), 1350 (ArN02-); 5H (90 M11z; CDCI 
2 -CH, 3), 2.9 8 (3 H, 3) 
2A 3 (H 0), 2.9 6 (3 H, s, 9 
s,, 2-CH. ), 7.57 (IH, d, J8.3,8H-phen), 7.65 (IH, d, J8.7,3H-Phen), 8.3 (IH, d, J8.3,7H- 
phen), 8.61 (IH, s, 6H-phen), 8.89 (IH, d, J8.7,4H-phen); m/z 253 (M', 39%), 223 (M' 
- NO, 7%), 207 (M' - N02,57%). 
2,9-Dimethyl-1,10-phenanthroline-5,6-dione (109). 
The combined aqueous filtrates from the nitration reaction was then extracted with 
chloroform and evaporated to give the crude dione 109 as a by-product of the nitration, 
This was purified by column chromatography [silica gel: 2% methanol/chloroform] to give 
the dione 109 as a bright yellow solid (1.8g, 16%), rn. p. 185-186OC; mcm-' 1690vs 
U 
ax 
(C=O), 1580vs, 1370vs, 1140s (C-CO-C); 8H (200 MHz, CDC13) 2.83 (6H, s, 2,9-ArCH3), 
7.43 (2H, d, J8.2,3,8H-phen), 8.3 8 (2H, d, J8.2,4,7H-phen), m/z 23 8 (M', 8.3 %), 210 
(M+ - CO, 100%). 
5-Nitro-2,9- bis-(trich I oro m ethyl)- 1,10- phen anth roline (110) 
The nitrophenanthroline 108 (2.0g, 7.9 mmole) was dissolved in carbon tetrachloride (150 
ml) With the aid of chloroform (20 ml), To this solution N-chlorosuccinimide (6.7g, 0.05 
mole) was added followed by a catalytic amount of 3-chloroperoxybenzoic acid to initiate 
the reaction, The mixture was refluxed for 24h, then cooled to room temperature, and 
filtered to remove solid succinimide. The filtrate was washed with several portions of 10% 
sodium carbonate solution, dried (Na. 2SOA filtered and evaporated to give the crude 
hexachlorinated product 110. This was purified by column chromatography [silica gel: 
chloroform] to give the title compound 
110 as a light-yellow solid (2.9g, 81%), m. p. 228- 
230T. Found: C, 36.37; H, 0.90; N, 8.88. Calc. forC, 4H5N2 C16: C, 36.56; H, 1,10; N, 
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9.14%); umaxcm-' 1510 (ArNO. ), 1330 (ArNO, ), 820-740 (C-CI); 5m (90 MHz; CDCl 3) 839 
(IH, d, J8.4,8H-phen), 8.44 (IH, d, J9.1,3H-phen), 8.58 (IH, d, J8A, 7H-phen), 8.78 
(IH, s, 6H-phen), 9.19 (IH, d, J9.1,4H-phen), m/z 459 (M', 5%), 424 Cl, 100%, 
isotopic cluster), 389 (M+ - 2CI, 20%, isotopic cluster), 354 (M+ - 3CI, 8%, isotopic 
cluster), 308 (354 - NO, 3%), 273 (308 - Cl, 2%, isotopic cluster), 237 (273 - Cl, 1.7%, 
isotopic cluster), 202 (237 - Cl, 1.4% , isotopic cluster). 
5-Nitro-1,10-phenanthroline-2,6-dicarboxylic acid (111) 
The hexachloride 112 (1.0g, 2.17 mmole) was added portionwise to 98% sulphuric acid (6 
ml), and the mixture heated at 80-90' under nitrogen for 6h. The dark-brown solution was 
allowed to cool after which the viscous solution was slowly poured over crushed ice/water 
resulting in the precipitation of the crude diacid 111 as a fine yellow solid. The precipitated 
solid was collected by filtration, washed with cold water and recrystallised from hot 
water/TBF to give the desired pure diacid 111 as a pale yellow solid (0.59g, 85%), m. p, 
218-220T. (Found: C, 50.77; H, 2.68; N, 12.42. Calc. forC14H7, N3 06 R20: C, 50,76; 
H) 2.74; N, 12.68%); u..., cm-' 3500-2900 (COOH), 1735 (C=O), 1540 (ArNO2), 1340 
(ArN02)5 ) 2.65 (H20), 8.44 (IH, d, J8.2,8H-phen), 1150 (C-0); 8H (90 MHz; DMSO-d6 
8,48 (IH, d, J8.8,3H-phen), 8.90 (IH, d, J8.2,7H-phen), 9.03 (IH, d, J8.8,4H-phen), 
9.13 (IH, s, 6H-phen); m/z 269 (M' -C02,42%), 225 (M- 2CO2,68%), 44(CO21,100%)- 
5-nitro-2,9-bis-(methoxycarbonyl)-1,10-phenanthroline (112) 
The hexachloride 110 (2.5g, 5.43 mmole) was added portionwise to 98% sulphuric acid (8 
ml), and the mixture heated at 80-90' for 6h. The mixture was then cooled in ice/water, 
then methanol (15 ml) was added with caution and the resulting mixture refluxed for a 
further 2h. After cooling, excess methanol was removed by evaporation and the residue 
neutralised to pH 6-7 by the addition of saturated aqueous sodium carbonate solution, 
resulting in precipitation, The crude product was collected 
by filtration, dried and 
recrystallised from methanol/chloroform to give the pure 
diester 112 as a white solid 
(1.59g, 86%), m. p. 258-260'C dec. (Found: C, 55.39; H, 3.19; N, 11.88. Calc. for C, 6H,, 
0.25H - C, 55.57; H, 3.21; N, 12.15%); u.,, cm-1 3500-3200 (0-H), 1730 (C=O), N3 06 20' 
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1540 (ArNO, ), 1340 (ArN02-), 1210 (C-0); 6H (90 MHz; CDCI 3) 3.12 (H, O), 4,13 (6H, 
CO, CH3), 8.57 (2H, s, 3,8H-phen), 8.59 (IH, d, J8.8,7H-phen), 8.77 (IH, s, 6H-phen), 
9.15 (IH, d, J8.8,4H-phen); m/z 341 (M, 2%), 311 (M' - NO, 7%), 283 (M- - COOCH35 
100%), 225 (M' - 2COOCH37 19%)- 
5-A min o-2,9- bis-(meth oxycarbonyl)- 1,10- phenanth roline (113) 
The nitro ester 112 (0.5g, 1.5 mmole) was mixed with methanol (50 ml) and refluxed to 
dissolve the solid starter. The resulting solution was allowed to cool before the addition of 
cyclohexene (0.72g, 8.8 mmole) and 10% palladium on carbon (; týO. Ig), and the mixture 
was heated at reflux under nitrogen for a further 2h. The mixture was filtered hot through 
celite, and the residue washed well with fresh hot methanol, the combined methanolic 
washings was then evaporated in vacuo to give the amino diester 113 as a bright yellow 
solid. Further purification by column chromatography [silica gel: I O%MeOH/CHC'31 gave 
113 in an analytically pure state (0.38g, 83%), m. p. 239-240'C. (Found: 58.06; H, 4.28; N, 
12.56. Calc. forC, 6HI3N3 04 R20: C, 5 8.3 1; H, 4.5 3; N, 12.76%); U .. , cm-1 
3320-3200 
(ArNH2), 1730 (C=O), 1510 (N-H), 1300 (C-N), 1150 (C-0); 51, (90 MHz; DMSO-d6)3.91 
(3H, S,, C02CHA 3.97 (3H, s, C02CHA 4.88 (4H, br s, D20 exchangeable, NH2, H20), 
7.00 (IH, s, 6H-phen), 8.16 (2H, s, 3,8-phen), 8.35 (IH, d, J8.8,4H-phen), 8.94 (IH, d, 
J8.8,8H-phen); m/z 311 (M, 6%), 253 (M' - COOCH3,43%), 195 (M' - 2COOCH3-, 
100%). 
5-(Bromohexanoylamino))-2,9-bis-(methoxycarbonyl)-1,10-phenanthroline (114). 
To a solution of 5-amino-2,9-bis-(methoxycarbonyl)-1,10-phenanthroline 113 (0.1g, 0.32 
mmole) and an excess of di i sopropyl ethyl amin e (50mg, 0,39 mmole) in anhydrous 
acetonitrile (10 ml) was added 6-bromohexanoyl cholride (60mg, 0.32 mmole). The 
reaction was stirred at room temperature under nitrogen for 2h, whilst 
being monitored by 
tlc [silica gel: 10%MeOWCHC131. The reaction mixture was quenched by the addition of 
water (10 rnl), and then extracted with 
C]F'C'3 (2 x 25 ml), the combined chloroform 
extracts was then washed with saturated 
NaHC03 solution (2 x 20 ml), and brine (2 x 20 
nil). The organic solution was then 
dried (Na2SO, ), filtered and evaporated in vacuo to give 
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a red/brown sticky oil. This was purified by column chromatography [silica (-),, rel-, 
5%MeOH/CHCI, ] to give the desired product 114 as a mustard coloured solid after 
trituration. wIth diethyl ether (100mg, 66%), m. p. 129-131T. (Found: C, 51.945 H, 4.64, 
N, 8.22; Br, 15.91. Calc. for C., H, N3 Br0, 
. 
H, 0: C, 5 2.18; H, 4.7 7, N, 8.3 0; B r, 
5 H) 00 
15.78%)- u .. aý, crn-' 
3460 (N-H, 03 0-2960 (C-H), 1750s (C=O), 1560 (NH, secondary 
amide), 1280s (C-0), 51, (200 MHz, CDC13) 2,0-1.6 (6H, m, -CH2-), 2.66 (2H, t, J7.3 5 
CO- 
CH2), 3.13 (2H, HO), 3.43 (2H, t, J6.7, Br-CH2), 4.02 (3H, s, COICH. ), 4.08 (3H, s, 
CO, CH, ), 7.75 (IH, d, J8.5,3H-phen), 7.95 (IH, s, 6H-phen), 8.1 (IH, d,, 18,5,8H-phen), 
8.30 (IH, d, J8.5,7H-phen), 8.34 (IH, d, J8.5,4H-phen), 9.49 (IH, s, DO exchangeable 
NH); m/z FAB 488 (M + H). 
5-(Hexanoylphen anth rid inium)-2,9- bis-(methoxycarbonyl)- Ij 0- phenanth roline(l 15). 
Phenanthridine (0.26g, 1,48 mmole) was heated to 115' in a pear-shaped flask, under 
nitrogen, to melt it. To this melt 114 (0.24g, 0.49 mmole) was added portionwise over 10 
minutes. The reaction mixture turned dark red/brown in colour and became very viscous. 
The reaction was monitored by tlc [silica gel: 15%MeOH/CHC'3] and was complete after 
2h, at which point it was allowed to cool to room temperature. Once cold the reaction 
mixture set solid, this was dissolved in chloroform (5 ml), and this solution was added 
dropWise to stirred diethyl ether, precipitating the product as a pale yellow solid. This was 
collected by filtration and further purified by repeating the reprecipitation step with fresh 
solvents; the desired quaternised product 115 being obtained as an off-white solid (250mg, 
73%). The best attempt at obtaining 115 in an analytically pure state was by 
recrystallisation. from hot water, however the recovered yield was always very poor 
(, -10%), m. p. 158T dec. (Found. - C, 61.45; H, 4.66; N, 8.23. Calc. 
for C34 H3, BrN4 05 
. 
H20: C, 61.32; H, 4.85; N, 8.17%); unýýcm-' 3500 (NH, OH), 1740s (C=O), 1630 (C=O, 
secondary amide); 8. (200 Nfflz; CDC13) 2.55-1.63 (6H, m, -CH2-), 2.9 (2H, m. 
CO-C". ). 
3.31 (2H, H20), 4.01 (6H, S. C02CHA 5.2 (2H, m, N'-CH. ), 9.35-7.4 (13H, m, 
3! 
04 ý 
5,, 6,7,8,9,1 OH-ph en an th ri dine and 3,4,6,7,8H-phenanthroline), 10.4 (IH, br s, D, O 
exchangeable N11t), 11.42 (IH, s, 2H-phenanthridine); m/z FAB 
587 (M - Br). 
195 
'N- (Hexan oyl phen an th ri din iu m)-2,9- bis-(carb oxyli c acid)- 1,10-phenan th i-oline (116). 
The quaternised dimethyl ester 116 (100mg, 015 mmole) was added to dst, lled water (10 
ml), the pH of which had been adjusted to ýtpH4 with dilute hydrobromic acid. The 
resulting mixture was then heated at 1000, whereupon the solid dissolved to give a pale 
yellow solution. The reaction was monitored by tlc [neutral alumina: 15%MeOH/CHC'31, 
and over time there was a gradual dissappearance of the starting material, and appearance 
of a baseline spot. The reaction appeared complete after 24h- the solution was now a deep 
yellow colour, With some brownish material around the inside of the flask. The solution 
was decanted off, frozen using an acetone/cardice bath, then freeze-dried on a high-vacuum 
pump, The desired probe 117 was isolated as a bright orange solid (47mg, 49%). Attemps 
to recrystallise this material have been unsuccessful, and chromatography by both normal 
and reverse phase systems have failed to give anything other than baseline spots, m. p. 
173'C dec. (Found: M-Br, 559.1973. C33H27N4 05 requires M, 559-1981); 6M (200 MHz; 
DMSO-d6) 1.62-2.18 (4H, m, -CH2CH2), 2.24 (2H, m, _CH2_), 4.01 (2H, m, CO-CH2), 5.18 
(2H, m, N+-CH2), 8,03-9.19 (13H, m, 3,4,5,6,7,8,9, IOH-phenanthridine and 3,4,5,7,8H- 
phenanthroline), 10.22 (IH, br s, CONH), 10.45 (IH, s, 2H-phenanthridine); m/z FAB 
559 (M - Br). 
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